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ABSTRACT
The glycerophosphoinositols are water-soluble, biologically active phospholipase 
A2  metabolites that are derived from phosphoinositides. The cellular concentrations of the 
glycerophosphoinositols have been shown to increase in hormone- and Ras-activated cells. 
Glycerophosphoinositol 4-phosphate (GroPIns4P) is the most active and well studied of 
the glycerophosphoinositols. When added exogenously, GroPIns4P can enter cells and 
affect various cellular functions, such as adenylyl cyclase (AC) activity (inhibition) and 
actin cytoskeleton organization (stimulation of ruffle and stress fibre formation). 
GroPIns4P acts at the level of the Racl and RhoA GTPases of the Rho family to form 
ruffle and stress fibres, and in addition, it increases the cytosolic fraction of GTP-bound 
Racl and favours its translocation to the plasma membrane.
In the present study, the mechanisms of action of the glycerophosphoinositols, with 
focus on GroPIns4P, have been characterized, with two potential mechanisms of action 
being revealed. On the one hand, GroPIns4P initiates a signal cascade that start from Src 
activation and leads to a phospholipase Cy-dependent increase in intracellular Ca2+ and the 
consequent activation of Ca2+/calmodulin kinase II (CaMKII); this kinase can, in turn, 
activate TIAM1, a specific exchange factor of Racl that is involved in Racl-dependent 
ruffle formation. On the other hand, GroPIns4P increases the binding between GDP-bound 
Racl and TIAM1 in pull-down assays and interacts with a protein complex that co- 
immunoprecipitates with TLAM1, and which also contains CaMKII. These data suggest 
that besides the signalling pathway initiate by Src, GroPIns4P can favour the formation of 
a large protein complex that could provide the machinery important for ruffle formation.
The other activities of GroPIns4P, such as AC inhibition and stress fibre formation, 
are not modulated by the same pathway as ruffle formation, thus suggesting that 
GroPIns4P is a multifunctional compound that is able to modulate different cellular 
functions by acting through multiple targets.
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CHAPTER 1
INTRODUCTION 
1.1 Aim of the study
The glycerophosphoinositols are natural, water-soluble, cell-permeable and 
biologically active compounds. Their formation has been linked to Ras activation and their 
activity involves many different cellular events. Glycerophosphoinositol 4-phosphate 
(GroPIns4P) is the most active and well studied of the glycerophosphoinositols, and it is 
able to modulate actin cytoskeleton organization. Actin filaments provide the basic 
infrastructure for the maintenance of cell morphology, which includes functions such as 
adhesion, motility, exocytosis, endocytosis and cell division. Alterations in actin 
polymerization, or actin remodelling, have a pivotal role in regulating the morphological 
and phenotypic events of a malignant cell. The aim of this study is to define the 
mechanisms of action of the glycerophosphoinositols in actin cytoskeleton organization, 
with this analysis focused on GroPIns4P, the most active and well characterized 
glycerophosphoinositol.
1.2 Function and modulation of the actin cytoskeleton
This section will provide a general background about the organization of the actin 
cytoskeleton, focusing on the process of actin polymerization for cell protrusion (formation 
of lamellipodia, ruffles and stress fibers). This will allow to better understand the 
mechanisms of action of glycerophosphoinositols on actin cytoskeleton organization.
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1.2.1 The cytoskeleton
The cytoskeleton contains a complex network of filamentous proteins that extends 
throughout the cytoplasm. It consists of an elaborate array of protein fibres that serve in 
functions such as establishing cell shape, providing mechanical strength, locomotion, 
chromosome separation in mitosis and meiosis, and intracellular transport of organelles. 
The cytoskeleton is made up of three kinds of protein filaments: microtubules, intermediate 
filaments and actin filaments (microfilaments) (Fig. 1.1).
Microtubules are straight, hollow cylinders with a diameter of about 25 nm; their 
length is variable, but they can grow up to 1 0 0 0 -times as long as they are thick. 
Microtubules are built by the assembly of heterodimers formed by a  and P tubulin that 
polymerize and form a spiral structure. This polymerization of tubulin dimers is powered 
by the hydrolysis of GTP and can occur at each end of the microtubule, even if it is more 
rapid at the plus end. The filaments can then shrink at each end by the release of tubulin 
dimers (depolymerization), which occurs more rapidly at the minus end (Hunter and 
Wordeman, 2000).
Microtubules participate in a wide variety of cell activities, most of which involve 
motion. This motion is provided by protein motors, like the kinesins, most of which move 
towards the plus ends of microtubules and the dyneins, which move toward the minus 
ends; in all cases the energy for movement is provided by ATP hydrolysis. The rapid 
transport of organelles, like vesicles and mitochondria, along the axons of neurons takes 
place along microtubules, with their plus ends pointed towards the end of the axon (Mallik 
and Gross, 2004).
The movement of chromosomes in mitosis and meiosis takes place along the 
microtubules that make up the spindle fibres. Both kinesins and dyneins are used as 
motors, and the spindle fibres arise from the microtubule organizing centre (MTOC). The 
MTOC in animal cells is the centrosome, which is located in the cytoplasm just outside the 
nucleus. Before mitosis, the centrosome duplicates and the two centrosomes move apart
14
a)
b)
c)
Figure 1.1 - Schematic representation of the structure of microtubules (a), 
intermediate filaments (b) and actin filaments (c) with the corresponding electro­
microscopy images.
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until they are on opposite sides of the nucleus (Dogterom et al., 2005). In addition to their 
role in spindle formation, centrosomes have other important roles in animal cells: as 
regulators of the correct signalling to proceed to S phase or cytokinesis. Each centrosome 
contains a pair of centrioles. The centrioles are built from a cylindrical array of nine 
microtubules, each of which has attached to it two partial microtubules. When a cell enters 
the cell cycle, and proceeds from Gi to S phase, each centriole is duplicated. The centrioles 
appear to be needed to organize the centrosome in which they are embedded, and are also 
needed to make cilia and flagella (Silflow and Lefebvre, 2001).
The intermediate filaments are cytoplasmic fibres that are an average of 10 nm in 
diameter, and thus they are "intermediate" in size between actin filaments ( 8  nm) and 
microtubules (25 nm). There are several types of intermediate filaments, each of which is 
constructed from one or more characteristic proteins. The keratins are found in epithelial 
cells and also form hair and nails; the nuclear lamins form a meshwork that stabilizes the 
inner membrane of the nuclear envelope; the neurofilaments strengthen the long axons of 
neurons; and the vimentins provide mechanical strength to muscle (and other) cells. 
Despite their chemical diversity, intermediate filaments have similar roles in the cell, 
which involves providing a supporting framework within the cell. For example, the nucleus 
in epithelial cells is held within the cell by a basket-like network of intermediate filaments 
made of keratins. Different kinds of epithelia use different keratins to build their 
intermediate filaments. Over 20 different kinds of keratins have been described, although 
each kind of epithelial cell may use no more than two of them. Up to 85% of the dry 
weight of squamous epithelial cells can consist of keratins (DePianto and Coulombe, 
2004).
Actin filaments are about 8  nm in diameter, and being the thinnest of the 
cytoskeletal filaments, they are also called microfilaments (in skeletal muscle fibres they 
are called "thin" filaments). Actin is the most abundant protein in the cytoplasm of 
mammalian cells, often amounting to 10 % to 20 % of the total cytoplasmic protein. Actin
16
filaments have many different functions in the cell: they form a layer just beneath the 
plasma membrane that provides mechanical strength to the cell, links transmembrane 
proteins (e.g. cell surface receptors) to cytoplasmic proteins, anchors the centrosomes at 
opposite poles of the cell during mitosis, and pinches dividing animal cells apart during 
cytokinesis. Moreover they can generate cytoplasmic streaming in some cells, generate 
locomotion in cells such as white blood cells and the amoeba, and interact with myosin 
("thick”) filaments in skeletal muscle fibres to provide the force of muscular contraction 
(Holmes et al., 1990).
Actin exists either as a globular monomer (called G-actin) or as a filament 
(designated F-actin). Different isoforms of G-actin can be found in cells: there are four a  
isoforms present in muscle cells, while the p and y isoforms are formed in non-muscle 
cells. They are characterised by the presence of two different lobes separated by a deep 
cleft, where the Mg2+/ATP complex is bound. F-actin has a polarity that is formed by the 
head-to-tail polymerization of asymmetric monomers. At the minus (pointed) end the ATP- 
binding cleft is exposed to the surrounding solution, and at the plus (barbed) end, the cleft 
is in contact with the neighbouring actin subunits (dos Remedios et al., 2003).
The first step in actin filament formation in vitro is called nucleation. In this low 
probability event, three actin monomers are believed to combine simultaneously, forming a 
thermodynamically unstable trimeric nucleus. Once a trimer is formed, this nucleus most 
frequently dissociates back into monomers. However, this nucleus occasionally survives 
long enough to permit the subsequent binding of additional actin molecules. As this 
elongation reaction proceeds in vitro, monomeric actin molecules (each containing ATP) 
are added one by one to both ends of the elongating nucleus, to form filaments. Monomer 
addition is more rapid at the plus end, and in the cell little or no monomer addition takes 
place at the minus end. After monomer incorporation into growing filaments, ATP-actin 
undergoes nucleotide hydrolysis to form ADP-actin subunits within the helical lattice of 
the filament. Once the actin filaments reach a steady-state length, ADP-actin monomers are
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released from the minus ends of the filaments at the same rate as new ATP-actin 
monomers are added to the plus ends (Carlier et al., 1987). There is a dynamic equilibrium 
between the monomeric pool (G-actin) and the filaments (F-actin), which depends on the 
different rates of polymerization at the pointed and barbed ends. Barbed ends elongate 5- 
10-times faster than pointed ends. The critical monomer concentration is 0.1 pM at the 
plus ends and 0.8 pM at the minus ends. When the concentration of actin monomers is 
between 0.1 and 0.8 pM, the plus ends elongate and the minus ends dissociate (steady 
state). This situation in which the net length of actin filament is constant is known as actin 
treadmilling (Korn et al., 1987).
In the cell, two additional issues are important: first, actin monomer addition occurs 
mostly, if  not exclusively, at the plus ends; and second, this process probably produces a 
pool of ADP-actin from which ATP-actin must be regenerated by exchange (not by direct 
phosphoryl transfer) with ATP in the cytoplasm. ATP-actin has a much higher affinity for 
the ends of actin filaments than ADP-actin does, and ATP-actin is the primary monomeric 
species of actin that adds to filament ends in the cell. Moreover, a multitude of actin 
binding proteins (ABPs) in the cell control the state of actin assembly and polymerisation 
events (dos Remedios et al., 2003).
1.2,1.1 A ctin binding proteins
In the cell, the transition between G-actin and F-actin is very closely regulated by 
numerous different proteins. They can act by sequestering actin monomers, by favouring 
actin nucleation, by linking the actin filaments to the membrane, and by determining the 
position and orientation of actin bundles.
The capping proteins bind at the ends of actin filaments. Depending on whether 
they bind at the plus or minus end, different capping proteins may stabilize the filament or 
promote its disassembly (Carlier and Pantaloni, 1994).
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Actin filaments may associate into bundles or networks via cross-linking proteins. 
Most cross-linking proteins are dimeric or have two actin-binding domains. Depending on 
the length of a cross-linking protein, or the distance between its actin-binding domains, 
actin filaments may be held close together in parallel bundles, or may be far enough apart 
to allow interactions with other proteins, such as myosin. Filamin is a V-shaped cross- 
linking protein; it causes actin filaments to associate in loose networks that give a gel-like 
consistency to some areas of the cytosol (Feng and Walsh, 2004). Spectrin is an actin- 
binding protein that forms an elongated tetrameric complex (Thomas, 2001). a-actinin is a 
bipolar linker that forms parallel bundles of actin filaments (Otey and Carpen, 2004).
The group of severing proteins contains ABPs that favour the dissociation of 
monomer from F-actin. Gelsolin functions in gel/sol transitions in the cytosol (Sun et al., 
1999). When activated by Ca2+, gelsolin severs an actin filament and caps the plus end, 
blocking filament regrowth. In the absence of Ca2+, gelsolin does not bind actin, as Ca2+ 
causes a conformational change in gelsolin that exposes one of its actin-binding site. Actin 
contributes a Glu carboxyl group to one of the two Ca2+-binding sites (Bryan and Kurth, 
1984; Yin and Stossel, 1980). Cofilm is a member of a family of proteins called actin- 
depolymerising factors (ADFs) (Bamburg, 1999). Cofilin binds along the sides of actin 
filaments and distorts the helical twist, and under some conditions, cofilin can sever actin 
filaments (McGough et al., 1997). Cofilin promotes dissociation of G-actin-ADP (as a 
complex with cofilin) from the minus ends of actin filaments. Cofilin binding to G-actin- 
ADP inhibits ADP/ATP exchange, inhibiting actin polymerization. Phosphorylation of 
cofilin causes it to dissociate from G-actin, which can then undergo ADP/ATP exchange 
and add to the plus ends of F-actin. In some cases, actin polymerization may be triggered 
by signalling cascades that lead to the phosphorylation of cofilin (Theriot, 1997). 
Thymosin fi4, is a small acidic peptide (5 kDa) that forms a 1:1 complex with G-actin, and 
it is proposed to “buffer” the concentration of free actin, by maintaining a pool of 
monomeric actin. An increase in the concentration of thymosin p4 can promote
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depolymerization of F-actin by lowering the concentration of free G-actin (Huff et al.,
2001). Profilin has a role in regulating actin polymerization. It forms a 1:1 complex with 
G-actin and binds at the plus end, on the opposite side to the nucleotide-binding cleft, 
altering the conformation of G-actin and making its nucleotide-binding site more open to 
the cytosol. This promotes ATP/ADP exchange (Goldschmidt-Clermont et al., 1992). 
Profilin binds to some membrane elements involved in cell-cell signalling, suggesting that 
they may be important in controlling actin assembly. It can bind to phosphatidylinositol 
4,5-bisphosphate (PI4,5P2) at the plasma membrane, through proline-rich sequences that 
are commonly found in membrane-associated signalling proteins (Vasp, Mena, etc....) 
(Lassing and Lindberg, 1985; Witke, 2004). These interactions allow the localization of 
profilin to the plasma membrane without inhibiting its binding to G-actin. Profilin also 
promotes the assembly of actin, acting as an ATP/ADP exchange factor. It increases the 
local concentration of G-actin-ATP, the form that is able to polymerize. Profilin is the only 
ABP that allows ATP/ADP exchange (Carlier and Pantaloni, 1994).
1.2.1.2. A ctin-n ucleation-prom oting factors
In vivo actin nucleation is dependent on the free barbed ends, which can arise by 
either de novo nucleation of filaments from a nucleation template, by uncapping of the 
barbed ends through the loss off the capping protein, or by severing of non-covalent bonds 
between monomers in filamentous actin, producing short filaments with free barbed ends.
The Arp2/2 complex is one of the major players for de novo synthesis of actin 
filaments. It is a conserved complex of seven polypeptides, two of which are actin-related 
proteins: Arp2 and Arp3. This complex is found in filament networks at Y-branches and in 
association with barbed ends at the leading edge of fixed cells. When is activated, it 
nucleates new actin filaments from the sides of existing filaments (Pollard and Beltzner,
2002). The exact mechanism by which the Arp2/3 complex nucleates actin is not
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completely understood. Two models of actin nucleation by the Arp2/3 complex have been 
proposed, each of which is supported by experimental evidence (Condeelis, 2001):
1) The dendritic nucleation model proposes that the nucleation activity of the Arp2/3 
complex to form a daughter filament is stimulated by binding to the sides of pre­
existing actin filaments (Fig. 1.2 ). The new filament will be shorter than the pre­
existing one (Pollard et al., 2000).
2) The protein barbed-end branching model proposes that the Arp2/3 complex binds 
to and branches free barbed ends, resulting in two new filaments with equal 
length (Fig. 1.2) (Pantaloni et al., 2000).
However actin nucleation can also start from:
3) Uncapping of barbed ends, through which Arp2/3 complex attaches and starts the 
polymerization (Barkalow et al., 1996);
4) Severing proteins, which create free barbed ends from pre-existing filaments. 
This is the case for the gelsolin Ca2+-dependent severing activity (McGough et 
al., 1997). Also, ADF/cofilin induces the detachment of G-monomers from actin 
filaments that have free barbed ends. Moreover, it increases the concentration of 
free G-actin, enhancing the polymerization rate (Ghosh et al., 2004).
In all of these cases the net result is the formation of a complex actin meshwork, 
with actin filaments that cross each other, typical of lamellipodial structures (Small et al.,
2002) (see Section 1.2.2).
The nucleation activity of Arp2/3 complex is regulated by multiple signalling 
pathways, through members of Wiskot-Aldrich-syndrome protein (WASP) family (Pollard 
and Borisy, 2003). There are at list six mammalian WASP family members, including 
WASP, N-WASP and four Scar/WAVEs. N-WASP can activate the Arp2/3 complex 
directly, and is recruited by Shigella and Vaccina viruses. Scar/WAVE is found in 
vertebrate cells and has been implicated in activating the Arp2/3 complex in lamellipodium 
formation; in fact, it localizes at their tips (Bompard and Caron, 2004).
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Figure 1.2 - Models of actin nucleation by the Arp2/3 complex. Left, the dendritic 
nucleation model proposes that the nucleation activity of the Arp2/3 complex to form 
a daughter filament (green) is stimulated by binding to the sides of pre-existing actin 
filaments (red). Right, the barbed-end branching model proposes that the Arp2/3 
complex binds to and branches free barbed ends, resulting in two new filaments 
(green). The initial stimulation of nucleation activity, by binding of a protein from the 
WASP family to the Arp2/3 complex at cell membrane, is common to both models. 
The stimulatory complex is formed following binding to a G-protein, GRB2 or other 
ligands to N-terminal domains of WASPs. This changes the WASP conformation and 
allows binding of the VCA domain to the Arp2/3 complex (Condeelis et al., 2001) .
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The initial stimulation of nucleation activity implies the binding of a protein from 
the WASP family to the Arp2/3 complex at the cell membrane. The stimulatory complex is 
formed following binding of a G-protein, or other ligand, to the N-terminal domains of 
WASPs. This changes the WASP conformation and allows binding of the verprolin- 
homology-cofilin-homology-acidic (VCA) domain to the Arp2/3 complex (Pollard and 
Borisy, 2003) (Fig. 1.3).
The signalling to actin at the leading edge of the lamellipodium implies that N- 
WASP is activated and targeted to the membrane. G-actin and the Arp2/3 complex bind 
the exposed COOH-terminal domain of N-WASP (VCA), forming a branching complex. 
Association of the branching complex with a filament leads to the formation of a branch, 
and the two branches grow at equal rates. N-WASP catalyzes several consecutive cycles of 
branching (Fig. 1.3) (see Section 1.2.2).
Ena/VASP (Vasodilator stimulating phosphoprotein) accumulates at the tip of 
lamellipodia and filopodia, corresponding to the sites of fast growing ends of actin 
filaments at the cell membrane. The amount of VASP recruited to the lamellipodium tips 
increased with the protrusion rate. More than a direct activator, this protein can function as 
a co-factor for actin nucleation (Pantaloni et al., 2001).
The Arp2/3 complex is not the nucleator of all actin filaments, as many cellular 
events that imply actin nucleation can occur also in the absence of this complex. At least 
some of these Arp2/3-independent structures are controlled by members of the forntin 
family of proteins. Formins are a family of highly conserved eukaryotic proteins 
implicated in a wide range of actin-based processes, including cell polarization, 
cytokinesis, hair cell stereocilia formation, sperm cell acrosome formation and embryonic 
development (Ridley, 1999; Wasserman, 1998; Zeller et al., 1999). A distinct class of 
formins, the Diaphanous-related formins (Drfs) has been defined on the basis of their 
ability to interact with the activated GTP-bound form of a Rho-type GTPase through an N-
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Figure 1.3 - Signalling to actin at the leading edge of the lamellipodium. N-WASP 
is activated and targeted to the membrane by signalling molecules (1). G-actin and the 
Arp2/3 complex bind the exposed COOH-terminal domain of N-WASP (VCA), 
forming a branching complex (2). Association of the branching complex with a 
fdament leads to the formation of a branch (3). The two branches grow at equal rates. 
N-WASP catalyzes several consecutive cycles of branching (Pantaloni et al., 2001).
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terminal Rho-binding domain (Evangelista et al., 1997; Habas et al., 2001; Imamura et al., 
1997; Kohno et al., 1996; Watanabe et al., 1997). These Drfs are regulated by auto­
inhibition through interaction between the diaphanous inhibitory domain (DID) and 
diaphanous auto-regulatory domain (DAD), and activated by Rho GTPase binding to 
GTPase-binding domains (GBD) (Alberts, 2001; Watanabe et al., 1999). This regulatory 
activity was originally characterized in mDial, a mammalian ortholog of Drosophila 
Diaphanous, which has been linked to actin filament assembly in both Drosophila and 
yeast (Watanabe et al., 1999), and a consensus DAD domain is a general feature of Drfs 
(Alberts, 2001). Some formins may be regulated by other signalling pathways or different 
mechanisms. The formins are able to nucleate actin bundles starting from the G- 
actin/profilin complex. The polymerisation occurs along the actin filament and the result is 
the formation of long and thin actin fibres that differ from the classical actin branching 
induced by the Arp2/3 complex (Fig. 1.4 a). For example in fibroblasts, mDial is required 
for Rho-dependent stress fibre formation (Nakano et al., 1999).
1.2.2. Assembling the actin cytoskeleton for cell attachment and movement
Cell migration is a critical component of many physiological and pathological 
events, including development, wound repair, angiogenesis and metastasis (Price et al., 
1997). In many cases, these events are mediated by cytokine, integrin and growth factor 
receptors that transmit a cascade of signals that are important for the regulation of the 
migration machinery (Keely et al., 1998). The driving force of cell movement is provided 
by the dynamic reorganization of actin cytoskeleton, directing protrusion at the front of the 
cell and retraction at the rear. The locomotory process for fibroblastic cells can be divided 
into essentially three independent sequential phases: (i) the polar extension of a leading 
lamella (lamellipodium) via the active motility of the anterior leading edge; (ii) the 
formation of anterior contacts with the underlying substrate (focal contacts); and (iii) the
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retraction of the trailing tail into the advancing cell body (Condeelis, 2001; Raftopoulou 
and Hall, 2004). The lamellipodium is characterised by the presence of a dense actin 
meshwork and fine bundles containing microfilaments. It contains extensively branched 
arrays of actin filaments, oriented with their plus (barbed) ends toward the plasma 
membrane. Actin monomers are incorporated at the membrane, bordering the front of 
lamellipodium; there, the actin treadmilling is active and the continuous nucleation pushes 
the cell forward (Small et al., 1998). Membrane ruffles are often found on the cell surface 
and at the advancing front of lamellipodium. They consist of dynamic fluctuating 
movements of the membrane (membrane curling), formed by continuous attachment and 
detachment of the membrane at the leading edge and characterised by accumulation of 
actin and vinculin as precursors of focal contacts (Rinnerthaler et al., 1988). Ruffles are 
believed to serve as sites of actin polymerisation, endocytosis (dorsal ruffles), receptor 
tyrosine kinase signalling, protease activation and receptor internalization (circular ruffles) 
(Lauffenburger and Horwitz, 1996). Filopodia or microspikes are another characteristic 
feature that can be found at the front of a moving cell. These consist of long, thin and 
transient processes that extend out from the cell surface. Bundles of parallel actin 
filaments, oriented with their plus ends towards the filopodial tip, are cross-linked within 
filopodia by the small actin-binding protein fascin (Small et al., 2002). Stress fibres form 
when a cell makes stable connections to a substrate. Bundles of crosslinked actin filaments 
extend from the cell surface through the cytosol. In a spreading fibroblast, the ventral stress 
fibres are commonly extended from an anchoring site (focal adhesion) close to the cell 
edge, to one with a perinuclear location. Actin filaments, the plus ends of which are 
oriented towards the cell surface on opposite sides of the cell, can overlap in more interior 
regions of a cell, in antiparallel arrays (Small et al., 1998). Myosin mediates sliding of 
antiparallel actin filaments during contraction of stress fibres. a-Actinin can cross-link 
actin filaments within stress fibres, as well as within lamellipodia (Defilippi et al., 1999) 
(Fig. 1.4b).
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Figure 1.4 - Ultra-structure of Actin at the level of Lamellipodia and stress fibre.
a) The branched actin networks found in fibroblast lamellipodia (A) and actin bundles 
in a bristle of Drosophila melanogaster (B) (bar, 0.1 pm); a schematic diagram 
showing branched (C) and unbranched (D) actin filaments. The Arp2/3 complex 
(green) crosslinks and stabilises branched filaments, whereas tropomyosin (purple) 
stabilises unbranched filaments (from Evangelista et al., 2003).
b) Schematic representation of the actin structures at the level of lamellipodia, 
filopodia end stress fibres in a moving cell.
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New focal adhesions are formed within and at the base of the lamellipodium, 
probably from pre-existing focal contacts. These sites, which undergo localized actin 
bundling, are favourable templates for stress fibre formation (Small et al., 1998).
Many different signalling molecules have been implicated in actin remodelling, 
including MAPK (mitogen activated protein kinase) cascades, lipid kinases, 
phospholipases, Ser/Thr and Tyr kinases and scaffold proteins. However, a specific family 
of proteins plays a pivotal role in regulating this pathway, favouring one morphological 
feature versus another: the Rho family of GTPases.
1.2.3. The Rho family of GTPases.
Small GTP-binding proteins (G-proteins) are monomeric proteins with molecular 
masses of 20-30 kDa, which are grouped into the Ras superfamily. The Ha-Ras and Ki-Ras 
genes were first discovered as the v-Ha-Ras and v-Ki-Ras oncogenes of sarcoma viruses 
(Kirsten and Harvey sarcoma) in around 1980 (Chien et al., 1979; Shih et al., 1978). The 
cellular oncogenes were then identified in humans and their mutations were found in some 
human carcinomas (Hall et al., 1983). Now, more than 100 small G-proteins have been 
identified in eukaryotes from yeast to humans and classified within the Ras superfamily 
(Takai et al., 2001). The members of this superfamily are structurally classified into five 
families: the Ras, Rho, Rab, Sarl/Arf and Ran families. The functions of many small G- 
proteins have been elucidated: the Ras subfamily members (Ras proteins) of the Ras family 
mainly regulate gene expression; the Rho/Rac/Cdc42 subfamily members (Rho/Rac/Cdc42 
proteins) of the Rho family regulate both cytoskeletal reorganization and gene expression; 
the Rab and Sarl/Arf family members (Rab and Sarl/Arf proteins) regulate intracellular 
vesicle trafficking; and the Ran family members (Ran proteins) regulate nucleo- 
cytoplasmic transport during Gl, S, and G2 phases of the cell cycle and microtubule 
organization during the M phase (Takai et al., 2001).
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These small G-proteins act as molecular switches, cycling between the GDP- and 
GTP-bound forms. When bound to GDP, they are inactive and when bound to GTP they 
undergo conformational changes that favour their interaction with downstream effectors. 
The GTP-bound form is converted by the action of the intrinsic GTPase activity to the 
GDP-bound form, which then releases the bound downstream effector.
The rate-limiting step of the GDP/GTP exchange reaction is the dissociation of 
GDP from the GDP-bound form. This reaction is extremely slow and therefore stimulated 
by a guanine nucleotide exchange factors (GEFs). A GEF first interacts with the GDP- 
bound protein and releases bound GDP, to form a binary complex of a small G-protein and 
the GEF. Then, the GEF in this complex is replaced by GTP to form the GTP-bound form. 
The GEFs are specific for each small G protein. Rho/Rac/Cdc42 and Rab proteins are also 
regulated by another type of factor, the Rho GDP dissociation inhibitors (GDIs) and Rab 
GDI, respectively. This regulator inhibits both the basal and GEF-stimulated dissociation 
of GDP by sequestering the GDP-bound form in the cytoplasm. The intrinsic GTP 
hydrolysis of the small GTPases is very slow and is enhanced by GTPase-activating 
proteins (GAPs). Most GAPs, such as Ras GAP and Rab3 GAP, are specific for each 
member or subfamily of small G-proteins, but some GAPs, such as p i90, a GAP active on 
Rho/Rac/Cdc42 proteins, show a wider substrate specificity (Fig. 1.5) (Takai et al., 2001).
The major players in actin cytoskeleton modification are the small GTPase of the 
Rho family. When activated, they have a pivotal role in the regulation of actin cytoskeleton 
dynamics, gene transcription, cell-cycle progression and membrane trafficking (Kaibuchi, 
1999). The mammalian Rho GTPases can be grouped into six different classes, consisting 
of the following members: Rho (RhoA, RhoB, RhoC), Rac (Racl, Rac2, Rac3, RhoG), 
Cdc42 (Cdc42Hs, G25K, TC10), Rnd (RhoE/ Rnd3, Rndl/Rho6 , Rnd2/Rho7), RhoD, and 
TTF (Aspenstrom, 1999). The structure of Rho GTPases is widely conserved and 
comprises both invariant regions, which do not change their position and conformation 
whatever the nature of the bound guanine nucleotide, and two variable regions, which
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Figure 1.5 - The Rho GTPase cycle. Rho GTPases cycle between an active (GTP- 
bound) and an inactive (GDP-bound) conformation. In the active state, they interact 
with one of over 60 target proteins (effectors). The cycle is highly regulated by three 
classes of protein: in mammalian cells, around 60 guanine nucleotide exchange factors 
(GEFs) catalyse nucleotide exchange and mediate activation; more than 70 GTPase- 
activating proteins (GAPs) stimulate GTP hydrolysis, leading to inactivation; and four 
guanine nucleotide exchange inhibitors (GDIs) extract the inactive GTPase from 
membranes.
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undergo structural changes upon GTP/GDP binding and that are called switch I (residues 
40-51) and switch II (residues 68-81) (Paduch et al., 2001). Moreover, they undergo 
posttranslational modifications in the C-terminal region that are important for their 
intracellular localization. Rho GTPases are synthesized as cytosolic proteins, but they have 
the capacity to associate with membranes through their C-terminal CAAX motif that is 
prenylated and the polybasic region immediately upstream of this CAAX motif (Dvorsky 
and Ahmadian, 2004). Unlike the Ras proteins, the prenylated Rho proteins can be 
sequestered in the cytosol by their interaction with RhoGDI, and the capacity to cycle on 
and off the membranes conferred by this interaction is believed to be integral to their 
biological activity (Schmidt and Hall, 2002; Zheng, 2001).
The activation of small GTPases of the Rho family implies their translocation to the 
plasma membrane, and this event is strictly related to their dissociation from GDIs. Once at 
the membrane, the Rho GTPases can interact with the GEFs and exchange GDP for GTP. 
The GAPs then allow GTP hydrolysis and favour the inactivation of these GTPases (Moon 
and Zheng, 2003)(Fig. 1.5).
Racl, RhoA and Cdc42 are the most studied GTPase of the Rho family. They are 
responsible for the formation of filopodia (Cdc42), lamellipodia with the corresponding 
focal contacts and ruffles (Racl), and stress fibres and focal adhesions (Rho) (Ridley and 
Hall, 1992; Ridley et al., 1992). Their activation can be hierarchical such that Cdc42 
activates Racl that activates RhoA, but this is not a common feature; down regulation of 
one G-protein upon the activation of another can also occur (Nobes and Hall, 1995). This 
feature is important during cell migration, when the three G-proteins are involved in 
different functions.
Racl is required at the cell edge to regulate actin polymerization and membrane 
protrusion. For efficient cell migration, this activity would be expected to be spatially 
restricted; in fact, a gradient of active Racl can be visualized in migrating fibroblasts with 
the highest concentrations at the leading edge (Kraynov et al., 2000). RhoA, on the other
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hand, is believed to regulate the contraction and retraction forces required in the cell body 
and at the rear, and would be expected to follow an inverse distribution with respect to 
Racl, even though this has not yet been directly demonstrated. Cdc42 is also important in 
cell migration because it establishes cell polarity. Inhibition of Cdc42 in cells at a wound 
edge cause a complete loss of polarity; cells protrude lamellipodia from all around their 
periphery, irrespective of whether there are cell-cell contacts. In addition, the Golgi 
apparatus reorientation to the anterior side of the nucleus, which is important to establish 
the direction of cell movement, does not occur (Mellor, 2004; Nobes and Hall, 1999).
1.2.3.1 Signalling upstream o f the Rho family GTPases
The activation of the Rho family GTPases originates from complex signalling 
events that start at the level of the plasma membrane. Tyrosine kinase receptors (RTKs) 
like growth factor receptors (for platelet-derived growth factor-PDGF-, epidermal growth 
factor-EGF-, hepatic growth factor-HGF-, etc...), integrin related receptors, and also G- 
protein coupled receptors (GPCR) (like LPA receptors) have been shown to initiate a 
signal cascade that leads to Rho GTPase activation. The exact mechanisms by which the 
receptors signal to the Rho GEF and then to the Rho proteins in mammalian cells are 
poorly understood. However, studies on two GEFs, p i 15 RhoGEF and Sos, have produced 
two examples for how such links can be organized. It has been shown that the LPA 
activates RhoA to induce the assembly of focal contacts and stress fibres (Tapon and Hall,
1997). This pathway is mediated by the LPA-dependent activation of a Gn heterotrimeric 
G-protein, which can directly interact with pll5RhoGEF (it contains an RGS domain, a 
regulator of G-protein signalling). This event can favour the activation of RhoA by this 
GEF (Gohla et al., 1998).
A model for Racl activation by RTKs relies on the fact that the activation of 
PDGF or insulin receptors leads to Ras activation by the Ras GEF domain of Sos. The
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activated Ras can, in turn, trigger phosphoinositide 3-kinases (PI3K) to produce 3 
phosphorylated phosphoinositides (see Section 1.4.1) which, by interacting with the 
pleckstrin homology (PH) domain (see Section 1.4.1.1) of Sos, unmask the Dbl-homology 
(DH) domain and render Sos into a functional Racl GEF. In addition to a Ras GEF at the 
C-terminus, Sos contains a Rho GEF domain DH in its N-terminus that has a GDP/GTP 
exchange activity specific for Rac. Besides Sos, many different GEFs exist and the 
pathway described above cannot explain their involvement in Rho GTPase activation. 
PI3K appears to have an important role though the formation of phosphatidylinositol (PI) 
3,4,5,trisphosphate (PI3 ,4 ,5 P3 ) (see Section 1.4.1), which participates in the localization of 
many different GEFs at the plasma membrane. Each GEF has the ability to regulate 
distinct signalling pathways downstream of the Rho GTPases, thus directing their signal to 
a specific effector. For example the co-expression of GEFs such as TIAM1 (see section 
1.2.3.2), Dbl (human oncogene from a diffuse B-cell lymphoma) (Eva and Aaronson, 
1985), or FGD1 (the Cdc42 GEF responsible for Faciogenital Dysplasia ) (Pasteris et al.,
1994) with either Racl or Cdc42 showed that TIAM1 and Dbl can activate the kinase 
activity of p21-activated protein kinase 1 ( PAK1) (Lim et al., 1996) but not that of c-Jun 
N-terminal kinase (JNK) (Hibi et al., 1993) whereas FGD1 was a potent activator of the 
JNK signalling pathway, although it evoked only a limited induction of PAK1 (Zhou et al.,
1998). Another potential way to achieve specificity in Rho GTPase signalling can be 
provided by the activity of the RhoGDI family of proteins (see Section 1.2.3). There are 
indications that the dissociation of Rho-RhoGDI complexes requires the concerted action 
of GEFs like Dbl and proteins of the ezrin-radixin-moesin family of actin-binding proteins 
(Takahashi et al., 1998). Moreover, signalling that leads to an increase in intracellular Ca2+ 
([Ca2 +]i) could favour the detachment of RhoGDI from Racl. It has been shown that Ca2+- 
dependent activation of protein kinase C (PKC) can disrupt the Racl-RhoGDI complex via 
phosphorylation of GDI. This event favours the translocation of Racl to the plasma 
membrane and consequently its interaction with the GEFs (Price et al., 1997).
In addition the pl30Cas/CrkII/DOCK180 pathway is also known to activate Racl 
(Buday et al., 2002; Hasegawa et al., 1996). Crk signalling proteins have been implicated 
as participating in growth factor induced migration. The expression of oncogenic v-Crk or 
cellular Crk lead to an enhanced phosphorylation of Cas and paxillin, two proteins that are 
integral parts of focal adhesions (Feller, 2001). Crk, is an adaptor proteins that consist of 
SH2 and SH3 domains, and contain no catalytic activity. The SH2 domain binds the 
phosphotyrosine-containing proteins pl30Cas (Crk-associated substrate) and the SH3 
domains binds DOCK180 (180-kDa protein downstream of Crk), which is able to activate 
Racl (Gotoh et al., 1995).
L2.3.2 TL4M1, a specific exchange factor for Racl
TIAM1 was originally identified in T-lymphoma cells as an invasion- and 
metastasis-inducing gene. This gene encodes a specific exchange factor for Racl, 
ubiquitously expressed and well conserved in different species. The human TIAM1 gene 
shows a high degree of homology to its murine counterpart, and it is widely expressed 
(Habets et al., 1994). The protein possesses the characteristic DH-PH domain (Dbl 
homology, catalytic, domain combined with a C-terminal PH domain) combination that is 
always found in members of the Dbl-like family of exchange factors. The TIAM1 protein 
is 1,591 amino acids long and contains several distinct domains. It is myristoylated at its 
N-terminus and contains two N-terminal PEST (sequences that are rich in proline-P- 
glutamic acid-E- serine-S- and threonine-T-) domains. The N-terminal PH domain (PHn) 
together with a coiled-coil region and an adjacent sequence (PHn-CC-EX), are important 
for membrane localisation (Michiels et al., 1997; Stam et al., 1997). The PHn domain 
interacts with a high affinity with PI3,4,5P3 over PI3 ,4 P2  and PI4 ,5 P2  at the plasma 
membrane (Stam et al 1997) (see Section 1.4.1.1). A Ras-binding domain (RBD) and a 
PSD-95/DlgA/ZO-l (PDZ) domain are important for the interaction of TIAM1 with Ras
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and other activators. The characteristic catalytic DH domain is related to the GEF activity 
of TIAM1 and is important for the Racl-TIAMl interaction (Worthylake et al., 2000). The 
C-terminal PH (PHc) domain cooperates with the catalytic DH domain in enhancing the 
GDP/GTP exchange of Racl, favours the interaction of the DH domain with Racl, and 
finally, determines the cytoskeletal localisation of TIAM1. The PHc domain does not bind 
the phosphoinositides, with the exception of a weak interaction with PI3P. Mutations in the 
PHc domain that abolished PI3P binding did not affect the in vitro GEF activity or the 
membrane localisation of TIAM1, but prevented the in vivo Racl activation (Baumeister et 
a l, 2003) (Fig. 1.6).
Membrane translocation of TIAM1 is important for Racl-dependent formation of 
membrane ruffles and also for JNK activation, in NIH 3T3 cells (Michiels et a l, 1997). 
The PHn-CC-EX domain is crucial for this event, since it can interact with PI3K products 
at the level of the plasma membrane. Intriguingly, PI3 ,4 ,5 P3 production does not cause the 
translocation of the isolated PHn and PHc domains of TIAM1 to the plasma membrane, 
and PI3-kinase inhibition does not reduce the ability of Cl 199-TIAM1 (a truncated but still 
active form of TIAM1 that lacks the myristoylated region) to translocate to the plasma 
membrane and induce membrane ruffle formation. However, truncation of the PHc domain 
made Cl 199-TIAM1-induced membrane ruffling dependent on PI3K activity (Mertens et 
a l, 2003).
Phosphorylation of TIAM1 is another event that may directly trigger the 
translocation and/or the activity of this GEF. TIAM1 was reported to be phosphorylated on
 ^ I
threonine residues by Ca /calmodulin kinase II (CaMKII) (see Section 1.3.4) and PKC in 
vitro; and upon treatment of Swiss 3T3 fibroblasts with LPA and PDGF in vivo (Fleming 
et a l, 1999; Fleming et a l, 2000). CaMKII, but not PKC, was able to stimulate TIAM1- 
induced nucleotide exchange on Racl in vitro. Moreover, upon LPA and PDGF 
stimulation, membrane translocation and threonine phosphorylation of membrane-bound 
TIAM1, can only be inhibited by KN-93, a CaMKII specific inhibitor, in NIH 3T3 cells
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Figure 1.6 - Structure of TIAM1 and pathways in which it is involved, a) Domain 
structures of representative of TIAM1 (see Section 1.2.3.2 for explanations), b) 
Regulation of TIAM1 in intracellular signalling networks. It is regulated by diverse 
mechanisms including phosphorylation by CaMKII or related kinases, interaction with 
PI3K product PI3,4,5P3, binding to cell surface molecule CD44 or cytoskeleton protein 
ankyrin, as well as direct binding to activated Ras.
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(Buchanan et al., 2000). PKC phosphorylation probably does not have a direct role in 
TIAMl-Racl signalling.
Direct interaction with proteins that directly couple TIAM1 with Racl versus a 
specific signalling pathway, is another way to activate this GEF. Through its RBD domain, 
TIAM1 can interact directly with Ras in its active form (GTP bound). This complex causes 
the activation of TIAM1, and consequently, can cooperate to cause the synergistic 
formation of Racl-GTP (Lambert et al., 2002). Thus, TIAM1 can function as a Ras 
effector and mediate Ras-dependent activation of Racl directly, in a PI3K-independent 
way.
The interactions of TIAM1 with different proteins can not only control its GEF 
activity, but also determine the downstream specificity of TIAMI-induced Racl signalling, 
as demonstrated by the following examples (Fig. 1.6):
1. Spinophilin was identified at the heads of dendritic spines, and it binds 
TIAM1 at the level of the PHn-CC-EX region, and localises to the plasma 
membrane. This protein can also bind P70 S6  kinase, a downstream effector 
of Racl that is involved in translation events. The binding with spinophilin 
targets TIAM1 and Racl at the level of P70 S6  kinase, favouring its 
downstream signalling. In contrast, spinophilin binding suppresses the 
ability of TIAM1 to activate PAK1 (Buchsbaum et al., 2003).
2. Ib2/JIP2 is a pancreatic P-cell/brain-specific protein, which is a scaffold for 
the MLK3-MKK3-P38-mitogen activated kinase (MAP) complex. It binds 
TIAM1 at the level of PHn-CC-EX and couples its signalling to P38 
kinase, thus enhancing p38 MAP kinase signalling (Buchsbaum et al., 
2002).
3. IRSp53 (Insulin receptor tyrosine kinase substrate p53), is known to link 
Racl and WAVE2, for lamellipodia protrusion (Miki et al., 2000). It 
interacts with the PHn-CC-EX region of TIAM1 and also binds Racl and
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Cdc42. The interaction between TIAM1 and IRSp53 favours the formation 
of the IRsp53/Racl complex that activates WAVE2 through a direct 
interaction, thus forming lamellipodia. PDGF, which activates TIAM1, 
favours its interaction with IRSp53. Under normal conditions, IRSp53 
overexpression causes filopodia formation by direct interaction with Cdc42. 
TIAM1 co-expression or PDGF stimulation shifts the signalling to Racl 
activation and lamellipodia protrusion (Connolly et al., 2005).
4. Another interactor of TIAM1 (through the PHn-CC-Ex domain) is the 
hyaluronic acid (HA) receptor isoform CD44v3. In parallel, the same 
domain of TIAM1 was shown to interact with the cytoskeletal protein 
ankyrin (Bourguignon et al., 2000). In fact, both CD44v3 and TIAM1 bind 
to the ankyrin repeat domains of ankyrin and both CD44v3 and ankyrin 
bind to the same domain of TIAM1. Based on these data, one can envisage 
that TIAM1 binds indirectly to CD44v3, using ankyrin as the hub. The 
significance of this interaction is still not clear, however.
1,2,3.3 Signalling downstream o f the Rho GTPases
The cellular targets of Racl and Cdc42 that promote changes to the actin 
cytoskeleton have been the subject of intense investigation. Potential pathways for the 
transduction of signals from active Racl and Cdc42 to actin polymerization into 
lamellipodia and filopodia have been recently uncovered. The Ser/Thr kinase p65PAK is 
commonly activated either by Racl or Cdc42, and it is believed to play an important role 
in regulating actin dynamics and cell adhesion during migration. It regulates focal adhesion 
turnover, with the help of PIX (PAK-interactive exchange factor) and GRK (G protein 
coupled receptor kinase) interactor 1 , for efficient integrin-dependent matrix adhesion 
during cell migration, to generate traction forces at the front of the cell (Manabe et al.,
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2002; Obermeier et al., 1998). In addition, p65PAK phosphorylates and activates LIM 
kinase (LIMK), which in turn phosphorylates and inactivates cofilin (Arber et al., 1998; 
Edwards et al., 1999). The ability of cofilin to cycle between active (unphosphorylated) 
and inactive (phosphorylated) forms is a critical feature for promoting filament 
treadmilling at the front of migrating cells (Bamburg and Wiggan, 2002).
Cdc42 activates WASP and N-WASP directly and the lipid PI(4 ,5 )P2  is an essential 
cofactor (Rohatgi et al., 2000; Rohatgi et al., 1999). This activation stimulates the Arp2/3 
complex, which can initiate actin polymerization either de novo, or at the barbed ends, and 
at sites of pre-existing filaments to form filopodia. Racl activates the Scar/WAVE family 
indirectly, and this involves IRSp53, which is known to link Racl and WAVE2 for 
lamellipodia protrusion (Miki et al., 2000). IRSp53 can also interact with Cdc42, and this 
interaction can favour the formation of a complex between IRSp53 and Mena, a member of 
Ena/VASP family, which can activate the Arp2/3 complex for actin polymerization and 
filopodia formation (Krugmann et al., 2001) (see also Section 1.2.1.2) (Fig. 1.7).
In the protruding lamellipodium, WAVE and Mena regulate actin polymerisation 
near the cell membrane and N-WASP regulates the formation of protruding filopodia 
(Nakagawa et al., 2001) (see Section 1.2.2). The GTP-bound form of Racl activates 
WAVE, which can then migrate to the lamellipodial edge through its N-terminal Scar 
homology domain (SHD). Subsequently, WAVE stimulates the Arp2/3 complex to 
promote actin filament nucleation and thus lamellipodia protrusion (Machesky et al.,
1999). Mena is recruited around the fast-growing ends of actin filaments through the 
EVH2 domain (Ena/VASP homology domain) and supplies monomeric actin molecules to 
elongate actin filaments branched by the Arp2/3 complex. Its action modulates the speed of 
lamellipodium protrusion downstream of various receptors (Mullins et al., 1998). When 
Cdc42 is activated in the lamellipodium, N-WASP can bundle actin filaments into 
microspikes, and can then elongate them to produce protruding filopodia (Nakagawa et al., 
2001) (Fig. 1.7)
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For stress fibre and focal adhesion formation, many downstream effectors of Rho 
have been identified; in particular the mechanism of stress fibres formation has been 
associated to the activity of a Rho associated kinase (Ishizaki et al., 1997) and mDia 
(Watanabe et al., 1997). These two enzymes can cause the contraction of pre-existing 
filaments and de novo actin polymerization (see Section 1.2.1.2). The Ser/Thr kinase 
pl60ROCK is involved in stimulating actin:myosin filament assembly and therefore 
contractility, as well as in detaching the rear of single migrating cells (Alblas et al., 2001; 
Nobes and Hall, 1999). In its active state, pl60ROCK, like p65PAK, can phosphorylate 
and activate LIMK, which in turn phosphorylates and inactivates cofilin, leading to 
stabilization of actin filaments within actin:myosin filament bundles (Maekawa et al., 
1999; Sumi et al., 2001). pl60ROCK interacts with and phosphorylates the myosin binding 
subunit of myosin light chain phosphatase, and thereby inactivates it (Kawano et al., 1999). 
This leads to increased levels of myosin phosphorylation, which then can cross-link actin 
filaments and generate a contractile force that, at the rear of a migrating cell, promotes 
movement of the cell body (Mitchison and Cramer, 1996). On the other end mDia can bind 
RhoA and this interaction opens up and activates this scaffold protein. It cooperates with 
pl60ROCK in the assembly of actin:myosin filaments, but its biochemical mechanism of 
action is still unclear (Uehata et al., 1997; Watanabe et al., 1999) (Fig. 1.7)
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Figure 1.7 Schematic representation of the signalling cascade that leads to actin 
cytoskeleton modifications. For explanations see Sections 1.2.3.1 and 1.2.3.3.
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1.3 Signalling enzymes
The glycerophosphoinositols have been shown to be biologically active in cells. A 
treatment with these compounds can initiate different signal cascades that involve many 
signalling enzymes. In details, the phospholipase A2 S (PLA2 S) are involved in the synthesis 
of the glycerophosphoinositols (Falasca et al., 1996) (see Section 1.4.3.1) and can be also 
inhibited by GroPIns4P and GroPIns (Corda et al., 2002). In addition the adenylyl cyclases 
(ACs) can be inhibited by treatment with GroPIns4P (see Section 1.3.3.2.1).
The aim of this study was to define the mechanism of action of the 
glycerophosphoinositols in actin cytoskeleton modulation, with a particular focus on 
GroPIns4P (the most active compound) (see Section 1.4.3.2.3). This analysis lead to the 
definition of a signal cascade that involves the activation of many enzymes such as 
Phospholipase Cs (PLCs), Ca2 +/calmodulin-dependent protein kinase II (CaMKII) and Src 
family kinases (as it will be demonstrated in Chapter 3).
This section will provide a general background about the structure and functions of 
both the signalling enzymes that are already known to be involved in the activity of 
GroPIns4P (PLA2  and AC) but also that have been found to be important for the present 
study (PLCs, CaMKII and Src).
1.3.1 Phospholipase A2
PLA2  enzymes catalyse the hydrolysis of the sn-2 ester linkage of the phospholipid 
substrate, resulting in the production of a free fatty acid, arachidonic acid (AA) in general, 
and the corresponding lysophospholipid.
The PLA2 S form a superfamily of enzymes divided in three different families, 
depending on their localization and activation. Within each family, different groups of 
PLA2 S are present. The family of secretory PLA2 S (SPLA2 ) is formed by low molecular
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weight (14-17 kDa), disulfide-linked secretory proteins, with a histidine residue at the 
catalytic centre and which require Ca2+ at mM concentration. The family of cytosolic 
PLA2 S (CPLA2 ) consists of 85-110 kDa proteins localised in the cytosol of resting cells. 
Upon activation, they translocate to the Golgi complex and ER. There are at least four 
CPLA2 S (a, p, y, 5) in mammals, all classified in the group IV and that all require Ca2+ at 
pM concentration for their activation (Dennis, 1994). From a structural point of view, they 
all contain two homologous catalytic domains, A and B, interspaced with a unique 
sequence. The C2 domain, important for Ca2+ binding, is conserved in the a, P and 5 
isoforms, whereas the y isoform has a site of famesylation at the C-terminus (Fig. 1.8). The 
third family comprises the other cytosolic forms of the PLA2 S that do not require Ca2+.
94-These are known as the iPLA2 S (Ca -independent) and are classified as group VI (Dennis, 
1997) (Table 1.1).
The Ca2+-dependent and cytosolic CPLA2 S have been implicated in the production 
of arachidonic acid (AA) and in eicosanoid biosynthesis; their activation has been reported 
to be via cell surface receptors. Once activated these PLA2 S translocate from the cytosol to 
intracellular membranes (Golgi complex, ER), where the phospholipids are hydrolysed. 
The proposed model for cPLA2a activation implies cell-surface-receptor-dependent 
stimulation and a consequent [Ca2+]j increase, followed by Ca2+ binding to the C2 domain 
that promotes cPLA2a translocation from the cytosol to the membranes. Upon membrane 
binding, major conformational changes in the enzyme take place to remove the lid from the 
active site (the catalytic cleft, in its inactive state, is covered by a lid containing an a-helix 
and a short turn) and to allow the fatty acyl chain of a substrate molecule to enter the active 
site (Bahnson, 2005).
Phosphorylation of cPLA2a by MAPK kinase, MAPKAP kinase and CaMKII are 
also important for its activity and the stabilisation of the active form at the membrane 
(Kudo and Murakami, 2002).
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Families Enzymes Other names Size
(kDa)
Ca2+
requireme
nt
Catalytic site domains
sPLA2 IB Pancreatic PLA2 14 mM His/asp dyad
IIA Synovial PLA2 14 mM His/asp dyad
nc 15 mM His/asp dyad
IID 14 mM His/asp dyad
HE 14 mM His/asp dyad
IIF 16 mM His/asp dyad
V 14 mM His/asp dyad
X 14 mM His/asp dyad
m 55 mM His/asp dyad
xn 19 mM His/asp dyad
cPLA2 IVA cPLA2a 85 <pM Ser/asp dyad C2dom
i v b cPLA2 p 110 <pM Ser/asp dyad C2dom
IVC cPLA2 y 60 none Ser/asp dyad
iPLA2 VIA iPLA2 p 85-88b none Ser/His/Asp triad Ankyrin
VIB iPLA2y 90 none Ser/His/Asp triad repeat
PAF-AH v h a Plasma-PAF-HA 45 none Ser/His/Asp triad
v iib PAF-HA-H 40 none Ser/His/Asp triad
vniA PAF-HA-Ia,-sub 30 none Ser/His/Asp triad
vnrn PAF-HA-Ic^-sub 30 none Ser/His/Asp triad
Table 1 . 1  - Classification of mammalian PLA2 (from Kudo and Murakami, 2002).
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Figure 1.8 - Structure of cPLA2s. Members of the cPLA2/Group VI PLA2  subfamily 
showing conserved domain and posttranslational modifications. Three functionally 
important serine residues can be phosphoiylated in cPLA2  (Hirabayashi et al., 2004).
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1.3.2 Adenylyl cyclase
The adenylyl cyclases (ACs) are a family of enzymes that are responsible for cyclic 
AMP (cAMP) production. They are integral membrane proteins composed of twelve 
transmembrane segments and a large cytoplasmic (catalytic) loop. The N-terminal 
hydrophobic domain (Ml) is organised into six membrane-spanning a-helices; this domain 
is followed by a 40-kDa cytoplasmic domain (Cl) and by a second transmembrane (M2) 
domain; finally, there is a second cytoplasmic domain (C2). The two cytoplasmic domains 
form the catalytic core of the protein and interact together (Fig. 1.9) (Sunahara et al., 
1996). The ten AC isoforms can be divided into five distinct families based on their amino- 
acid sequence similarities and functional attributes. The Ca2 +/CaM-sensitive forms are 
types AC1, AC3 and AC8 . The GPy-stimulated forms are represented by AC2, AC4 and 
AC7. AC5 and AC6  are distinguished by their sensitivity to inhibition by both Ca2+ and 
Gaj isoforms (Ga0, Gan, Gaj2 , Gai3 and Gaz). AC9 is the most divergent of the 
membrane-bound family and is highly insensitive to the diterpene forskolin. The last 
isoform is a soluble AC (sAC), and it is the most divergent of all the mammalian cyclases, 
as it is not membrane bound. In general, all membrane bound AC isoforms are found in, 
but not limited to, excitable tissues, such as neurons and muscle. Within the brain, AC 
isoforms localize to different, discrete, brain regions. Although most isoforms are widely 
expressed, AC1 and AC3 are expressed only in brain. The soluble cyclase is expressed 
predominantly in the testis, although splice variants have been identified displaying a 
broader distribution pattern (Cooper, 2003).
The activity of AC is mostly regulated by heterotrimeric G proteins and the
Ca2+/calmodulin (Ca2 +/CaM) complex. The hormonal activation of AC occurs primarily
through receptors coupled to the stimulatory G protein, G as; whereas the members of the
Gaj family exert an inhibitory effect selectively on certain AC isoforms (AC6  and AC5).
Interestingly Gaj does not compete with G as for the binding to the ACs. The heterodimer
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a)
Figure 1.9 - Organisation of the AC. The figure represents the main structural 
features of mammalian ACs. a) The primary sequence of more than 100 amino acids 
is interrupted by a number of specialised domains, b) General topology and 
organisation of the enzyme. The N-terminus hydrophobic domain (Ml) is organised 
into six membranes-spanning a-helices, this domain is followed by a 40-kDa 
cytoplasmic domain (Cl) and by a second transmembrane (M2) domain; finally, there 
is a second cytoplasmic domain (C2). The two cytoplasmic domains form the 
catalytic core of the protein and interact together.
Regulatory signals
Isofo D istrib u tion Py a i a o <*s
PKA PKC Forskolin Ca/CaM Ca2+
rm
II B rain, lu n g
t
n/e n/e T T n/e
IV W id ely
distributed
T T
VII W id ely
distributed
t T T
V heart>brain T 1 n/e 1 I T T n/e 1
VI Heart, brain>  
other tissu es
n/e 1 n/e 1 1 T n/e 1
VIII N eural tissue n/e T n/e
I N eural tissue 1 I 1 1 t
III Predom inantly
o lfactory
n/e I n/e t
Table 1.2 -  Classification of the AC isoforms.
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Gpy can modulate the activity of AC either activating, as in the case of AC2, AC4 and 
AC7, or inhibiting, as for AC1 and AC8 , the enzyme. Also, for the Ca2+/CaM complex 
there is this dual effect, stimulatory at the level of some isoforms and inhibitory versus 
other isoforms. Other proteins, like protein kinases, are able to differently modulate AC 
activities (Table 1.2) (Sunahara and Taussig, 2002).
The product of AC is cAMP, the first second messenger that was identified, which 
is involved in the regulation of cell metabolism, cell shape and gene transcription 
(Sutherland, 1972) via reversible protein phosphorylation. Elevated levels of cAMP in the 
cell lead to activation of different cAMP targets. The main targets of cAMP are the cAMP- 
dependent protein kinases (cAPKs) (Walsh et al., 1968). However, not all of the effects of 
cAMP are mediated by a general activation of cAPKs; several cAMP-binding proteins 
have been described: the cAMP receptor of Dictyostelium discoideum, which participates 
in the regulation of development (Klein et al., 1988a); cyclic-nucleotide gated channels, 
which are involved in the transduction of olfactory and visual signals (Goulding et al., 
1992; Kaupp et al., 1989); and the cAMP-activated guanine exchange factors Epac 1, 2, 
which specifically activate the monomeric G protein Rap (Kawasaki et al., 1998).
1.3.3 Phospholipase C
Many of the earliest key events in the regulation of various cell functions elicited by 
the interactions of many signalling molecules with their cell surface receptors trigger the 
hydrolysis of a minor membrane phospholipid, (PI4 ,5 P2 ), by PLC. This reaction produces 
two intracellular messengers, diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3 ),
9+which mediate the activation of (PKC) and [Ca ]* release, respectively.
In the late 1980s and early 1990s ten mammalian PLC isozymes were isolated and 
their corresponding DNAs sequenced (Rhee and Bae, 1997; Rhee et al., 1989). They have 
been divided in three subtypes, p, y and 5; recently a new isoform has been identified
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(PLCs) that contains several domains that are not present in any other known PLC (Lopez 
et al., 2001). The molecular mass of the PLCS isozymes is ~85 kDa, that of the p and y 
isoforms is in the range of 120-155 kDa, and that of PLCs is 230-260 kDa. The amino acid 
sequences of the PLC isozymes are relatively non-conserved, with the exception of two 
regions, known as the X and Y domains that form the catalytic core. These domains are 
comprised of alternating a-helices and p-strands and resemble an incomplete triose 
phosphate isomerase a/p barrel domain, which is important for the binding of the substrate 
and which requires Ca for its catalytic activity. The sequence between the X and Y 
domains comprises 40 to 110 residues in the PLCp and PLC5 and 190 residues in the 
PLCs. PLCy has a larger region (~400 residues) that contains two Src homology 2 (SH2) 
domains and one Src homology 3 (SH3) domain, which bind phosphotyrosine (pTyr)- 
containing sequences and proline-rich sequences, respectively. The p, y and 5 isozymes all 
contain an N-terminal PH domain that is important for their membrane localization (see 
Section 1.4.1.1), and an EF-hand domain localized between the PH and the X domains. 
This EF-hand motif consists of a helix-loop-helix structure and serves as a flexible link 
between the PH domain and the rest of the protein. Another important domain is the C2
O t
domain in the C-terminus; it binds Ca and is fundamental for the activity of PLC8 . The 
PLCy isozyme contain an additional PH domain that is split by the SH2/3 domains, while 
PLCp shows a long C-terminal sequence (~45 amino acids) downstream of the Y domain. 
PLCs differs from the other types and has a Ras-exchange-factor-like domain (Ras-GEF) 
and a RBD (Fig. 1.10a) (Rhee, 2001)
Each PLC isoform is characterised by different regulation of the catalytic activity. 
The PLCp isozymes are regulated by heterotrimeric GTP-binding proteins and function as 
effectors of GPCRs. In the classical G-protein model of PLC activation, the binding of an 
agonist triggers the receptor-catalysed exchange of GTP with the bound GDP on the a- 
subunit of the heterotrimeric G-protein. The GTP-a subunit then dissociates from the
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membrane and binds PLCp, increasing its catalytic activity. Alternatively, the Py 
heterodimer can also bind alone or in cooperation with the a  monomer and activate PLCp. 
The activation comprises conformational changes and the translocation of PLCp to the 
plasma membrane, in compartments enriched in PI3P (the specific ligand of the PLCP-PH- 
domain) (Fig 1.10b) (Rebecchi and Pentyala, 2000). PLCy is activated by growth factors, 
such as PDGF, EGF, and by immunoglobulin and cytokine receptor stimulation. Binding 
of a growth factor to its receptor results in dimerization of the receptor subunits, 
stimulation of the intrinsic tyrosine kinase activity, and the consequent auto­
phosphorylation of the receptor. The recruitment of PLCy results in the binding of its SH2 
domain to a phosphorylated tyrosine on the receptor, then PLCy is phosphorylated by the 
kinase activity of the receptor itself or of enzymes activated by it (as is the case with the 
non-receptor tyrosine kinases, like the Src family proteins) (Barfod et al., 2005; (Weiss, 
1993). This phosphorylation is necessary but not sufficient for PLCy activation. An 
important event is the tethering to the plasma membrane of PLCy, operated by the 
interaction of the PH domain with the PI3K product PI3 ,4 ,5 P3 (Bae et al., 1998a). The 
activation of PI3K is also associated with RTK signalling. Besides this classical route, the 
activation of PLCy can derive also from GPCR activation. One possibility is that ligand 
activation of the heterotrimeric G-protein Py subunit results in an intracellular signal that 
induces the extracellular activation of a transmembrane metalloproteinase. This can lead to 
the extracellular processing of a transmembrane growth factor precursor, and to the release 
of the mature factor, which directly activates a RTK. Another possibility is a direct 
activation of an intracellular tyrosine kinase by an active Ga subunit (Fig. 1.10c) (Rhee, 
2001). Independently of tyrosine phosphorylation, a direct binding of phosphatidic acid 
(PA) or arachidonic acid (AA) could be responsible for PLCy activation (Hwang et al., 
1996; Liu e ta l, 1999).
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Figure 1.10 - Structure of PLCs and their pathways of activation, a) Domain 
organisation of the four types of PLC isozymes. The X and Y catalytic domains as 
well as the PH, EF-hand, C2, SH2, SH3, RasGEF, and RA domains are indicated in 
Section 1.3.3. b) GPCR-mediated activation of PLC(3 isozymes. An agonist-occupied 
GPCR induces the exchange of GDP for GTP on the G protein a  subunit and the 
subsequent dissociation of this subunit from the membrane-associated (3y dimer. The 
GTP-bound a  subunits mediate the targeting of PLCp to the membrane and activate it 
as a result of interaction with the C2 domain and downstream COOH-terminal region 
of the enzyme (right). The membrane-anchored (3y dimer also recruits PLC p by 
interacting with the PH and Y domains (left). The membrane localisation of PLCp 
isozymes might be further promoted by interaction of the PH domain with PI3P 
(PI3P) generated in response to legation of the GPCR (from Rhee et al., 2001). c) 
PLCy can be activated either by RTKs or by GPCR. The phosphorylated receptor 
RTK provides a structural scaffold for the assembly of a signalling complex that 
includes PLCy. GPCR can trans activate the RTK through the activation of Src tyrosin 
kinases (from Rhee et al., 2001).
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The mechanism by which the PLCS isozymes are coupled to receptors remains
04-unclear. Their affinity for Ca is greater than that of the other isozymes. The binding of 
Ca2+ to the EF-hand domain promotes the association of the PH domain with PI4 ,5 P2  and 
the formation of a ternary complex containing the C2 domain, the phosphatidilseryne (the
04-substrate) and Ca also favours the activation of PLCS (Yamamoto et al., 1999).
1.3.4 Ca2+/calmodulin kinase II
04-The Ca /calmodulin-dependent protein kinases (CaMK) are a family of Ser/Thr 
protein kinases that are activated upon binding to the Ca2+/CaM complex. The family 
consists of CaMK I, II and IV and they have an extremely wide tissue distribution. The 
CaMKII group is encoded by four genes (a, p, y, S). The CaMKII isoforms share 80-90% 
identity, and the a  and p isoforms are found mainly in neuronal tissues, while the y and 5 
isoforms are broadly expressed (Braun and Schulman, 1995). CaMKII is a ubiquitously 
expressed protein kinase that transduces elevated Ca2+ signals in cells to a number of target 
proteins, ranging from ion channels to transcriptional activators. It is a multimeric enzyme 
composed of identical or mixed isoforms. The holoenzyme is an oligomeric protein 
comprised of twelve 50-60-kDa subunits that are arranged as two stacked hexameric rings. 
The various CaMKII subunits comprise an N-terminal catalytic region, a central regulatory 
domain containing an auto-inhibitory domain (AID), a Ca2+/CaM binding motif, a variable 
sequence and the C-terminal subunit association domain that is required for oligomer 
formation (Morris and Torok, 2001) (Fig. 1.11a).
CaM is the most ubiquitous calcium-sensing protein, and it contains four "EF" 
hand motifs with high specificity for binding four Ca2+ ions. The Ca2+/CaM complex 
interacts with the Ca2+/CaM binding motif of CaMKII, favouring the activation of the 
enzyme. In the absence of bound Ca2 +/CaM, CaMKII is maintained in an inactive 
conformation because of an interaction of the AID with the catalytic domain of its own
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subunit. The Ca /CaM complex binds to a sequence that partially overlaps the AID,’ 
presumably causing a conformational change and thereby disrupting the interaction of the 
AID with the catalytic domain, and producing kinase activation. Upon activation by 
Ca2+/CaM binding, the kinase undergoes an immediate autophosphorylation on Thr-286. 
This autophosphorylation occurs within the oligomeric complex (intramolecular) and 
between adjacent subunits (intersubunit) that have bound Ca2+/CaM (Braun and Schulman,
1995). This rapid autophosphorylation on Thr-286 has two important regulatory 
consequences: first, the subsequent dissociation rate for Ca2+/CaM upon removal of Ca2+ is 
decreased by several orders of magnitude; second, even after full dissociation of 
Ca2+/CaM, the kinase retains its activity until a phosphatase dephosphorylates the Thr-286 
(Ca /CaM-independent or constitutively active). Thus, transient elevation of intracellular
04-Ca can give a prolonged response through the constitutive activity of auto- 
phosphorylated CaMKII. The Ca2+/CaM binding site is also the main target of CaMKII 
inhibitors like KN-93, which leave the kinase in its inactive conformation (Fig. 1.11b) 
(Sumi et al., 1991)
CaMKII coordinates a large variety of cellular functions, such as carbohydrate 
metabolism, gene expression, membrane excitability, the cell cycle and changes in strength 
of neuronal communication that underlie learning and memory (Braun and Schulman, 1995). 
In NIH 3T3 cells, inhibition of CaMKII leads to cell cycle arrest in G1 and apoptosis, thus 
suggesting an involvement of CaMKII in cell-cycle progression, by transduction of signals 
from growth factors and/or survival factors (Tombes et al., 1995). CaMKII can be activated 
by growth factors, like PDGF, or ligands of GPCRs, like LPA; this activation can favour 
TIAM1 phosphorylation, Racl activation, and consequently, the modification of the actin 
cytoskeleton (Fleming et al., 1999; Fleming et al., 2000). A fraction of CaMKII is associated 
with the cytoskeleton as it can interact with a-actinin, myosin-V and F-actin, and in this 
way, it can phosphorylate many substrates (Bayer and Schulman, 2001). The signalling 
pathways initiated by cAMP can also produce an increase in [Ca2+]i and thus activate
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Figure 1.11 - Structure and mechanism of activation of CaMKII. a) Schematic 
representation of a CaMKII subunit, which is comprise of an N-terminal catalytic 
region, a central regulatory domain containing an auto-inhibitory domain (AID), a 
Ca2+/CaM binding motif, a variable sequence and the C-terminal subunit association 
domain that is required for oligomer formation, b) Ca2+/CaM-activation and 
mechanism of action of KN-93, a CaMKII specific inhibitor. It binds to the CaM 
binding site preventing the binding of the Ca2+/CaM complex.
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CaMKII (De Cesare et al., 1999). The final event is the stimulation of immediate early 
genes that are regulated by cAMP response elements (CREs), such as c-fas (Sheng et al., 
1991). Phosphorylation of CREB (CRE binding protein) on Ser-133 is essential for 
transactivation, because it is required for binding of the ubiquitously expressed CREB 
binding proteins CBP and p300, which function as transcriptional co-integrators (De 
Cesare et al., 1999).
1.3.5 Src tyrosine kinases, downstream effectors of growth-factor signalling
The signalling pathways activated upon growth factor stimulation require several 
phosphorylation events. Receptor and non-receptor tyrosine kinases cooperate to transduce 
the signal to downstream targets. Among the non-receptor tyrosine kinases, the Src family 
plays a pivotal role in may different cellular events. The importance of this kinase stems 
from work on the Rous sarcoma virus that expresses the cancer-causing oncogene v-Src (an 
active form of Src) (Weiss et al., 1977). Src is the cellular homologue of v-Src in human, 
chicken and other animals. It derives from the c-Src cellular gene (the proto-oncogene), and 
its activity is regulated by intramolecular interactions controlled by tyrosine phosphorylation. 
Another way to modulate Src is through protein-protein interactions with sequences 
containing phosphotyrosine and proline-rich motifs, which bind the SH2-SH3 domains of 
Src (Martin, 2001).
The Src kinases are expressed ubiquitously, but brain, osteoclasts, and platelets 
express 5-200-fold higher levels of these proteins than most other cells (Brown and Cooper,
1996). In fibroblasts, Src kinases are bound to endosomes, perinuclear membranes, secretory 
vesicles and the cytoplasmic face of the plasma membrane, where they can interact with a 
variety of growth factor and integrin receptors (Roskoski, 2004). The Src kinases are 
controlled by tyrosine kinases, integrins, GPCR, antigen- and Fc-coupled receptors, cytokine 
receptors and steroid hormone receptors (Parsons and Parsons, 2004).
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There are eleven members of the Src family kinase in humans. These are Blk, Brk, 
Fgr, Frk, Fyn, Hck, Lck, Lyn, Src, Srm, and Yes. Moreover, the human genome contains a 
Yes pseudogene (YESps). Src, Fyn, and Yes are expressed in all cell types, while Srm is 
found in keratinocytes, and Blk, Fgr, Hck, Lck and Lyn are found primarily in 
haematopoietic cells. Frk occurs chiefly in bladder, brain, breast, colon and lymphoid cells, 
whereas Brk occurs in colon, prostate, and small intestine (Roskoski, 2004).
In the structure of the protein, from the N- to C-terminus, it is possible to 
distinguish a regulatory region and a catalytic part. The regulatory region consists of a 14- 
carbon myristoyl group attached to an SH4 domain, then a unique domain, an SH3 domain 
that binds to proline-rich sequences of target proteins, an SH2 domain that binds to the 
regulatory p-Tyr-527 and an SH2-kinase linker. The catalytic part consists of a protein 
tyrosine kinase domain, which presents a bi-lobed structure. The smaller amino-terminal 
lobe (N-lobe) of the protein kinase is primarily involved in anchoring and orienting ATP; the 
G-rich loop forms part of the nucleotide-phosphate binding site. The larger carboxyl- 
terminal lobe (C-lobe) is responsible for binding the protein substrate. The catalytic site of 
Src lies in a cleft between the two lobes. Within each lobe is a polypeptide segment that has 
an active (when phosphorylated in Tyr-416) and restrained (a-helical non-phosphorylated) 
conformation. The two lobes move relative to each other and can open or close the cleft. 
Finally, there is a C-terminal regulatory segment that can be phosphorylated in Tyr-527 
(Boggon and Eck, 2004) (Fig. 1.12a).
Src kinases are regulated by alternative phosphorylation/de-phosphorylation events: 
Tyr-416 is the main phosphorylation site of Src kinases that results in their activation via 
autophosphorylation. The Tyr-527 at the C-terminus, when phosphorylated by C-terminal 
Src kinase (CSK), cause the inhibition of Src kinases activity. The phosphorylated C- 
terminus interacts with the SH2 domain, causing the closed inactive structure of Src kinases 
(Fig. 1.12b). Protein-tyrosine phosphatases, such as cytoplasmic PTP1P, Shpl, Shp2 and 
several other transmembrane enzymes including PTPa, CD45, PTPs and PTPX, can de-
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Figure 1.12 - Src structure and activation, a) Domain organisation of Src; The 
unique, SH4, SH3, SH2 and protein kinase domains are indicated in Section 1.3.5. b) 
Src activation by unlatching, unclamping, and switching. Or by direct interaction with 
G a subunit of heterotrimeric G proteins. This figure is reproduced from Harrison, 
2003 and Ma et al., 2000)
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phosphorylate p-Tyr-527 (unlatching), causing the detachment of the SH2 domain, a 
consequent opening of the catalytic cleft (unclamping), and the autophosphorylation of 
Tyr-416, which stabilise the Src kinases in their active form (Fig. 1.3.5b) (Roskoski, 2004) 
Another way to modulate the activity of the Src kinases is via heterotrimeric G-proteins. It 
has been demonstrated that Gets and Gaj, but not Gaq, Gai2  or Gpy, directly stimulate the 
kinase activity of downregulated c-Src or Hck, another member of the Src family kinases. 
Gots and Gcti bind to the catalytic domain (N-lobe) and change the conformation of Src, 
leading to increased accessibility of the active site to substrates. These data demonstrate 
that the Src kinases are direct effectors of G proteins (Ma et al., 2000) (Fig. 1.12b).
Src kinases activity during cell polarization and migration is important as an 
upstream signal to transduce growth-factor stimulation, for example by activating PLCy or 
by activating Racl exchange factors, like PIX or VAV (Barfod et al., 2005), and also as a 
downstream effector of Racl and Cdc42 during peripheral actin and adhesion remodelling 
that is required for directional migration. The Src kinases are targeted to the peripheral 
adhesion sites, where they are able to convert Rho-dependent focal adhesions into smaller 
focal complexes along Racl-induced lamellipodia (or Cdc42-induced filopodia) (Timpson 
et al., 2 0 0 1 )
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1.4 The phosphoinositides and their aqueous derivatives
This section will provide a general background about the phosphoinositides, 
lysophosphoinositides and glycerophosphoinositols. A particular attention will be 
addressed on the metabolic pathway and the known functions of the 
glycerophosphoinositols.
1.4.1 The phosphoinositides
The phosphoinositides represent a minor fraction (approximately 10%) of the total 
membrane phospholipids (Toker, 2002), and they consist of a double acylated 
diacylglycerol moiety which is phosphodiesterified to myoinositol, a six-carbon cyclic 
polyalcohol. The inositol headgroup contains five free hydroxyl groups with the potential 
to become phosphorylated. Thus, numerous derivatives of phosphatidylinositol (PI) that 
present single or multiple monoester phosphates in the inositol head group exist in cells, 
many with unique functions. To date, the following phosphoinositides have been identified 
in cells: PI-3-phosphate (PI3P), PI-4-phosphate (PI4P), PI-5- phosphate (PI5P), PI-3,4- 
bisphosphate (PI3 ,4 P2 ), PI-3,5-bisphosphate (PI3 ,5 P2 ), PI-4,5-bisphosphate (PI4 ,5 P2 ) and 
PI-3',4,5-trisphosphate (PI3 ,4 ,5 P3 ) (Takenawa and Itoh, 2001).
The phosphoinositides are mainly localised on the cytoplasmic side of the plasma 
membrane, where they are not likely to provide only a structural role, but where they also 
exert specific regulatory functions, such as agonist stimulated signal transduction. The 
phosphoinositides can interact specifically with a wide range of proteins, providing their 
translocation from one area of the cell to another, or producing conformational changes in 
the proteins, which can also result in modulation of the activity of the proteins. 
Alternatively, the phosphoinositides are substrates of different enzymes, including the 
phosphoinositide kinases (PIKs), phosphatases and phospholipases (see also Sections
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1.3.1, 1.3.2) that can lead to the production of several second messengers that originated 
from the phosphoinositides. The result of these processes is that the phosphoinositide- 
protein interactions can initiate downstream signalling cascades leading to cell growth, 
proliferation, differentiation, death, secretion, vesicle trafficking, motility and intracellular 
metabolism (Toker, 2002).
The function of each phosphoinositide depends on when and where it is made, 
moved to and broken down within the cell. The synthesis of PI occurs in the ER, while the 
subsequent phosphorylation steps occur in post-ER compartments (Gehrmann and 
Heilmeyer, 1998; Loijens et al., 1996). Indeed, PIKs have been localised to most 
intracellular membrane compartments, including the plasma membrane, the nucleus, 
secretory granules, endosomes, the ER and Golgi complex.
Many PIKs were initially described as enzymatic activities, capable of transferring 
a phosphate to a specific position on the inositol ring of PI or its phosphorylated 
derivatives. Studies on purified enzymes led to categorisation into three main families: the 
PI3Ks, PI 4-kinases (PI4Ks) and PIP-5-kinases (PIP5Ks) (Fruman et al., 1998; Honda et 
al., 1999). Over the last decade the genes encoding several of these enzymes have been 
identified and sequence comparisons generally support the distinct classification of PI3Ks, 
PI4Ks and PIP5Ks. These enzymes phosphorylate, respectively, the D3, D4 and D5 
positions of the inositol ring, thus forming the differently phosphorylated 
phosphoinositides. The phosphoinositide phosphatases act in the opposite direction to the 
PIKs, dephosphorylating the inositol ring. Three different classes of phosphatases exist: the 
5-OH specific that eliminates the phosphate from position 5 of inositol (e.g. SHIP 1-2), the 
4-phosphate phosphatases that appear to participate in PI3K signalling, and the 3-OH 
phosphatases, like PTEN/MMAC1 (products of tumour suppressor genes), that are 
important for the conversion of PI3 ,4 ,5 P3 to PI4 ,5 P2  (Toker, 2002) (Fig. 1.13).
Each phosphoinositide exhibits a unique stereochemistry, and can elicit a distinct 
biological response. Indeed, the phosphoinositides pathways constitute perhaps the most
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Figure 1.13 - Pathways of phosphoinositide synthesis and degradation (De Matteis 
et al., 2002). Blue and light-blue arrows indicate routes of phosphoinositide 
phosphorylation and dephosphorylation, respectively (note that some of these 
reactions are established in vitro but not yet in vivo). The phosphoinositides can be 
hydrolysed by PLC to generate IP3 and DAG from PI4,5P2; by PLA2 to form the 
lysophosphoinositides; PLA/lysophospholipases (LPLA,) to form the 
glycerophosphoinositols; and by phospholipase D (PLD) to form phosphatidic acid 
(Ching et al., 1999). PLC acts preferentially on PI45P2, whereas the other 
phospholipases may act on the different Pis (for simplicity in the Figure, all the 
phospholipases are shown acting only on PI4,5P2).
complex signalling network in the cell, and their location and specificity are of great 
importance.
1.4,1.1 The phosphoinositides as docking sites for proteins
As docking sites for proteins, the phosphoinositides can function as messengers 
themselves in the localisation and assembly of protein machineries. The differential 
localisation of these phosphoinositides is a pre-requisite for this function. The 
unphosphorylated form (PI) is the immediate precursor of all the phosphoinositides and 
localises to cytoplasmic membrane leaflets (Vanhaesebroeck et al., 2001). The most 
abundant monophosphorylated form is PI4P, produced by PI4K and resident in the Golgi 
complex; PI3P also localises in the Golgi complex, where it is involved in intracellular 
membrane trafficking. PI4 ,5 P2  is the most abundant bis-phosphorylated phosphoinositide, 
and is mostly enriched at the plasma membrane, where it is involved in clathrin cage 
assembly and actin polymerization, and where it is also hydrolyzed by the PLCs for the 
initiation of signal cascades (see also Section 1.3.1). PI3 ,4 ,5 P3 , can be found on the plasma 
membrane but its detection is a result of extracellular or intracellular stimulation events, 
which leads to local increases of PI3 ,4 ,5 P3 .
Several protein domains that bind to phosphoinositides with high affinity have been 
identified over the last few years. Among the best characterised are the FYVE (Fabl, 
YOTB, Vacl and EEA1), PH (pleckstrin homology) and PX (Phox homology) domains 
(reviewed in Gillooly et al., 2001; Lemmon and Ferguson, 2000; Wishart et al., 2001). 
These domains recruit proteins to specific membrane regions in cells, via their interactions 
with phosphoinositides, and they can also serve as allosteric regulators of enzyme activities 
and protein-protein interactions. The localization of the phosphoinositides is strictly 
correlated to their function. All FYVE domains tested bind to PI3P, whereas PH and PX
61
domain display a variety of specificities. Surprisingly, there is little structural similarity 
between the different phosphoinositide-binding domains.
The FYVE domain was discovered in 1998 (Burd and Emr, 1998; Patki et al.,
1998) as a specific recognition site for PI3P. This 65-residue module is known to exist in 
37 human proteins, the majority of which have been implicated in endocytic/vacuolar 
membrane trafficking (e.g. EE1, Rabenosyn-5, Hrs proteins) (Gillooly et al., 2001) or in 
signalling (e.g. SARA) and cytoskeleton organisation (e.g. the Fdg family of proteins) 
(Takenawa and Itoh, 2001). The structure and specificity of the FYVE domains are 
conserved, consisting of a pair of small p-sheets and a short a-helix. Stabilisation is 
provided by two zinc ions, each contained by a cluster of four cysteines. The PI3P head- 
group fits into a shallow groove next to the first P-strand (Stenmark and Aasland, 1999).
PH domains are the most thoroughly characterized of the phosphoinositide 
recognition modules, and they have been adopted by a wide range of protein architecture 
and have a variety of different roles in signalling, cytoskeleton organization, membrane 
trafficking and lipid modification (Dowler et al., 2000; Kavran et al., 1998; Rameh et al.,
1997). Their 120-residue sequence has been found in several hundred human proteins. The 
PH domain is formed by seven-stranded antiparallel p-sheets with a strong bend, which 
results in an orthogonal sandwich (Hyvonen et al., 1995). This domain also has a 
characteristic C-terminal a-helix that blocks one end of the twisted sheet. All the PH 
domains are electro-statically polarised, with the positively charged face coinciding with 
three variable loops connecting the p-strands. The loops are the most variable regions 
between different PH domains, and may account for their diversity in specificity and 
affinity for the phosphoinositides. A significant minority of PH domains binds specifically 
and tightly to one phosphoinositide (e.g. The PLC5 PH domain is specific for PI4 ,5 P2 , the 
BTK and Grpl PH domains are specific for PI3,4,5Ps); the rest of the PH domains 
associate weakly and promiscuously with several phosphoinositides.
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The PX domain is a 125-residue module that was originally named through its 
presence in the p40Phox and p47Phox subunits of the neutrophil NADPH oxidase 
superoxide generating complex (Ponting, 1996). PX domains have now been found in at 
least 57 mammalian and 15 yeast proteins, including kinesins, phospholipases, protein 
kinases, SNAREs and sorting nexin (reviewed in Wishart et al., 2001). Analysis of the 
yeast Vamp7-PX domain by NMR spectroscopy has demonstrated that it has a specific 
PI3P-binding motif and this has a key role in regulating its subcellular localisation and 
function in vacuolar sorting (Cheever et al., 2001). The PX domain of cytokine- 
independent survival kinase, on the other hand, binds selectively to PI3 ,5 P2  and PI3 ,4 ,5 P3  
(Song et al., 2001).
Other phosphoinositide binding domains include the C2 (present in protein kinase 
C, PI3K , Rac GTPases and other enzymes) and SH2 (present in Src, PLCy and other 
enzymes) domains that are present in many kinases and phosphatases and have little 
specificity (Bae et al., 1998b; Rameh et al., 1995; Rameh et al., 1998). Nonetheless, these 
interactions are important for recruiting diverse cytosolic proteins to the plasma membrane 
in response to receptor activation.
1.4.1.2 The phosphoinositides as precursors o f second messengers
One of the most important roles of the membrane phosphoinositides and their 
products is as second messengers that allow the transduction of information from 
extracellular stimuli into a given intracellular response. The phosphoinositide metabolites 
that are known to be important second messengers are IP3  and DAG, both derived by the 
action of PLC enzymes on PI4 ,5 P2  (see Section 1.3.1). These two second messengers have 
independent mechanisms of action: IP3 is classically associated with the increase in [Ca2+]i 
and DAG activates several isoforms of PKC (Michell, 1992).
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94- 94-IP3  increases [Ca ]j by opening a Ca channel (IP3  receptor) situated in the ER. 
The cytosolic Ca2+ concentration in resting cells is maintained at low levels (~100 nM) by 
enzymes that translocate Ca2+ ions across the plasma membrane or into intracellular stores.
94-The cytosolic Ca level is increased physiologically when cells are challenged with certain 
stimuli, such as hormones, growth factors, depolarisation or mechanical deformation. The 
Ca2+ ions can be released from intracellular stores or can enter the cell across the plasma
94*membrane, or a combination of the two (Berridge et al., 2003). For mobilising [Ca ]j 
stores, IP3 receptors are the main route in almost all cell types. IP3 receptors are large 
(1200 kDa) tetrameric proteins, each subunit of which projects an amino-terminal domain 
into the cytoplasm; their membrane-spanning carboxy-terminal regions form an integral
9 1
Ca channel. IP3 binding by the amino-terminal domains causes a conformational change 
that promotes channel opening (Bosanac et al., 2004). Up to 500 nM [Ca2+]j works 
synergistically with IP3 to further activate IP3 receptors. At higher concentrations, [Ca2+]i 
inhibits IP3 receptor opening. The inhibition of IP3 receptors by [Ca2+]i is thought to be a 
crucial mechanism for terminating channel activity and thus preventing pathological 
[Ca2+]i increase (Bootman et al., 2002).
DAG is one of the key lipid second messengers that are generated transiently 
following the stimulation of seven-transmembrane and tyrosine-kinase receptors. Binding 
of DAG to the Cl domains of the PKC isozymes of the classic (cPKCa, pi, (311 and y) and 
novel (nPKC5, e, r| and 0) families results in their activation (Parekh et al., 2000). Phorbol 
esters, natural compounds that bind to Cl domains of PKC isozymes and thus mimic DAG 
action, affect cell proliferation, differentiation, survival and transformation (Ron and 
Kazanietz, 1999).
As discussed in full detail in Section 1.3.2, the PLA2  enzymes catalyse the 
hydrolysis of the sn-2 ester linkage of the phospholipid substrate, resulting in the 
production of a free fatty acid (generally AA), and the corresponding lysophospholipids. 
The AA is metabolized to prostaglandins by the cyclooxygenase pathway and to
64
leukotrienes by the 5-lipoxygenase pathway. In addition, AA and other unsaturated fatty 
acids are themselves important regulators of specific cellular processes, including the 
activation of PKC and PLCy, the modulation of ion channels, and cell death (Hirabayashi 
et al., 2004). CPLA2 0 1  has been shown to have a pivotal role in the biosynthesis of these 
inflammatory lipid mediators. Lysophospholipids concomitantly produced can be 
acetylated to generate platelet-activating factor (PAF), when the sn-1 position of the 
phospholipid contains an alkyl-ether linkage. Other lysophospholipids are also reported to 
have several biological functions. These lipid mediators are implicated in the 
pathophysiology of asthma, arthritis and other inflammatory diseases (Kudo and 
Murakami, 2002).
The activity of PLA2  is relevant to this study. The focus will be on a PLA2  activity 
specific for the membrane phosphoinositides (PI-PLA2 ). The main initial products are the 
AA and lysophosphoinositides. Starting from the lysophosphoinositides, the sequential 
hydrolysis of the fatty acid at the sn-1 position leads to the production of the 
glycerophosphoinositols. This last event requires the activity of a lysolipase, or the action 
of cPLA2 « and cPLA2 y, since both display lyso-phospholipase activity and can 
sequentially deacylate the sn-2 and sn-1 positions of these phospholipids (Leslie, 1991; 
Stewart et al., 2002). cPLA^S may not function as a PLA2  but rather as a PLAi and lyso- 
phospholipase, for the sequential release of the sn-1 and sn-2 fatty acids (Song et al., 
1999).
The cellular functions of the lysophosphoinositides and the 
glycerophosphoinositols will be described further in the following sections.
1.4.2 The lysophosphoinositides
The plasma membrane lysophosphoinositide pool is continuously 
deacylated/reacylated to maintain a constant concentration of the phosphoinositides.
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Okuyama (Kobayashi et al., 1996) and colleagues indicated that the production and 
removal of lysophosphoinositides can occur by a Ca2+-insensitive Pi-specific PLAi that is 
coupled to a LPI-specific PLC. This activity is also accompanied by a lysoPLA.2 activity 
that produces glycerophosphoinositol (GroPIns) (Ueda et al., 1993). When exogenously 
added to cells, the lysophosphatidylinositol (LPI) can be metabolized to inositol 1:2-cyclic 
monophosphate (Insl:2cP) by an extracellular PLC activity, or incorporated into the 
plasma membrane as a precursor of the phosphoinositides. The incorporated LPI can be 
further hydrolyzed to Insl:2cP via a intracellular PLC-like activity and to GroPIns via a 
lysoPLA activity, depending on the cell system (Corda et al., 2002; Falasca et al., 1998) 
(Fig 1.14).
LPI has been reported to increase by 2-3-fold in K-Ras transformed thyroid cells in 
response to the increased activity of PLA2 . In addition, treatment with LPI can cause an 
increase in [3 H]-thymidine incorporation both in Ras-transformed and in differentiated 
thyroid cell lines (Falasca and Corda, 1994). These data suggest that LPI has a mitogenic 
activity and that its formation is responsible for the increase in cell growth that is typical of 
transformed cells.
A number of lysophospholipids have been reported to be mitogens in different cell 
systems. The best characterised of these is lysophosphatidic acid (LPA), which is known to 
be the agonist of a specific GPCR. It initiates a complex signal cascade that activates the 
small G-protein Rho and affects the organization of the actin cytoskeleton (Moolenaar,
1999). In addition, LPA is also a marker for, and induces proliferation of, breast and 
ovarian cancers (Goetzl et al., 1999; Xu et al., 1995). Lysophosphatidylcholine (LPC) is 
also a mitogen, and it is associated with vascular, inflammatory and autoimmune diseases 
(Asaoka et al., 1991) and ovarian cancer (Fang et al., 2000). It has also been shown that 
LPC activates a signalling cascade as the ligand for the immunoregulatory A2G receptor (a 
GPCR) (Kabarowski et al., 2001)
DAG
PtdIns4,5R7 t
Ptdlns PtdIns4P
Ptdlns
Insl:2cP
GroPIns
LPI LysoPLA
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Insl:2cP
Ins 1 P
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Fig. 1.14 - Main potential pathways of metabolism from extracellularly applied 
or extracellularly produced LPI. Potential receptor activation by LPI is not included 
(see Section 1.4.2 for details) (Corda et al., 2002).
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The mitogenic activity of LPI is pronounced in Ras-transformed cells (thyroid cells 
and fibroblasts), while LPA is active also in normal cells. These lysophospholipids show 
different mechanisms of action that have allowed the exclusion of the presence of a unique 
receptor; moreover, LPI appears to be more active in cell systems in which it is also 
accumulated, thus suggesting that this compound can function as an autocrine modulator of 
cell growth. In fact it as been shown that in Ras-transformed fibroblasts (FRT-Fibro cells) 
and thyroid cells, LPI accumulates in the extracellular space. Thus, LPI accumulates inside 
the cell, and then is released and consequently activates its specific receptor (Falasca et al.,
1998). The presence of a specific receptor for LPI is strongly suggested by the fact that 
suramin, a membrane-impermeant antagonist of growth factors, completely prevents LPI 
activity (Corda et al., 2002).
The mechanism of action of LPI in fibroblasts includes the activation of a PLC that 
leads to [Ca2+]j increases, PLA2  activation and AA release. These events produce AC 
inhibition and a decrease in cAMP (see Section 1.3.3). Also, in pancreatic cells it is 
possible to follow a similar effect, while in yeast the LPI activates AC and inhibits PLD. In 
thyroid cells the LPI pathway involves tyrosine kinase activation (Falasca and Corda, 
1994; Falasca et al., 1995). These effects of LPI are all exerted at low micromolar 
concentrations (~10 jaM), which are below its critical micellar concentration (~75 jaM). An 
additional effect of LPI is to completely inhibit the Ras-GAP and neurofibromatosis type 1 
proteins, but at concentrations of >100 jaM (micellar form) (Falasca et al., 1995).
In summary, LPI is a mitogen that can act via a receptor-mediated mechanism. It is 
particularly active in transformed cells, which show an elevated concentration of 
lysophospholipids, and it can be accumulated in Ras-transformed cells more rapidly than in 
normal cells.
Besides LPI, the phosphorylated derivatives, the LPIPs such as LPI4P, LPI4 ,5 P2 , 
which are produced upon deacylation of their corresponding phosphoinositides (PI4P and 
PI4 ,5 P2 ) can also be found in cells. Once formed, the LPIPs are rapidly dephosphorylated
68
to LPI, and there are no indications of the presence of a reacylation pathway (Corda et al., 
2002; Palmer, 1986). In parallel to the dephosphorylation it is also possible to follow a 
deacylation by a LysoPLA2  that produces the glycerophosphoinositols, GroPIns4P and 
GroPIns4 ,5 P2 . In various cell types, it is possible to follow receptor and calcium-dependent 
GroPIns4P formation, and corresponding increase in LPI4P (Corda et al., 2002).
1.4.3 The glycerophosphoinositols
L4.3.1 Metabolic pathway o f the glycerophosphoinositols
The presence of GroPIns in cell extracts was originally seen in the 1960s and 1970s 
in early studies of phosphoinositides hydrolysis, when in vitro enzymatic activities relating 
to their formation were described (Irvine et al., 1978; Kemp et al., 1961). The formation of 
GroPIns was first described as requiring the combined action of a PLA2  and a lysolipase. 
More recently, an extracellular phospholipase B that is able to deacylate both the sn-1 and 
sn-2 positions of phospholipids and that has been identified in the intestine of different 
mammalian species has been proposed (Chaminade et al., 1999). The formation of GroPIns 
and its monophosphorylated form, GroPIns4P, has been reported in several tissues and cell 
lines (Corda et al., 2002)(Table 1.3).
Of interest, there is the observation that both GroPIns and LPI accumulate in Ras- 
transformed cells. The cellular systems used were KiKi or KiMol cells, which are 
transformed by the K-Ras oncogene and which originated from a normal rat thyroid cell 
line (FRTL-5 cells). The effect of the transformation was a 6 -fold increase in GroPIns. A 
parallel increase in membrane pools of phosphoinositides was also detectable in 
transformed cells, and this was related to a decrease in free cytosolic inositol. Furthermore, 
cell lines expressing temperature-sensitive mutants of oncogenic Ras display an
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Table 2
Stimulation o f  glycerophosphoinositols production in cells
Tissue,tell preparation Stimulant
GlyeeraphospJtoinositois
Peritoneal macrophages Zymosan particles, concanavalin A
Phtelets Thrombin
Grain slices Oxotrcmorine-M
Cerebral cortical slices Carbaehoi noradrenaline
Neutrophils fMetLcuPhc, concanavalin A
CG2B glioma cells Acetylcholine
Kidney slices Noradrenaline
Umbilical vein endothelial cells Histamine
Uterine decidua cells TPA
NIH 3T3 fibroblasts Ras/src/met 'trk/mas’raFva v transformation
Rat-1 Ras transformation
RAW264.7 macrophages Cholera and pertussis toxins
Vascular smooth muscle cells Atrial natriuretic peptide
Thyroid slices Thyrotropin, carbaehoi, noradrenaline
Vascular smooth muscle cells Endothelin
Adrenal fasciculata reticularis cells ACTH1-39
Precapillary resistance arteries Spontaneous hypertension, noradrenaline
Kupffer cells PAF
Thyroid cells Thyrotropin, carbaehoi ATP
Pemreabi I ized pituitary GH3 cells S'-CMP
HLGD cells DifFcrcntiatbn (DMSO)
Kupffer cells PAF, cholera toxin-*-PAF
Thyroid cells Ras transformation
Normal and Ras-transformed thyroid cells A231B7
Myeloid blast cells Differentiation (PMA)
Kupffer cells Endoibe1in-3
T-helper cells Tax transformation
Yeast Glucose
HLGD cells Differentiation (rcthoic aeid>‘GCSF)
HLGD cells DifFcrcntiatbn (dihydraxyvitamin Dj)
Myeloid blast cells Differentiation (spontaneous)
B and T lymphocytes Maturation
Renal proximal tubule cells Lindane
Various Receptor stimubtion
Hepatoeytes Pre-maturation
NG-1 OS-15 cells Differentiation (cAMP)
PCI2 cells DifFcrcntiatbn (NGF)
Various Receptor stimubtion
NIH 3T3 fibroblasts FITPa transfection
Kupfler cells PAF, A23187
RBL cells A231R7
CtroPIi;s4P
Precapillary resistance arteries Spontaneous hypertension, noradrenaline
Yeast Glucose
Thyroid cells Ras transformation
Hepatoeytes Liver development
NG-108-15 cells DifFcrcntiatbn (cAMPJ
Fibrobbsts EGF/insulinATP/LPA'A23187
Thyroeyics ATP/thyrotropin
PC12 cells EGF/NGF
RBL celts Antigen to IgE receptor
Rat heart al-odrcnoccptor
RBL cells A23187
Ras-transformed thyroid cells A23187
Abbreviations are as used in text.
u C. Iurisci and D. Corda, unpublished data; see text
Table 1.3 - Stimulation of GroPIns and GroPIns4P production in cells. From 
Corda et al., 2002. _n
accumulation of lysophosphoinositides and glycerophosphoinositols only at the permissive 
temperature. The modification in phosphoinositide pools and the parallel formation of 
GroPIns, were accompanied by striking changes in cell morphology (Alonso and Santos, 
1990; Valitutti et al., 1991).
These increases in GroPIns and LPI appear to be related not only to Ras 
transformation, but more in general to the activation of Ras pathways. Hence, these 
compounds are formed upon the activation of receptors, including those coupled to Ras, 
and high GroPIns levels can be measured during cellular responses, such as with the 
differentiation of hepatic and neuronal cells, where Ras is activated (Corda and Falasca, 
1996; Falasca et al., 1996). However, the correlation between Ras transformation and an 
increase in GroPIns has to be verified in individual cases, as was more recently examined 
by liquid chromatography-tandem mass spectrometry (to directly measure the GroPIns 
levels in cell extracts) (Berrie et al., 2002). Here the GroPIns levels in selected parental and 
Ras-transformed cells, as well as in some carcinoma cells, ranged from 44 to 925 pM, 
without increasing during transformation in all of the cell types (Table 1.4) (Berrie et al., 
2002).
In some cellular system (such as Ras-transformed thyroid cells, epithelial cells and 
fibroblasts), the activity of PLA2  is specific for the hydrolysis of the phosphoinositides, as 
the level of lysophosphoinositides is the only change seen after stimulation (the formation 
of LPC and lysophosphatidylethanolamine was not detectable). This suggests that a PI- 
specific PLA2  is present in these cells (Corda and Falasca, 1996; Falasca and Corda, 1994). 
This enzyme deacylates the phosphoinositides at the sn-2 position resulting in the 
production of AA; then a lysolipase (probably the same PLA2  that can also display a 
lysolipase activity, see Section 1.4.1.2) deacylates the sn-1 position of the glycerol 
backbone of phosphoinositides, thus forming the glycerophosphoinositols (Fig. 1.15a). As 
reported in Table 1.3, in many different cell types the formation of GroPIns has been 
associated with an ionophore (A23187)-dependent increase in [Ca2+]i and with many of the
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Figure 1.15 - Synthesis and metabolic pathway of the glycerophosphoinositols
(Corda et al., 2002). a) Schematic representation of the formation of LPI and GroPIns 
from PI via the sequential actions of a PLA2 and a LysoPLA, activity (see text for 
details). AA, arachidonic acid; SA, stearic acid; PLA2, 5«-2-specific phospholipase A; 
LPLA,, sn-1 -specific lysophospholipase A. b) A scheme for the known and potential 
metabolic interconversion pathways with particular reference to the 
lysophosphoinositides and the glycerophosphoinositols. Hollow arrows: direction of 
relevant enzymatic activities; asterisk: enzyme pathways known to be receptor 
activated; dotted arrows: potential metabolic pathways yet to be investigated; broken 
arrow: GroPIns4P is a reported substrate for Ptdlns-specific PLC51 in vitro (Wu et al., 
1997), but was not seen to undergo a PLC-like attack in Swiss 3T3 membranes in 
vitro (Berrie et al., 1999).
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other stimuli used also implying an increase in [Ca2 +]j, indicating that a Ca2+-dependent 
cPLA2 is involved (Corda et al., 2002).
In Swiss 3T3 cell extracts, GroPIns can be formed through the dephosphorylation 
of GroPIns4P; this is the only detectable catabolic pathway for GroPIns4P (Berrie et al.,
1999). The enzyme involved in the dephosphorylation is membrane associated, requires 
free Ca2+ (100-1000 nM) and is specific for GroPIns4P (Berrie et al., 1999). GroPIns4P can 
also be phosphorylated to GroPIns4 ,5 P2  by a Ca2+-insensitive cytosolic enzyme. The 
reacylation to phosphoinositide has been found only for GroPIns, which can be converted 
into PI both in whole cells and in membrane fractions. A schematic representation of the 
known and potential metabolic pathways for the formation of lysophosphoinositides and 
glycerophosphoinositols is given in Figure 1.15b. While the amount of GroPIns detectable 
in normal and transformed cells is generally in the range of 44-925 pM, when GroPIns4P 
is formed, it represent less than 3% of the GroPIns levels (Corda et al., 2002). Thus it will 
normally range from 1 to 50 pM.
1.4,3.2 Biological activities o f the glycerophosphoinositols
The glycerophosphoinositols are formed in many different cells types upon 
stimulation with growth factors, hormones and Ca2 +-ionophores. To understand their 
biological function, these compounds were given exogenously to cells and their potential 
actions on different signalling pathways were analyzed. The results of these studies are 
summarized below.
1.4.3.2.1 Adenvlvl cyclase and PLA? inhibition
The biological activities and mechanism of action of the glycerophosphoinositols
was originally characterised in thyroid cells. GroPIns4P was the only active compound,
and it was able to inhibit AC (see Section 1.3.3). The first evidence was that in isolated
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membranes of thyroid cells, AIF ' 4  (aluminium fluoride)-activated AC was inhibited by 
48% by the addition of GroPIns4P, with an IC5 0  of 30 pM (Iacovelli et al., 1993). This 
GroPIns4P-dependent inhibition of AC was also seen in intact cells, when the AC was 
activated by cholera toxin (CTX) or thyrotropin: 50 pM GroPIns4P caused a 67% 
inhibition of CTX-activated AC and a 20% inhibition of thyrotropin-activated AC (with an 
IC5 0  of 14 pM). Both AIF ' 4  and CTX activate AC via heterotrimeric G-proteins. By 
mimicking GTP, AIF' 4  causes the dissociation of the G a subunit from the Py dimer, while 
CTX ADP-ribosylates the G as subunit, favouring its activation (Gill and Meren, 1978). 
Thyrotropin is the main hormonal activator of AC in thyroid cells and it also acts through 
G-proteins. Based on these observations, it was proposed that GroPIns4P inhibits AC when 
it is activated by Gs proteins at least in the thyroid cell system. This proposal was 
supported by the demonstration that when AC was activated directly (by forskolin, which 
binds AC and causes structural changes that leads to its activation; Klein et al., 1988b), it 
was not inhibited by GroPIns4P. This AC inhibition also has a physiological relevance, as 
shown by thyrotropin-induced iodine uptake, which was inhibited by the treatment with 
GroPIns4P (Iacovelli et al., 1993). This GroPIns4P-dependent AC inhibition was then 
verified and confirmed in other cell lines, including smooth muscle cells, pituitary cells, 
pneumocytes, RBL cells and fibroblasts (Corda and Falasca, 1996; Falasca et al., 1997).
An additional correlation to cell function was seen in fibroblasts, were GroPIns4P
potentiates EGF-stimulated cell growth, which is known to be inhibited by cAMP. Upon
EGF treatment, the GroPIns4P concentration increases in a rapid and transient manner in
Swiss 3T3 fibroblasts: a 2-4-fold increase was visible after 15 sec of treatment, with the
maximal increase observed at 1 min (5-6-fold); within 2 min, the GroPIns4P levels return
to basal (Falasca et al., 1997). The levels of GroPIns were not affected by this EGF
treatment. This increase in GroPIns4P upon EGF treatment was observed also in other cell
lines, like NIH 3T3, FRT-fibro and PC-12 cells. The mechanism by which this EGF
treatment produced GroPIns4P was also investigated by applying a series of inhibitors, and
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in particular, wortmannin (a PI3K inhibitor) was able to prevent GroPIns4P formation. The 
expression of a dominant-negative mutant of the small GTPase Racl also inhibited the 
formation of GroPIns4P, and a dominant-positive mutant resulted in an increase in basal 
GroPIns4P levels (Falasca et al., 1997). This could be explained by the fact that Racl is 
essential for EGF-induced PLA2  activation (Peppelenbosch et al., 1995). In Swiss 3T3 
cells, forskolin and CTX-dependent cAMP synthesis was inhibited by EGF. Exogenously 
added GroPIns4P also inhibited forskolin and CTX-activated AC in the same cell system, 
with an IC5 0  of 0.1 pM (Fig. 1.16a) (Falasca et al., 1997). The EGF-dependent AC 
inhibition paralleled the changes in GroPIns4P levels: the maximal inhibition of cAMP 
was associated in time with the formation of GroPIns4P, which was maximal at 1 min and 
persisted for 30 min (Fig. 1.16b). Moreover, the extent of EGF-dependent AC inhibition 
was similar to that observed with exogenously added GroPIns4P and was prevented by the 
same inhibitors that blocked the production of GroPIns4P (Falasca et al., 1997). All these 
data suggested a potential role of GroPIns4P as second messenger, formed upon activation 
of the EGF-dependent Ras-Racl pathway that leads to PLA2  activation, and finally to AC 
inhibition (Ras-PI3K-Racl -PLA2 -GroPIns4 P-cAMPl).
Further indications that G-proteins can be a target of GroPIns4P come from the 
observations that GroPIns4P inhibits Gi-mediated activation of PLA2  in thyroid cells, as 
does GroPIns, but not GroPIns4,5P2. In FRTL5 thyroid cells, low micromolar 
concentrations of GroPIns and GroPIns4P inhibit purinergic- and adrenergic-receptor- 
induced AA release, which is known to involve the activation of Gj proteins (Berrie and 
Falasca, 2000; Corda et al., 2002). In line with these data, melittin- or calcium-induced AA 
release, which is Gi-independent, was not affected by either GroPIns or GroPIns4P (Corda 
et al., 2002). However, to date, there is no experimental evidence of a direct interaction of 
the glycerophosphoinositols with the G-proteins, as indicated by overlay and binding 
assays. The possible explanation of these effects of the glycerophosphoinositols
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Figure 1.16 - GroPIns4P-dependent AC inhibition, a) GroPIns4P-dependent 
inhibition of forskolin-induced cAMP levels in Swiss 3T3 cells. Data are presented as 
pmol/ml. GroPIns4P was added at the indicated concentrations 60 min prior to 
forskolin; the incubation was then carried out for 30 min. Similar results were obtained 
by increasing the cAMP levels with 10 nM cholera toxin, b) EGF-induced inhibition of 
the basal, cholera toxin-induced, and forskolin-induced cAMP levels in Swiss 3T3 
cells. Data are presented as pmol/well. The inset shows the percentage of inhibition 
induced by EGF over the basal (open squares), cholera toxin-stimulated (open circles) 
or forskolin-stimulated (closed squares) cAMP levels. (Falasca et al., 1997).
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could relate to an action at the level of the regulatory proteins that can modulate the 
activity of the G-proteins (Corda et al., 2002).
1.4.3.2.2 Modulation o f  the actin cvtoskeleton
As previously mentioned (Section 1.4.3.1), the formation of the
glycerophosphoinositols has been correlated to Ras activation. Ras-dependent pathways 
are important for many proliferative cellular events, such as cell growth, proliferation, 
motility and invasion. The glycerophosphoinositols have not shown any clear direct effects 
on cell growth (Falasca et al., 1996) although other cell functions downstream Ras, like 
cell motility and invasiveness, were analysed. All these events require modification of the 
structure of the actin cytoskeleton. For this reason, a possible role for the 
glycerophosphoinositols in the organization of actin cytoskeleton was studied in Swiss 3T3 
fibroblasts. Between the glycerophosphoinositols tested, the most powerful was 
GroPIns4P; its exogenous addition in serum-starved fibroblasts caused the rapid formation 
of membrane ruffles (detected within 1 min, and maximal at 2 min) followed by the 
formation of stress fibres (at 10-15 min) (Mancini et al., 2003) (Fig. 1.17). These effects 
were dose dependent: the 10-20% increase in ruffles after 1 pM GroPIns4P treatment 
reached an 80% increase when the concentration of GroPIns4P was 50-100 pM. These 
concentrations were also compatible with the evaluated cellular levels of GroPIns4P, 
which as mentioned before, is in the low pM concentration range (the basal level is less 
than 3% of GroPIns, which generally ranges from 44-925 pM), and increased by 1.5- to 6- 
fold after stimulation (Berrie et al., 2002; Corda et al., 2002). Under identical conditions, 
GroPIns and GroPIns4,5P2 had no measurable effects. The possible products of GroPIns4P 
degradation (inositol 1-phosphate, inositol 4-phosphate and inositol 1,4-bisphosphate) or 
reacylation (LPI, LPI4P) were also tested but no effects on ruffle or stress fibre formation 
were seen (Mancini et al., 2003).
Control
GroPlns-4P
2 m in
12 min
Figure 1.17- GroPIns4P and EGF-induced modifications of the actin cytoskeleton
in Swiss 3T3 cells. Serum-starved Swiss 3T3 cells (A) were treated with either 50 pM 
GroPIns4P (B and C) or 20 ng/ml EGF (D and E) for 2 and 12 min, respectively. Cells 
were fixed and stained with TRITC-labelled phalloidin. (F and G) Higher 
magnification of the boxed areas in B and E, respectively. Bar =20 pm (Mancini et al., 
2003).
Table 1. Effects of N17Rac, N17Cdc42, and C. botulbiwn C3 transferase microinjcvtion on the GroPIns-4P-inchiced actin cytoskeleton 
reorganization
Ruffles Stress Fibers
Injected Non injected Injected Noninjected
N17 Cdc42
GroPlns-4P (2 mini 21.9 -  4.0 317 £  6.0 20.7 z  5.2 23.8 Z  10.1
GroPIns-4P (12 mini 0.7 £  0.5 1.1 £  0.8 73 Z  26 73.1 Z 4.9
N17 Rac
GroPIns-4P (2 min) 0.7 Z  0.6* 36.7 Z 6.0 24.7 Z  6.5 22.0 -  6.1
GroPIns-4P (12 min) 0 0.4 Z  0.3 56.9 r  5.2 66.7 Z 7.7
C. botulmwn
GroPIns-4P (12 min) 10.6 Z 1.5* 40.8 -  2.5
Serum-starved Swiss 3T3 coils microinjected with NI7Rac, N17Cdc42, or C. botitlinttm C3 transferase were treviled with GroPlns-4P (50 jiMV 
Cells were fixed and stained with TRITC-labeled plvrlloidin as described under MATERIALS AND METHODS. Samples of control 
(noninjected) and injected cells from thrcv to five independent experiments were subjected to double-blind morphological scoring as 
described under MATERIALS AND METHODS An example of the actin structures identified as ruffles and stress libers is shown in Figure 
1 (F and G, respectively).
• Statistically significant difference j> <  0.05 (injected vs. noninjected). A parallel scoring was also performed in control cells, resulting in a 
level of ruffling and stress fibers ot 0.7 Z  0.2 and 4.1 Z 0.4, respectively. The total number of injected cells assessed under each condit ion 
ranged from 20 to 50, and equivalent numbers of noninjected cells were selected at random and also scored.
Table 1.5 - Effects of N17Rac, N17Cdc42, and C. botulinum C3 transferase 
microinjection on the GroPIns4P-induced actin cytoskeleton reorganisation
(Mancini et al., 2003).
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The investigation of the mechanism of action of GroPIns4P on ruffle and stress 
fibre formation revealed that the small G-proteins of the Rho family are involved (Mancini 
et al., 2003). As indicated in Section 1.2.3, the role of the small G-proteins of Rho family 
in the control of distinct actin structures has been extensively documented (Nobes and 
Hall, 1995). Cdc42 induces filopodia formation, Racl modulates the formation of 
lamellipodia and membrane ruffles and RhoA regulates the formation of stress fibres and 
focal adhesions (Ridley, 1998). The microinjection of serum-starved Swiss 3T3 cells with 
myc-tagged N17-Racl (a dominant negative mutant) completely abolished the activity of 
endogenous Racl and prevented Racl-dependent cellular functions (Ridley et al., 1992). 
Under these conditions, GroPIns4P-dependent ruffle formation was completely inhibited, 
while stress fibres still formed. The dominant-negative construct for Cdc42 (N17-Cdc42), 
which completely abolishes the activity of endogenous Cdc42, had no influence on actin 
cytoskeleton modifications induced by GroPIns4P. To block the activity of endogenous 
RhoA, cells were microinjected with C. botulinum C3 transferase which ADP ribosylates 
and inactivates the RhoA proteins (Ridley and Hall, 1992). Under these conditions, stress 
fibre formation induced by GroPIns4P was completely prevented, but ruffles were still 
formed (Mancini et al., 2003). Together, these results led to the conclusion that GroPIns4P 
acts upstream of Racl and RhoA and requires active Racl (but not Cdc42 and RhoA) to 
form ruffles and active RhoA (but not Racl and Cdc42) to form stress fibres (Table 1.5).
The effects of GroPIns4P were similar in type, extent and time course to those of 
EGF. In serum-starved Swiss 3T3 cells, this growth factor was able to cause the rapid 
formation of membrane ruffles followed by stress fibres (within 10 min). Even if  the final 
effects of EGF or GroPIns4P treatment were similar, the enzymes involved were different. 
EGF initiates a signalling cascade that involves the activation of PI3K and PLA2 , enzymes 
connected to the activation of Racl and RhoA (Nobes et al., 1995). Thus, EGF was 
completely blocked in the presence of either the PI3K inhibitor wortmannin or methyl 
arachidonil fluorophosphonate (MAFP), a cell-membrane permeant, irreversible inhibitor
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of PLA2  (Lio et al., 1996). Under the same conditions, GroPIns4P was still active (Mancini 
et al., 2003). Collectively, these results indicated that GroPIns4P modifies the actin 
cytoskeleton via a mechanism of action that is different from that of EGF, and suggested 
that GroPIns4P may act on a molecular target close to the activation of Racl and RhoA 
themselves.
The action of GroPIns4P on Racl has also been demonstrated in living cells. In 
Swiss 3T3 cells, GFP-tagged Racl showed a predominant cytosolic localisation upon 
serum starvation. During the first 2 min of stimulation of living cells with GroPIns4P (50 
pM), a clear accumulation of Racl-GFP became detectable at the plasma membrane, 
within specific structures exhibiting the morphology and dynamics typical of actin ruffles. 
When these cells were fixed and stained for actin with phalloidin, it appeared that actin and 
Racl-GFP indeed colocalized in ruffles at the plasma membrane (Fig. 1.18). Within 12 
min of treatment with GroPIns4P, Racl-GFP assumed again a diffuse localization, and 
ruffles disappeared, while stress fibres were formed (Fig 1.18) (Mancini et al., 2003).
The effect of GroPIns4P on Racl was also evaluated by assessing the ability of this
agent to activate Racl in living cells. The fraction of active (GTP-bound) Racl present in
serum-starved Swiss 3T3 cells exposed to GroPIns4P (50 pM) was 2-fold higher than in
untreated cells (near maximal, obtained by in vitro addition of 100 pM GTPyS). The
activation of Racl was rapid and sustained in time (Fig 1.19), and GroPIns4P was already
active at a 1 pM concentration, reaching a maximal 2-fold increase at 50 pM (Mancini et
al., 2003) (Fig. 1.19). GroPIns and GroPIns4,5P2 were also tested for their ability to
activate Racl, and surprisingly a certain degree of activation was detectable, but only when
the cells were treated with a 100 pM concentration of these agents. The time course of
activation also differed from that of GroPIns4P; both GroPIns and GroPIns4,5P2 caused a
rapid and transient activation of Racl (Fig 1.19). These data suggest that the duration and
the extent of the Racl activation induced by these compounds, have important roles in
initiating the signal cascade, leading to actin rearrangements and might reflect a different
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Actin Rac-GFP Merge
Figure 1.18 - Localisation of Racl and actin in GroPIns4P-induced membrane 
ruffles. Sub-confluent Swiss 3T3 cells were transfected with the pEGFP-Racl 
construct. Twenty-four hours after transfection, cells were treated with GroPIns4P (50 
pM) for 2 min (D-F) or 12 min (G-I), fixed, and stained with TRITC-labelled 
phalloidin. Unstimulated control cells are shown in A—C. Arrowheads show areas of 
extensive membrane ruffles where Rac colocalised with F-actin (Mancini et al., 
2003).
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mechanism of activation. In line with this, agents which produce a transient activation of 
Racl, such as LPA, do not induce ruffling like GroPIns and GroPIns4,5P2 (Mancini et al., 
2003). Thus, the duration and the extent of Racl activation is important for membrane 
ruffling, and could explain how only GroPIns4P is able to produce this response.
Analysis of the effects of GroPIns4P on the GDP/GTP exchange (GEF activity) and 
GTPase activity (GAP activity) of Racl have shown that GroPIns4P does not affect either 
the intrinsic GEF activity or the exchange activity enhanced by Racl GEF proteins. The 
intrinsic GAP activity of Racl and the GTPase activity enhanced by its GAP protein were 
also not affected by GroPIns4P (Mancini et al., 2003).
In conclusion, GroPIns4P activates intracellular molecular steps leading to a 
reorganization of the actin cytoskeleton via the activation of the small GTPase Racl. This 
Racl activation is mediated by a mechanism that is different from that initiated by growth 
factors, and it is long-lasting. Because agents that produce a transient activation of Racl 
(such as LPA) do not induce ruffling, the latter feature is relevant for clarifying both the 
mode of Racl activation by GroPIns4P and the manner in which activated Racl leads to 
ruffling.
1.43.23 Inhibition o f tumour cell invasion o f the extracellular matrix.
The small G-proteins of the Rho family are involved in a variety of cellular events, 
such as differentiation, motility and secretion, many of which are important for tumour 
development and metastatic invasion (see Section 1.2.3). The ability of the 
glycerophosphoinositols to modulate Rho protein function was exploited in relation to the 
capacity of tumour cells to migrate toward a chemoattractant and to invade an extracellular 
matrix (ECM). ECM invasion is a complex process that occurs during morphogenesis, 
differentiation, cell migration, apoptosis and tumour invasion.
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Figure 1.19 - GroPIns4P-dependent Racl activation. 1) Regulation of Racl 
activity by GroPIns4P. (A) Serum starved Swiss 3T3 cells were treated with 50 pM 
GroPIns4P for 2 min. Lysates from unstimulated and stimulated cells were processed 
and analyzed by Western blotting with an Ab against Racl. Lysates from control 
cells were incubated with GTPyS (100 pM) or GDP (1 mM) for positive and 
negative controls, respectively. Racl relative activation was calculated as the 
amount of PBD (Pak binding domain)-bound Racl in stimulated cells, and 
normalised vs. the amount of Racl in unstimulated cells. (B) Western blots from one 
of the representative experiments showing activation of Racl. (C) Time course of 
Racl activation by GroPIns, GroPIns4P, and GroPIns4,5P2. Serum-starved Swiss 
3T3 cells were treated with these stimuli (50 pM) for the indicated times. Racl- 
relative activation was calculated as the amount of PBD-bound Racl in stimulated 
cells, and normalised vs. the amount of Racl in unstimulated cells. 2) Dose response 
of GroPIns, GroPIns4P, and GroPIns4,5P2 on Racl activation. (A) Serum-starved 
Swiss 3T3 cells were treated with the indicated amounts of GroPIns, GroPIns4P, or 
GroPIns4,5P2 for 5 min; lysates from unstimulated and stimulated cells were 
processed and analyzed by Western blotting with an Ab against Racl. Racl-relative 
activation was calculated as the amount of PBD-bound Racl in stimulated cells, and 
normalised vs. the amount of Racl in unstimulated cells. (B) Western blots from one 
of the representative experiments showing the amount of activated Racl present in 
the affinity precipitations and the constant level of endogenously expressed Racl in 
the different cell lysates. (Mancini et al., 2003)
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Treatment with GroPIns and GroPIns4P at the maximal active doses known to 
activate the Rho GTPases (50 pM) inhibited the migration of MDA and A375 cells 
through the ECM (48% and 50% inhibition, respectively). The ECM invasion implies two 
distinct events: the migration of cells and the degradation the matrix. The ability of the 
glycerophosphoinositols to affect one or both of these events was tested, and it was shown 
that GroPIns and GroPIns4P inhibited the total area of degradation of the matrix, from 10- 
20% (1 pM) to 60% (100 pM), both in MDA and A375 cells. However, the migration in a 
modified Boyden chamber (versus a chemoattractant, such as serum-free 3T3-cell- 
conditioned medium) was not influenced by either GroPIns or GroPIns4P. A possible 
effect of these compounds on cell adhesion to the substrates can be excluded, since the 
number of adhering cells (relative to the control) was not affected (Buccione et al., 2005)
GroPIns and GroPIns4P reduce the ability of cells to degrade the ECM. The bis- 
phosphorylated form of GroPIns, GroPIns4,5P2, was ineffective in all of the assays 
(Buccione et al., 2005). The specialised cellular structures in which the ECM degradation 
occurs are the invadopodia (Chen, 1989). These are enriched in structural and signalling 
proteins, like the integrins, actin, the actin-binding proteins, the tyrosine kinases and the 
matrix metallo proteases (MMPs). No relevant changes in the structure and the proteins of 
invadopodia upon treatment with the glycerophosphoinositols were seen. However, the 
invadopodial machinery was less efficient in cells treated with GroPIns and GroPIns4P, 
thus implying that these compound act at a different level, altering the MMP secretion 
machinery or a component of invadopodia that is as yet unknown (Buccione et al., 2005).
1.4.4 Mechanism of action of the glycerophosphoinositols
The biological activities of the glycerophosphoinositols are related to G-proteins 
and cause many different cellular events (AC inhibition, Racl activation, modification of 
the actin cytoskeleton). An obvious question concerning the mechanism of action of these 
compounds derives from these data: whether they act directly on an intracellular target or
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as agonists of a specific receptor. So far, studies conducted with GroPIns4P have shown 
that it does not bind to the plasma membrane specifically and with a high affinity. Instead, 
GroPIns4P crosses the plasma membrane to reach equilibrium rapidly with the cell 
cytoplasm (Berrie et al., 1999). The uptake of GroPIns4P was measured in Swiss 3T3 
cells; it occurred very rapidly and reached equilibrium within 2-5 min. This rapid entry of 
GroPIns4P into Swiss 3T3 cells parallels the previously reported time courses of the 
intracellular effects of extracellularly applied GroPIns4P. The most likely explanation for 
this rapid cross-membrane equilibration of GroPIns4P is the presence of a GroPIns4P (or 
glycerophosphoinositol) transporter within the membrane. Indeed, a specific transporter for 
GroPIns in the yeast Saccharomyces cerevisiae has been described (Patton et al., 1995). In 
yeast the extracellular production of GroPIns is specific and regulated, and it is a major 
pathway for phosphoinositide metabolism; moreover, glucose stimulation of 
phosphoinositide metabolism leads to the production not only of GroPIns but also of 
GroPIns4P and GroPIns4 ,5 P2  within the yeast cell (Hawkins et al., 1993). This has thus led 
to the identification of the yeast GIT1 ORF that encodes a predicted Gitlp protein of 57.3 
kDa, which contains a sugar-transport motif and twelve membrane-spanning domains, and 
which represents the specific permease involved in the uptake of GroPIns in yeast (Patton- 
Vogt and Henry, 1998) While the presence and selectivity of an equivalent mammalian 
glycerophosphoinositol transporter remains to be confirmed, the rapid entry of GroPIns4P 
into Swiss 3T3 cells strongly suggests that the glycerophosphoinositols are taken up by 
mammalian cells through a similar mechanism to that used by yeast (Berrie et al., 1999).
1.5 Importance and potential implications of glycerophosphoinositols
The aim of this work is to characterise the mechanism of action of 
glycerophosphoinositols on actin cytoskeleton organization. The analysis was focused on the
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GroPIns4P. The other two compounds (GroPIns and GroPIns4 ,5 P2 ) were tested in parallel 
mostly to verify the specificity of action of GroPIns4P.
The pathway of GroPIns4P-dependent ruffle formation is the best characterized in 
this work. The ruffle is a morphological feature visible mostly upon growth factor 
stimulation (see Section 1.2.2). The action of GroPIns4P can mimic the activity of growth 
factors even if it differs in the extent of the effects and the pathway activated. For example, 
EGF stimulation leads to ruffle formation in a PI3K dependent way, whereas GroPIns4P 
does not need this enzyme to do the same thing (Mancini et al., 2003).
The identification of the main targets of GroPIns4P will be important, as it will 
allow to extend the study also in other cellular systems. A part from the cytoskeleton 
modification, GroPIns4P is able to inhibit AC and, together with GroPIns, to inhibit PLA2  
and matrix degradation by melanoma cells. We cannot exclude that the mechanism of action 
is the same in these other events. On the other and it could be also possible that GroPIns4P 
has multiple targets and, depending on the cell type, it could produce different effects.
The results obtained from this study will allow the definition of the mechanism of 
action and the role of the glycerophosphoinositols in the regulation of the actin cytoskeleton, 
which might then lead to the identification of these compounds as potential leads for the 
development of pharmacologically active compounds. It will also allow us to determine 
whether they are potential second messengers involved in the transduction of receptor 
signalling.
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CHAPTER 2
MATERIAL AND METHODS
2.1 Materials
Cell culture
NIH 3T3, HEK293T and SYF cells were from the American Tissue Type 
Collection (ATTC, USA). Human fibroblasts were kindly provided by the Istituto 
Dermatologico dell'Immacolata (IDI, Italy). Dulbecco's Modified Eagles Medium 
(DMEM), OptiMEM, calf serum (CS), penicillin, streptomycin, trypsin-EDTA, and L- 
glutamine were from GIBCO (UK). Foetal calf serum (FCS) was from Biochrom.
The E. Coli DH5a strain was from Stratagene. Tryptone and yeast extract were 
from Promega
Reagents
All the general laboratory salts were obtained at their maximal purities from Sigma- 
Aldrich (WI, USA). HEPES, paraformaldehyde, bovine serum albumin (BSA), saponin, 
glucose, leupeptin, aprotinin, phenylmethylsulfonyl fluoride (PMSF), antipain, 
phenanthroline, pepstatin, triethanolammine, ethylenediaminetetraecetic acid (EDTA), 
ethylene glycolbis (P-aminoethylether)-N,N,N’,N’ tetraacetic acid (EGTA), Tris 
[Hydroxymetyl] aminomethane*HCl (Tris*HCl), DL-dithiothreitol (DTT), tetanolysin, 
agar, glutathione, IPTG, sodium azide, Trypan Blue, ATP, GTP, GTP-yS, p-NAD+ p- 
aminobenzamide-agarose and thrombin were from Sigma-Aldrich (WI, USA). MES (2[N- 
morpholinojethansulphonic acid) and polyethylene glycol (PEG) 4000 were from Merk. 
Dextran T-500 was from Pharmacia. Hanks Balanced Salt Solution (lOx) without Ca2+ and
Mg2+ (HBSS~) and with Ca2+ and Mg2+ (HBSS) were from GIBCO. Perchloric acid, 
methanol, acetic acid, phosphoric acid and acetone were from Calbiochem (USA). Sterile 
water was from Diaco (Italy). The catalytic subunit of pertussis toxin (PTX) and the 
cholera toxin (CTX) were from Calbiochem (USA).
Plastic materials
All the plastic cell culture materials were from Coming (USA). Filters (0.45 and 0.2 
pm) were from Amicon (USA). Glass-bottomed wells were from Mattek.
Instrumental equipment
The P-scintillation counter was from Beckman Coulter (LS 6500; USA). The 
vacuum filtration apparatus was from Millipore (USA). The electrophoresis and blotting 
apparatus were from Hoefer Scientific instruments, Germany. The Instant Imager was from 
Canberra Packard (CT, USA) and the gel dryer from Hoefer Scientific Instruments 
(Germany).
Microscopes: Axiophot microscope with a lOOx 1.3 objective (Carl Zeiss, Jena, 
Germany). LSM 510 confocal microscope equipped with 40x and 63x objectives (Zeiss, 
Germany). 1X70 microscope (Olympus, Hamburg, Germany) equipped with a TILL 
Photonics imaging system (Grafelfing, Germany).
Plasmids
The pRK5myc, encoding RhoA, pGEX-4T-Racl, encoding Racl-GST and pGEX- 
4T, encoding GST, were kindly provided by Dr. A. Hall (University College London, 
London, UK). All of the TIAM1 expressing constructs and the corresponding deletion 
mutants (see Table 2.1) were kindly provided by Dr. I. Fleming (University of Dundee, 
Dundee, UK). The pSM-c-Src, encoding for wild-type Src, was kindly provided by Dr. S. 
Gutkind (NIH, Bethesda, USA). The pEGFPcl-Racl, encoding for Racl-GFP, was cloned
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in this laboratory (Mancini et al., 2003). The pEGFP, encoding for GFP, was from 
Molecular Probes.
SDS-PAGE
The acrylamide-bisacrylamide stock solution was from Eurbio. Sodium dodecyl 
sulphate (SDS), Ponceau Red, Comassie Brilliant Blue, Tween-20, ammonium persulphate 
(APS), glycine and Trizma base were from Sigma-Aldrich (WI, USA). Pre-stained 
molecular weight markers were from Amersham Pharmacia Biotech AB (Sweden). 
Methanol, glycerol, silver nitrate, sodium thiosulfate, formaldehyde, citric acid and acetic 
acid were from Carlo Erba (Italy). N,N,N’,N’ tetramethylethylenediamine (TEMED) was 
from Bio-Rad (Germany). The Nitrocellulose filters were from Schleicher & Schuell 
(Germany). The 3MM paper was from Whatman (UK). Kodak X-Omat film (Amersham)
Antibodies and probes
The anti-Myc antibody (clone 9E10) was from Roche Diagnostics (Indianapolis, 
USA). Tetramethyl rhodamine isothiocyanate (TRITC)-labelled phalloidin and fluorescein 
isothiocyanate (FITC)-labelled phalloidin were from Sigma- Aldrich (St. Louis, USA). 
Fluo3-AM, and the Alexa 488- and Alexa 546-conjugated goat anti-rabbit and anti-mouse 
antibodies were from Molecular Probes. The secondary antibodies conjugated to horse 
radish peroxidase (HRP) and directed against mouse, rabbit and goat IgG were from 
Calbiochem (USA). The origins of the primary antibodies were specified in Tables 2.2 and 
2.5.
Glycerophosphoinositols
GroPIns was from Euticals (Italy), while GroPIns4P and GroPIns4 ,5 P2  were 
prepared by Cristiano Iurisci (Department of Cell Biology and Oncology; Consorzio Mario 
Negri Sud Italy) by deacylation of their corresponding phosphoinositides (PI4P and
90
PI4 ,5 P2 , respectively; from Avanti Polar Lipids, USA); the procedure is based on the 
original work of (Clarke and Dawson, 1981). For the [3 H]GroPIns4P, see radioactive 
compounds section below.
Stimuli and inhibitors
PDGF was from Upstate (USA), LPA from Avanti Polar Lipids. KN-93, U73122, 
U73433, PP2, SU6656 and Mowiol were from Calbiochem. Ionomycin, ATP, genistein 
and BAPTA-AM were from Sigma-Aldrich. PTX was kindly provided by Dr. R. Rappuoli 
(Chiron Vaccines, Siena, Italy).
Kits
The “CaMKII activity assay” kit and purified CaMKII were from Upstate. The “D- 
myo-inositol 1,4,5-trisphosphate (IP3 ) [3 H] Biotrak assay system”, the Cyclic AMP [3 H] 
assay system”, the ECL reagents, the Glutathione-Sepharose™ 4B beads, the Protein-A 
Sepharose™ CL-4B beads and Protein-G Sepharose™ S4 fast flow beads were from 
Amersham Pharmacia Biotech. Lipofectamine/plus reagent was from GIBCO BRL (UK). 
The QIAGEN Plasmid Maxi Kit was from Qiagen (USA). The Protein Assay Kit was from 
Bio-Rad Laboratories (UK).
Radioactive compounds and solutions for the analysis
[y3 2 P]ATP (3000 Ci/mmole; BLU/NEG502A), [y3 5 S]GTPyS (1250 Ci/mmole, 
NEG030H), and the Filter Count and Ultima Gold scintillation fluids were from Perkin 
Elmer (USA). Cellulose nitrate membrane filters (45 pm) were from Whatman (England; 
UK). [3 2 P]NAD (specific activity 1000 Ci/mmol) was from Amersham Pharmacia Biotech 
(NJ, USA). [3 H]GroPIns4P was obtained by deacylation of [3 H]PI4P (ARC, USA; code 
number ART-185; specific activity 15-30 Ci/mmole), as originally described by Clarke and 
Dowson (1981) and carried out by Cristiano Iurisci
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2.2 Cell culture
2.2.1 Growth media
HEK293T and SYF cells were grown in DMEM supplemented with 2 mM 
glutamine, 1 U/ml penicillin and streptomycin, and 10% FCS. NIH 3T3 cells, and human 
fibroblasts were grown in DMEM supplemented with 2 mM glutamine, 1 U/ml penicillin 
and streptomycin, and 10% CS. Complete media were prepared by adding the serum and 
antibiotics required to DMEM (lx) and filtering the mixture through a 0.2 pm filter.
2.2.2 Growth conditions
All cell lines were grown under a controlled atmosphere in the presence of 5% 
CC>2 /9 5 % air at 37 °C. Cells were grown in petri dishes until 90% confluence. The medium 
was removed and 0.25% trypsin solution was added for 2-5 min. The medium was added 
back to block the protease action, and the cells were collected in a plastic tube and 
centrifuged for 5 min at 200x g. The pellet was resuspended in fresh medium and placed 
into new petri dishes.
2.3 DNA preparation and cell transfection
2.3.1 Preparation of competent cells
Competent bacteria were obtained using the rubidium chloride method (Kushner, 
1978). The DH5a E. Coli strain was streaked and incubated overnight on a plate of Luria 
Broth (LB; 10 g/1 of tryptone, 5 g/1 yeast extract and 10 g/1 NaCl). The next day, one single 
colony was inoculated into 10 ml LB and grown overnight at 37 °C with shaking at 225 
rpm. One ml of the overnight saturated culture was inoculated into 9 ml fresh LB and
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grown until the optical density at 550 nm (OD5 5 0 ) was 0.3. The bacteria were subcultured 
1:20 into 100 ml pre-warmed LB and grown until an OD5 5 0  of 0.48. The cells were chilled 
on ice and centrifuged at lOOOx g  at 4 °C for 5 min. The supernatant was then removed, 
and the pellet was gently resuspended in 40 ml 30 mM potassium acetate, 100 mM RbCl, 
10 mM CaCl2 , 50 mM MnCl2 , 15% (v/v) glycerol, pH 5.8. The bacteria were left on ice 
for 2 h, and then centrifuged and resuspended in 4 ml 10 mM MOPS, pH 7.0, 75 mM 
CaCl2 , 10 mM RbCl, and 15% (v/v) glycerol.
2.3.2 Transformation of bacteria by heat shock
Competent cells were thawed on ice and around 10 ng of plasmid added. After 
mixing, the cells were left on ice for 30 min and then heat shocked for 90 sec at 42 °C. 
After addition of 800 pi LB, the bacteria were grown at 37 °C for 45 min under constant 
shaking at 225 rpm. The culture was then plated on LB agar containing the appropriate 
selective antibiotics and incubated overnight at 37 °C. The next day, an isolated bacterial 
colony was picked from the plate and used to inoculate 2 ml of LB containing the 
appropriate antibiotics. Sterile glycerol was added to the bacterial culture (30%, v/v) for 
long-term storage at -80 °C.
Table 2.1 - List of plasmids
Plasmid Fusion protein Resistance Application
pEGFP-Racl Racl-GFP Kanamycin Eukaryote expression
pEGFP-cl GFP Kanamycin Eukaryote expression
pcDNA-C 1199-TIAM1 C1199-TIAM 1 -HA* Ampicillin Eukaryote expression
pMT2-Cl 199-TLAM1 C1199-TIAM 1 -GST* Ampicillin Eukaryote expression
pEGFP-Cl 199-TIAM 1 C1199-TIAM 1 -GFP* Kanamycin Eukaryote expression
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pEGFP-APHn-TIAM 1 APHn-TIAM 1 -GFP Kanamycin Eukaryote expression
pEGFP-APHc-TIAM 1 APHc-TIAM 1 -GFP Kanamycin Eukaryote expression
pEGFP-APH-TIAM1 APH-TIAM1 -GFP Kanamycin Eukaryote expression
pGEX-Racl Racl-GST Ampicillin Bacteria expression
pGEX GST Ampicillin Bacteria expression
pSM-c-Src Src Ampicillin Eukaryote expression
pRK5 RhoA RhoA-Myc Ampicillin Eukaryote expression
* C1199-TIAM1 is a mutant of TIAM1 that lacks the N-terminal myristoylated 
region, but that keeps the same behaviour as the wild-type protein (Michiels et al., 1997). It 
is easily transfectable compared to the full-length protein, and thus it is preferentially used 
for the studies in which TIAM1 is overexpressed.
2.3.3 DNA preparation
A single colony of transformed DH5a E. Coli bacteria was used to inoculate 500 
ml LB that included the selective antibiotics. After a 15-20-h incubation, the bacteria were 
collected by centrifugation at 10600x g  for 10 min at 4 °C and processed according to the ; 
“maxi plasmid purification protocol” of the “Qiagen-plasmid-kit”. The DNA obtained was 
resuspended in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 7.5) to a final concentration 
of 1 mg/ml and stored at 4 °C, or for long-term storage, at -20 °C.
2.3.4 Lipofectamine-based cell transfection
NIH 3T3 and SYF cells were transfected with the Lipofectamine/Plus reagent. The 
cells were seeded on glass coverslips in 24-well plates in normal culture medium, at a 
concentration suitable to have 50-70% confluence for transfection. About 24 h after 
seeding, a transfection mixture was prepared by first diluting the DNA with the PLUS 
solution and lipofectamine in separate polypropylene tubes, and followed by the mixing of
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the two solutions by pipetting. For each well, 0.4 pg DNA and 4 pi PLUS were diluted in 
150 pi OptiMEM (Gibco/BRL, NY, USA) and 1 pi lipofectamine was diluted in 150 pi 
OPTI-MEM. The two solutions were incubated for 15 min at room temperature (RT), and 
then were mixed together and incubated for a further 15 min at RT. Meanwhile, the cells 
were washed with OptiMEM medium. Then the final transfection mixture was added to the 
cells for 3 h. At the end of the incubation, 300 pi culture medium containing 20% CS was 
added to the cells for an additional 12 h. Finally, the solution was replaced with fresh 
medium.
2.3.5 Calcium-phosphate-based transfection
HEK293 cells were cultured in DMEM supplemented with 10% FCS and 
antibiotics (1 U/ml penicillin, 1 pg/ml streptomycin) and split 1: 6  every 4-5 days. One day 
before transfection, the cells were subcultured into 15-cm petri dishes at a density of 5 xlO4  
cells/cm . The cells were transfected using the calcium phosphate method (Graham and 
van der Eb, 1973; Jordan et al., 1996) where a HEPES-buffered solution was used to form 
a calcium phosphate precipitate that was layered directly onto the cells. The precipitate 
containing calcium phosphate and DNA was formed by slowly mixing an equal volume of 
HEPES-buffered saline (50 mM HEPES, 280 mM NaCl, 1.5 M Na2 HP0 4 , pH 7.05) with a 
solution containing 2.5 M calcium chloride and the 25 pg DNA/15 cm dish. The resulting 
solution was added directly to the growth medium, and the cells were incubated for 16 h 
with the calcium phosphate precipitate under standard growth conditions. The precipitate 
was then washed out and the cells fed with complete medium for a further 48 h.
2.4 Immunofluorescence procedures
2.4.1 Solutions
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PBS: 1.5 mM KH2 P 04, 8  mM Na2 HP04, 2.7 mM KC1, 137 mM NaCl, pH 7.4. 
Paraformaldehyde: 4% (w/v) paraformaldehyde was dissolved in heated PBS (65 °C) by 
adding a few drops of concentrated NaOH and the pH brought to 7.4 with 1 M HC1. 
Blocking solution: 0.05% saponin, 0.5% BSA, 50 mM NH4 C1 in PBS.
Mowiol: 20 mg Mowiol were dissolved in 80 ml of PBS, stirred overnight and then 
centrifuged for 30 min at 1 2 0 0 0 x g  to eliminate the unsolubilised particles.
Table 2.2 - List of the primary antibodies used for immunofluorescence:
Specificity 
(antibody name)
Source Animal source Dilution use
Anti-HA Babco mouse 1 / 1 0 0
Anti-Myc Roche Diagnostics mouse 1 / 1 0 0
Anti-TIAMl Santa Cruz rabbit 1 / 2 0
Anti-p-Src Upstate rabbit 1/500
Anti-c-Src Santa Cruz mouse 1/250
2.4.2 Cell treatments
Cells were seeded on glass coverslips in 24-well plates in normal culture medium at 
a concentration suitable for 70% confluence. The day after, the NIH 3T3 cells were serum 
starved using DMEM supplemented with 2 mM glutamine, 1 U/ml penicillin and 
streptomycin for 24 h. The SYF cells were serum starved with DMEM supplemented with 
2 mM glutamine, 1 U/ml penicillin and streptomycin and 0.1% FCS for 12 h and the 
human fibroblasts were starved in DMEM supplemented with 2 mM glutamine, 1 U/ml 
penicillin and streptomycin for 12 h. Then the cells were treated with the different stimuli, 
in order to follow modifications to the actin cytoskeleton, and a number of inhibitors were 
applied to the cells to block specific pathways. Table 2.3 summarises the concentrations, 
times of stimulation, and specificities of all of the agents used.
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Table 2.3 - List of the agents used to study actin cytoskeleton modifications
Compound Application Concentration and 
time of incubation
References
GroPIns4P
Ruffle and stress 
fibre formation, 
Racl activation and 
translocation to the 
plasma membrane
50 pM, 
for 2 to 30 min Mancini et al., 2003
GroPIns Racl activation 100 pM, 
for 2 to 30 min
Mancini et al., 2003
GroPIns4,5P2 Racl activation 100 pM, 
for 2 to 30 min
Mancini et al., 2003
PDGF 
(Platelet derived 
growth factor)
Ruffle formation, 
Racl activation and 
translocation to the 
plasma membrane
1 0  ng/ml, 
for 5-10 min
Mellstrom et al., 1988
LPA
(lysophosphatidic
acid)
RhoA activation 
and stress fibre 
formation
10 pM 
for 5-15 min
Ridley et al., 1992
KN-93 CaMKII inhibitor
20 pM added 
24 h before 
stimulation
Fleming et al., 1998; 
Sumi et al., 1991
BAPTA-AM [Ca2+]j chelator
20 pM added 
30 min before 
stimulation
Fleming et al., 1998
U-73122 PLC inhibitor 5 pM added 10 min 
before stimulation
Bleasdale et al., 1990
U-73433 Inactive analogue 
of U-73122
5 pM added 10 min 
before stimulation
Bleasdale et al., 1990
PP2 Src inhibitor
10 pM added 
1 0  min before 
stimulation
Bain et al., 2003
SU6656 Src inhibitor
10 pM added 
1 0  min before 
stimulation
Bain et al., 2003
Genistein RTK inhibitor
10 pM added 30 
min before 
stimulation
Akiyama et al., 1987
PTX To block Goii
5 nM added 
24 h before 
stimulation
Pittman, 1984
2.4.3 Immunofluorescence analysis for ruffle and stress fibre formation
After the various treatments, the cells (NIH 3T3 or SYF) were fixed with 4% (w/v) 
paraformaldehyde for 15 min, permeabilised in blocking solution for 20 min, and then 
incubated with 0.1 pg/ml TRITC- or FITC-labelled phalloidin or for 45 min for
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filamentous actin visualization (according to Mancini et al., 2003). All of these steps were 
carried out at RT, and coverslips were rinsed in PBS after each step. The coverslips were 
mounted by inverting them onto 15 pi of Mowiol. After 2 h at RT, the cells were examined 
with an Axiophot microscope using a lOOx 1.3 objective (Carl Zeiss, Jena, Germany).
For the morphological scoring of cells, the samples from each independent 
experiment (performed in duplicate) were subjected to blind scoring for ruffle and stress 
fibre formation. As used by Mancini et al. (2003), the assessment was on the basis of a null 
score (zero) for the absence of the feature, followed by a score of one or two according to 
the level of response of each individual cell (one, partial response; two, full response). The 
cell phenotypes were quantified by counting 2 0 0  cells in each sample (potential maximum 
score =400). The data were then expressed as percentage scores (±SD) that represent the 
scores for each morphological feature expressed as percentages of the potential maximum 
scores. Scoring of the control cells was performed in the same way, evaluating the 
presence of the features of interest in untreated cells. Across the repeated independent 
experiments, data are given in the Figures, legends and text as percentages of each 
response with respect to the individual controls for a given pattern of response.
2.4.4 Immunofluorescence analysis for protein localization
NIH 3T3 and SYF cells were transiently transfected by Lipofectamine/Plus with 
GFP-, Myc- or HA-tagged constructs (see Table 2.1); while human fibroblasts were not 
transfected, they were used to follow endogenous Src. After cell starvation (see Section 
2.3.3), the time courses of effects of different stimuli in the absence and presence of 
different agents (see Table 2.3) were followed. The cells then were fixed in 4% 
paraformaldehyde (w/v) for 15 min, permeabilised in blocking solution, and for 
filamentous actin visualisation, incubated with 0.1 mg/ml TRITC- or FITC-labelled 
phalloidin for 45 min (according to Mancini et al., 2003), for the cells overexpressing
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GFP-tagged constructs. When the cells were transfected with constructs that can be 
visualised with an antibody (or non-transfected in the case of human fibroblasts), after 
permeabilisation, they were incubated with the specified antibodies diluted in blocking 
solution (see Table 2.2 for the list and dilutions of antibodies used in this study) for 2-3 h 
at RT. After incubation with the primary antibody, cells were washed three times in PBS 
and incubated with a fluorescent-probe (Alexa 488 or Alexa 546)- conjugated secondary 
antibody directed against the constant region of the primary IgG molecule, for 1 h at RT. 
Secondary antibodies were diluted 1:400 in blocking solution. Finally, the actin was 
stained with TRITC- or FITC-phalloidin as detailed above. Coverslips were mounted in 
Mowiol on microscope slides. To check the specificity of the GFP-tagged constructs, the 
same experiments were performed also with cells overexpressing GFP. This always 
showed a nuclear and cytoplasmic localisation for GFP that did not change upon treatment.
The samples were then analysed and quantified blind on a laser scanning 
microscope: the samples were observed by an LSM 510 confocal microscope equipped 
with a 63 x objective (Zeiss, Germany). Optical confocal sections were taken at 1 Airy unit 
with a resolution of 512x512 pixels and exported as JPEG files. The quantitative 
evaluation of the immuno-staining patterns was performed on at least 50 cells per sample 
in at least three independent experiments, each performed in duplicate. The results are 
given in the Figures, legends and text, as percentages of cells displaying a given pattern.
2.5 Measure of fCa2+h
2.5.1 Procedure
NIH 3T3 cells were plated into glass-bottomed wells (Mattek) at 4xl0 5 cells/well in 
normal culture medium at concentrations suitable for 50-70% confluence. The day after, 
the cells were incubated with 4 jliM Fluo3-AM (a dye that fluoresces upon binding to Ca2+;
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excitation wavelength, 488 ran) in a HEPES-buffered saline solution containing 10 mM 
HEPES, pH 7.0, 137 mM NaCl, 5 mM KC1, 4 mM MgCl2, 3 mM CaCl2 *2H20  and 25 mM 
glucose, for 30 min at 37 °C (Klepeis et al., 2001). After two washes in the HEPES- 
buffered saline solution, the cells were placed in an open well with 1 ml HEPES solution, 
and positioned on the stage of a 1X70 microscope (Olympus, Hamburg, Germany) 
equipped with a TILL Photonics imaging system (Grafelfing, Germany). For each 
experiment, the cells were scanned for at least 30 sec to establish a base-line fluorescence 
reading before the addition of the different stimuli (see Table 2.4). The live imaging was 
carried out by taking two sequential movies: the first one taken each 2 0 0  msec for 2  min 
(to monitor any rapid Ca2+ variations) and the second then taken each sec for 6  min, to 
monitor what happened up to 8  min from the treatment. In each time-lapse movie, the 
increase in fluorescence obtained upon stimulation was seen as a gradual change in colour 
(from blue to red, as minimal and maximal fluorescence levels, respectively). In each 
experiment, the NIH 3T3 cells were added with the HEPES-buffered saline solution and
94-monitored to check that no spontaneous [Ca ]\ rise occurred. Then GroPIns4P and the 
other stimuli were added as necessary (see Table 2.4). Between each stimulation, the cells 
were washed with the saline solution to allow the [Ca2+]j to return to physiological 
concentrations. For each sample, from 5 to 12 cells were monitored for at least 8  min. A 
series of agents were applied before the stimulation (the same as used also to modulate 
ruffle formation; see Table 2.3).
To prevent the influx of extracellular Ca2+, cells were incubated in a Ca2+-free 
HEPES-buffered saline solution (10 mM HEPES, pH 7.0, 137 mM NaCl, 5 mM KC1, 4 
mM MgCl2, 1 mM EGTA, 25 mM glucose) for 30 min prior to the stimuli adition.
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Table 2.4 - List of the stimuli used for [Ca2+]i measurements
Compound Application Concentration References
GroPIns4P
Ruffle and stress 
fibre formation, Racl 
activation and 
translocation to the 
plasma membrane
50 pM Mancini et al., 2003
GroPIns Racl activation 100 pM Mancini et al., 2003
PDGF 
(Platelet derived 
growth factor)
Activation of PLCy 
through TRK 
signalling
1 0  ng/ml Secrist et al., 1990
ATP
Activation of PLCp 
through GPCR 
signalling
100 pM
Giovannardi et al., 1992
Ionomycin
Create pores at the 
level of the plasma 
membrane
10 pM Beeler et al., 1979
2.5.2 Image analysis
Each cell was selected at random and the fluorescence of each frame was calculated 
by the TILL Photonics imaging system. The background signal was determined from the 
average of three different areas adjacent to the cell. The fluorescence values were 
transferred to Microsoft Excel to perform the calculations, and after the background 
subtraction, they were plotted as increases in fluorescence per second.
The estimation of fluorescence intensity of Fluo3-AM is shown as the pseudoratio 
(AF/F) indicated by the following formula: AF/F0=[(F-F0)/(F0-B)] where F is the maximal 
level of fluorescence obtained upon stimulation, FO is the fluorescence under basal 
conditions and B is the background fluorescence (Klepeis et al., 2001; Takahashi et al., 
1999). Apart from dye saturation, AF/FO is thought to approximately reflect the [Ca2+]i if 
there is no change in dye concentration, intracellular environment or path length (Svoboda 
et al., 1997). The lag phase (time between the stimulation and the increase in [Ca2+]j), the 
time of stimulation (duration of the effects of the stimulus) and the percentage of
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responsive cells were also measured. The results are given in Table 3.1, 3.2 and 5.1 and 
they represent the means of all of the experiments performed.
2.6 Enzymatic activity assays
2.6.1 CaMKII activity assay
The activity of CaMKII was measured by the “CaMKII activity assay” kit 
(Upstate). NIH 3T3 cells were plated at 3.5 xlO5 cells/well in 6 -well plates, and the day 
after they were starved in DMEM, 0.1% BSA. After 20 h of starvation, the cells were 
stimulated with 50 pM GroPIns4P and 10 ng/ml PDGF. The treatment with BAPTA was 
performed as indicated in Table 2.3. After stimulation, the cells were harvested, lysed with 
30 passes through a 27-gauge needle, and centrifuged at 2000x g  for 3 min at 4 °C. The 
CaMKII assay was performed using from 2 to 5 pg of lysate proteins, per sample. The 
CaMKII activity was measured by monitoring the phosphorylation of a synthetic CaMKII 
substrate (autocamtide-2 ) in the presence (calcium-dependent activity) or absence 
(calcium-independent activity) of calcium and calmodulin, as provide by the CaMKII 
activity assay kit. The assays were conducted in a total volume of 50 pi, containing final 
concentrations of 20 mM MOPS, pH 7.5, 25 mM p-glycerophosphate, 1 mM Na- 
orthovanadate, 1 mM DTT (ADB buffer), 0.5 pM PKA and PKC inhibitor peptides, 1 pCi 
[y3 2 P]ATP and 20 pM total ATP, 75 mM Mg2+ and 500 pM autocamtide-2 substrate. When 
the assay was performed in the absence of Ca2+, 5 mM EGTA was added to the ADB 
buffer (ADBI buffer) and when the assay was performed in the presence of Ca2+, 2 mM 
CaCh was added to the ADB buffer (ADBII buffer). After 10 min at 30 °C, 25 pi of each 
samples were spotted onto P81 phosphocellulose paper squares, which were then air-dried 
for 1 min. The squares were washed 3 times in 40 ml 0.75% phosphoric acid for 5 min 
each, and once in 20 ml acetone for 5 min. The radioactivity associated with the dried
paper squares was quantified by scintillation counter by using Ultima Gold scintillation 
fluid (PerkinElmer). The results given in the Figures are presented as percentages of 
maximal CaMKII activation, obtained by performing the assay in the presence of the 
ADBII buffer.
The same assay was performed starting from cell lysates and purified CaMKII, 
instead of intact cells. Here the cells were seeded into 6 -well plates. The day after, the cells 
were harvested and lysed (30 passes through a 27-gauge needle) in ADBI buffer with 
added protease inhibitors (0.5 pg/ml leupeptin, 2 pg/ml aprotinin, 0.5 mM phenanthroline, 
2 pM pepstatin and 1 mM PMSF). The assay with the purified enzyme was performed with 
0.25 pg of purified CaMKII incubated with 50 pM GroPIns4P. Then the assays to 
determine the activity of CaMKII were performed following the same procedure described 
above.
2.6.2 TIAM1 phosphorylation by CaMKII
These assays were conducted using the same conditions used for the CaMKII 
activity assay (Section 2.6.1). The reaction was carried out in a total volume of 50 pi, 
containing final concentrations of 20 mM MOPS, pH 7.5, 25 mM P-glycerol phosphate, 1 
mM Na-ortovanadate, 1 mM DTT, 0.5 pM PKA and PKC inhibitor peptides, 1 pCi [y3 2 P] 
ATP and 20 pM total ATP, 75 mM Mg2+, 1 mM CaCl2 . Ten pi of the immunoprecipitated 
TIAM1-HA (see Section 2.8.3) were incubated in the buffer for 45 min at 30 °C. To stop 
the reaction, 40 pi of 4 x Laemmli sample buffer were added to each sample. After 5 min 
of boiling, the samples were loaded onto a 10% polyacrilamide gel (see Section 2.7). The 
Western blotting was quantitatively analysed for the level of TIAM1 phosphorylation 
using an Instant Imager (Packard Instruments Co.). The same assay was performed using
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purified TIAM1-GST (2 pg) (see Section 2.9.2) and purified CaMKII (0.25 pg) (Upstate), 
instead of the immunoprecipitate.
2.6.3 IP 3  measurements
NIH 3T3 cells were plated at 3.5 xlO5 cell/well in 6 -well plates, and the day after 
they were starved in DMEM, 0.1% BSA. After 20 h of starvation, the cells were stimulated 
for 2 to 15 min with 50 pM GroPIns4P at 37 °C, or with other stimuli, including thrombin 
(5 IU/ml), PDGF (10 ng/ml) and ATP (100 pM). The treatments were performed in 
DMEM, with 20 pM LiCl. For the experiments performed with cell lysates, the NIH 3T3 
cells were harvested and lysed by 30 passes through a 27-gauge needle, in a buffer 
containing 20 mM HEPES, pH 7.4, 3 mM EGTA, 0.2 mM EDTA, 0.83 mM MgCl2 , 1.5 
mM CaCl2 , 20 mM NaCl, 30 mM KC1, 1 mM DTT, 20 mM LiCl and protease inhibitors 
(0.5 pg/ml leupeptin, 2 pg/ml aprotinin, 0.5 mM phenanthroline, 2 pM pepstatin and 1 mM 
PMSF). Then the cells were treated as described above. The reaction was stopped by 
adding 20% perchloric acid for the IP3 extraction and the samples were left 20 min on ice, 
before being centrifuged for 20 min at 2000x g at 4 °C. The pH was adjusted to 7.0 with 
KOH in the presence of phenol red as a pH indicator. After a second centrifugation step, 
the intracellular concentrations of IP3 were measured using the “D-myo-inositol 1,4,5- 
trisphosphate (IP3 ) [ H] Biotrak assay system” from Amersham.
When the experiments were performed with cell lysates, anti-PLCp and anti-PLGy 
antibodies (20 pg/ml; as described in Ferry et al., 2001) were added prior to performing the 
stimulation, to selectively block the PLCp or PLCy. Then the assays were performed as 
described above.
The quantification of IP3 provided by the kit is based on competition between [3 H] 
IP3 (the tracer) and unlabelled IP3 (produced by the samples) for the interaction with a
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binding protein, prepared from bovine adrenal cortex. For each experiment, a standard 
curve with known IP3 concentrations was performed, and the quantity of IP3 present in the 
samples was extrapolated from the curve (as described in the kit). Once the pmols of IP3 
per sample had been calculated, the results were plotted as percentage increases versus the 
control (untreated sample).
2.6.4 Adenylyl cyclase assays
NIH 3T3 cells were grown to confluence in 12-well plates in complete growth 
medium. The cells were washed twice with HBSS and then stimulated with CTX (10 nM) 
for 30 min at 37 °C in HBSS containing 0.4% BSA, 10 mM HEPES and 0.5 mM 3- 
isobutyl-l-methylxanthine (pH 7.4), in the absence or presence of GroPIns4P (50 pM) or 
LPA (10 pM). The treatment with PTX (5 nM) was done 24 h prior to the stimulation of 
the cells. The intracellular cAMP content of the NIH 3T3 cells was extracted with ethanol 
and measured using a commercial radioimmunoassay (“Cyclic AMP [3 H] assay system”; 
Amersham) and the experiments were performed in triplicate. For each experiment, a 
standard curve with known cAMP concentrations was performed, and the quantity of 
cAMP present in the samples extrapolated from the curve (as described in the kit). The 
results are expressed as pmols cAMP/well.
2.6.5 Src activity assay
Human fibroblasts or NIH 3T3 cells were plated into 6 -well dishes (1.5x10s 
cells/well). The day after, the cells were serum starved (see Section 2.4.2) for 20 h and then 
subjected to stimulation with GroPIns4P and PDGF (see Table 2.2). After this treatment, 
the cells where lysed in 150 pi buffer containing 60 mM Tris-HCl, pH 7.4, 30 mM P- 
glycerophosphate, 50 mM p-mercaptoethanol, 1 mM Na3 V0 4 , 2% SDS, 10% glycerol and
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protease inhibitors (0.5 pg/ml leupeptin, 2 pg/ml aprotinin, 0.5 mM phenanthroline, 2 pM 
pepstatin and 1 mM PMSF). Finally, after the addition of 50 pi of Laemmli sample buffer 
(4x), the samples were sonicated for 10 sec and processed for SDS-PAGE and Western 
blotting (see Section 2.7) with anti-p-Src, anti-c-Src or anti-Yes antibodies (see Table 2.5 
for dilutions).
2.7 SDS-PAGE preparation and analysis
2.7.1 SDS-PAGE
Solutions
1) Acrylamide-bisacrylamide mixture: 40% (w/v) acrylamide-bisacrylamide
(37.5:1)
2) Running buffer: 200 mM glycine, 20 mM Trizma base, 4 mM SDS pH 8.3;
3) Laemmli sample buffer (lx): 125 mM Trizma base, 4% SDS, 20% glycerol, 10% 
p-mercaptoethanol, pH 6 .8 .
Assembly of polyacrylamide gels
Two 16 cm x 15 cm glass plates were assembled to form a chamber using two 1.5 
mm plastic spacers lined up with the lateral edges of the glass plates. This chamber was 
fixed using two clamps and then mounted on a plastic base that sealed the bottom.
The ‘running’ polyacrylamide gel was prepared by mixing H2 O, 40% (w/v) 
acrylamide-bisacrylamide solution, 1.5 M Tris-HCl, pH 8 .8 , 10% (w/v) SDS, in order to 
have the selected concentrations of acrylamide and 375 mM Tris-HCl, 0.1% (w/v) SDS. 
Then, 0.06% (w/v) APS and 0.06% (v/v) TEMED were added; the solution was pipetted 
and poured in the gap between the plates, leaving ~5 cm for the stacking gel. Soon after 
pouring, the gel was covered with a layer of 375 mM Tris-HCl, pH 8 .8 , and left at RT for
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~1 h. The Tris-HCl layer was removed after gel polymerisation. The ‘stacking’ 
polyacrylamide gel was prepared by mixing H2 O, 40% (w/v) acrylamide-bisacrylamide 
solution, 0.5 M Tris-HCl, pH 6 .8 , 10% (w/v) SDS, in order to have 4% (w/v) acrylamide, 
125 mM Tris-HCl, 0.1% (w/v) SDS. Then, 0.1% (w/v) APS and 0.07% (v/v) TEMED were 
added, and the solution was pipetted and poured onto the ‘running’ gel. Immediately, a 15- 
well comb was inserted between the glass plates and this was left to polymerise for 1 h at 
RT.
Sample preparation
Samples were prepared by adding an equal volume of 4x Laemmli sample buffer 
and boiling for 5 min; they were then loaded into the wells. The lateral wells were loaded 
with 10 pi pre-stained molecular weight standards (Amersham). The chamber was then 
assembled into the electrophoresis apparatus (Hoofer Scientific Instruments, Germany), 
and the electrophoresis was carried at a constant current of 8  mA (for overnight runs) or 
30-40 mA (for 4-h runs).
2.7.2. Silver Staining
Polyacrylamide gels were soaked in fixing solution (methanol: acetic acid: H2 O 
50:5:45) for 20-30 min with stirring, washed twice with H2 O (2 min per wash), and then 
left in H2 O for 1 h on a shaking platform. The gels were then incubated for 1-2 min in 
sensitizing solution (0.02 % sodium thiosulfate) and rinse with two washes of H2 O (30 sec 
each). Finally, the gels were incubated with the staining solution (0.1% silver nitrate) for 
30 min and developed with the developing solution (0.04% formaldehyde in 2% sodium 
carbonate). The development was quenched by adding 1% acetic acid, and the gels were 
dried in a gel dryer.
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2.7.3 Coomassie Brilliant Blue staining
Gels were incubated in staining solution (50% methanol, 40% H2 0 , 10% acetic acid 
and 500 mg Coomassie Brilliant Blue/1 1) for 2 h, washed and then destained with 30% 
methanol, 10% acetic acid in H2 O. The gels were dried in a gel dryer.
2.7.4 Western blotting
Solution:
1) "Transfer buffer": 20 mM Trizma base, pH 8.3, 200 mM glycine;
2) Blocking buffer: 50 mM Tris-HCl, pH 7.5, 3% BSA (or alternatively 5% dry skim 
milk), 0.05% Tween-20,150 mM NaCl;
3) TTBS: 50 mM Tris-HCl, pH 7.5, 0.05% Tween 20,150 mM NaCl;
4) TBS: 50 mM Tris-HCl, pH 7.5,150 mM NaCl.
Nitrocellulose blotting
The polyacrilamide gels were soaked for 15 min in transfer buffer, together with 
two pieces of 3MM paper (Whatmann, UK) and one of nitrocellulose 
(Schleicher&Schuell). The gel was assembled into a sandwich as follows: first a sheet of 
filter paper was covered with the nitrocellulose, the gel was then placed onto the 
nitrocellulose, and finally, a second sheet of filter paper was placed on the gel. This 
sandwich was then assembled into the blotting apparatus (Hoefer Scientific Instruments, 
Germany) and the transfer was carried out at 500 mA. At the end of the run (typically 4-5 
h), the sandwich was disassembled and the nitrocellulose was soaked in 0.2% Ponceau 
Red, 5% acetic acid for 5 min, to visualise the protein. The filters were then rinsed with 5% 
acetic acid to remove excess unbound dye.
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Immunodetection of antigens
The nitrocellulose filters were cut into strips with a razor blade. The strips were 
incubated in blocking buffer for 30 min at RT, then with antibodies directed against the 
proteins of interest, which were diluted at the appropriate concentrations in the blocking 
solution. A list of antibodies used in this study and their working dilutions is provided in 
Table 2.5. Incubations with the primary antibodies were carried out for 2 h at RT, or 
overnight at 4 °C. At the end of this incubation, the antibodies were removed and the strips 
washed with TTBS for 3 x 3 min. The strips were incubated for 1 h with the appropriate 
HRP-conjugated secondary antibodies (1:5000 in TTBS, 3% BSA) and washed 2 x 3  min 
with TTBS and 2 x 3  min with TBS. At the end of the washing, the strips were incubated 
with the ECL developing solution according to the manufacturer instructions, for ECL- 
based detection visualised by autoradiography.
Table 2.5 - List of the antibodies used for Western blotting
Specificity 
(antibody name)
Source Animal source Dilution
Anti-HA Babco mouse 1/1000
Anti-GFP Our Department rabbit 1/20000
Anti-TIAMl Santa Cruz rabbit 1/500
Anti-p-Src Upstate rabbit 1/1000
Anti-c-Src Santa Cruz mouse 1/1000
Anti-Yes Santa Cruz mouse 1/1000
Anti-GST Our Department rabbit 1/10000
2.8 Cytosol overexpressing TIAM1
2.8.1 Cytosol preparation
The cell cytosol was prepared according to (Self and Hall, 1995) from HEK293T 
cells transfected with constructs overexpressing C1199-TIAM1 (henceforth referred as 
TIAM1 for brevity) or its deleted mutants, either HA or GFP tagged (see Table 2.1), by the
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calcium phosphate method (Section 2.2.6). The cells were plated in seven 15 cm petri 
dishes, transfected the day after, and then after 48 h of transfection the cells were lysed by 
vortexing in a buffer containing 25 mM Tris-HCl, pH 7.6, 100 mM NaCl, 10 mM MgCl2 , 
1% glycerol and 1% NP-40, and then centrifuged 30 min at 90,000x g. The supernatant 
was recovered, its protein concentration evaluated by a protein assay kit (Bio-Rad, see 
Section 3,7.2), and then it was aliquoted and frozen at -80°.
2.8.2 Evaluation of protein concentrations
Protein concentrations were evaluated using a commercially available protein assay 
kit (Bio-Rad Laboratories, UK), according to the manufacturer instructions.
2.8.3 Immunoprecipitation of TIAM1
The TIAM1-Ha-overexpressing cytosol (220 pg) was diluted in a buffer containing 
25 mM Tris-HCl, pH 7.6, 100 mM NaCl, 10 mM MgCl2 , in a final volume of 200 pi. The 
lysate was then incubated with 1.5 pg of an antibody against the HA tag (Babco), 
overnight at 4 °C in a rotating wheel. The day after, 12 pi of 75% protein G (high affinity 
for antibodies raised in mouse) was added to the samples for 2 h in a rotating wheel. The 
immunoprecipitation of the GFP-tagged mutants was performed as for the HA-tagged 
construct, although the cytosol (220 pg) was pre-cleared with a 1 h-incubation with 50% 
protein A at 4 °C in a rotating wheel. Then the antibody against GFP (2 pg) was incubated 
overnight, and the day after, it was precipitated with 12 pi of 50% protein A (high affinity 
for antibodies raised in rabbit). After the incubations, the samples were centrifuged at 800x 
g  for 10 min at 4 °C and washed 4 times in the dilution buffer. Finally an SDS-PAGE was
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run and the amount of immunoprecipitated protein, was determined by Western blotting 
(Section 2.7) and quantified by NIH imaging program.
2.9 Fusion protein preparation
2.9.1 Purification of glutathione S-transferase (GST) fusion proteins
All the GST-fusion constructs (cloned in p-GEX vectors) were purified using the 
Glutathione-Sepharose™ 4B beads (Amersham Pharmacia Biotech AB, Sweden) 
according to the instructions of the manufacturer. The DH5a E. Coli strain harbouring the 
GST-fusion protein of interest was grown in LB (500 ml) plus ampicillin (60 mg/ml) until 
the OD6 0 0  was about 0.7-0.9. At this point, the fusion protein was induced for 2 h at 37 °C 
with 1 mM IPTG. The cells were harvested by centrifugation at 400x g for 10 min at 4 °C, 
and then resuspended in 20 ml 20 mM Tris-HCl, pH 7.6, 100 mM NaCl, 5 mM MgCk, 
0.5% NP-40, 10 pM GDP, 1 mM DTT in the presence of a cocktail of protease inhibitors 
(0.5 pg/ml leupeptin, 2 pg/ml aprotinin, 0.5 mM phenanthroline, 2 pM pepstatin and 1 mM 
PMSF) (according to Mancini et al., 2003). The suspension was stirred for 30 min, and 
then sonicated three times for 1 min, on ice. The lysed cells were centrifuged at 12,000x g 
for 10 min at 4 °C. Meanwhile, 1.2 ml of a Glutathione-Sepharose resin was diluted up to 
10 ml in ice-cold lysis buffer without DTT and protease inhibitors, to remove the 
preservative, and centrifuged at 2000x g  for 5 min at 4 °C. The supernatant was discarded, 
and the resin was resuspended in the buffer. This procedure was repeated twice. The 
supernatants from the bacterial lysates were added to the Glutathione-Sepharose resin and 
incubated for 30 min at 4 °C on a rotating wheel. The beads were washed with 3 x 20 ml of 
the buffer used also for the resin, and poured into a column. Protein elution was started by 
the addition of 500 pi 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 5 mM MgCk, 1 mM DTT, 
10 pM GDP and 5 mM glutathione (elution buffer). Five hundred pi was collected
(fraction 1) and this procedure was repeated four times. The fractions containing the 
protein were quantified using the BioRad Protein Assay Kit (BioRad), and 2 pi of each 
fraction were analysed by SDS-PAGE and stained with Coomassie Brilliant Blue or silver 
stained. The fractions were then dialysed overnight against a buffer containing 10 mM 
Tris-HCl, pH 7.6, 20 mM MgCl2, 0.1 mM DTT.
2.9.2 Purification of TIAM1-GST from HEK293T cells
TIAM1 was purified from HEK293T cells that had been transiently transfected 
with pMT2-Cl 199-TLAM1 plasmid encoding for TIAM1-GST (according to Fleming et al., 
1997, with some modifications). The cells were plated in ten 15 cm petri dishes and 
transfected by the calcium phosphate method with TIAM-GST (as described in Section 
2.3.5). After 72 h of transfection, the cells were collected and then resuspended in the lysis 
buffer (5 mM DTT, 1% Triton X-100, 10 mg/ml leupeptin, 10 mg/ml antipain, 1 mM 
PMSF in lx  PBS). The cells were then lysed with 20 passes through a 27-gauge needle, 
and centrifuged for 5 min at 10,000x g  at 4 °C. The supernatant was diluted 1/10 with PBS, 
5 mM DTT, and incubated overnight with the glutathione resin (50%). The day after, the 
resin was recovered by centrifugation for 5 min at l,000x g  at 4 °C, and then washed 3 
times with PBS, 5 mM DTT. The elution was carried out in 50 mM Tris-HCl buffer, pH
7.4, containing 10 pM reduced glutathione. Two sequential elutions of 1 ml each were 
performed, and these eluates were dialysed overnight against 1 1 PBS. Ten pi of each 
fraction was then analysed by SDS-PAGE and stained with Coomassie Brilliant Blue or 
silver stained.
When TIAM1-GST was used in the pull-down assay, the GST was removed by 
thrombin. This cleavage was done instead of elution from the glutathione beads, in a buffer 
containing 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 2.5 mM CaCl2  and 10 IU thrombin 
The beads were incubated for 2 h at RT on a rotating wheel, and then centrifuged at 1 OOOx
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g  for 10 min at 4 °C. The supernatant containing the cleaved TIAM1 was then incubated 
for 30 min at RT with 20 pi of a resin that binds thrombin (p-aminobenzamide-agarose), to 
eliminate this enzyme, and then centrifuged at lOOOx g  for 10 min at 4 °C. The supernatant 
obtained in this way was dialysed overnight against 11 PBS (see Section 2.4.1) at 4 °C.
2.10 Membrane preparation
2.10.1 Solutions
Potassium phosphate buffer (PFB; 200 mM, pH 7.4): 1.36 g K2 HPO4  and 1.14 g K2 PO4  
dissolved to 50 ml in H2 O.
Protease inhibitors: 2.0 pg/ml aprotinin, 0.5 pg/ml leupeptin, 2 pM pepstatin, 0.5 mM 
phenanthroline, 1 mM PMSF.
Hypotonic buffer: 10 mM TES, pH 7.0, 1 mM EDTA.
Sucrose buffer: 10 mM TES, pH 7.5, 250 mM sucrose.
PTX treatment was performed on intact cells as described in Table 2.2, 24 h prior to the 
preparation of the membranes.
2.10.2 Plasma membranes
Plasma membranes were prepared following the procedure described by (Gettys et 
al., 1994), with some modifications. NIH 3T3 cells at 80-90% confluence ( 6  x 108 cells for 
each preparation) were washed with HBSS=, and then lysed with a Teflon glass Potter 
homogeniser in hypotonic buffer. The unbroken cells and nuclei were removed by low 
speed centrifugation at 400x g for 5 min at 4 °C, and the crude membranes were collected 
from the supernatant with a centrifugation for 20 min at 48,000x g at 4 °C. The pelletted 
membranes were re-suspended in the sucrose buffer, at a final concentration of ca. 100-150
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mg/ml. Two hundred mg membranes were mixed to a 14 g pre-weighted aqueous two- 
phase system composed of 5.12 g 20% dextran T-500, 2.56 g 40% polyethylene glycol 
4000, 0.4 ml 200 mM PFB, pH 7.2, 1. 6  ml 1 M sucrose and distilled water. Separation was 
achieved by centrifugation at 2500x g  for 20 min at 4 °C. The upper phase was removed 
and repartitioned against a fresh lower phase, while to increase the yield of the plasma 
membranes, the lower phase was extracted with a fresh upper phase. Finally, the two upper 
phases containing the plasma membranes were combined, diluted 5-fold in sucrose buffer, 
and collected by centrifugation at 20,000x g  for 30 min at 4 °C. The purified plasma 
membranes were re-suspended at 1 mg/ml in 25 mM HEPES, pH 7.4, 150 mM NaCl, 1 
mM EDTA, and protease inhibitors, and stored at -80 °C.
2.10.3 Total membranes
NIH 3T3 cells at 80-90% confluence ( 6  x 108 cells for each preparation) were 
washed with HBSS=; harvested using HBSS= with 5 mM EGTA, and centrifuged at 500x g 
for 5 min at 4 °C. The pellet was then resuspended in hypotonic buffer and lysed by three 
steps of sonication (15 sec each). The lysate was centrifuged at 700x g  for 10 min at 4 °C, 
to eliminate the unbroken cells, and then at 90,000x g  for 90 min at 4 °C, to recover the 
total membranes. The pellet was resuspended in 20 mM HEPES, pH 7.4, with protease 
inhibitors.
2.10.4 PTX-dependent ADP-ribosylation of Gai in plasma membranes
The ADP-ribosyltransferase activity was measured following the incorporation of 
radioactive ADP-ribose into the membrane components. The ADP-ribosylation assay was 
carried out following the procedure described by Lupi et al. (2000), with some 
modifications. Samples (5 pg NIH 3T3 plasma membranes) were incubated with 50 pi
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ADP-ribosylation buffer (50 mM PFB, pH 7.4, 5 mM MgC^, 4 mM DTT, 10 pM GTPyS, 
700 pM p-NAD+ and 4.5 pCi [3 2 P]NAD) for 60 min at 37 °C in the presence of the 
catalytic subunit of PTX (100 nM), to allow the ADP-ribosylation of the aj subunit of the 
heterotrimeric G proteins. The reaction was terminated by diluting the samples with 50 pi 
Laemmli sample buffer (2x), and analysed by 12% SDS-PAGE. The proteins were 
electroblotted (as described in Section 2.7.4), and the filters were exposed to Kodak X- 
Omat film (Amersham).
2.11 Pull-down assays
2.11.1 Pull-down assay with cell cytosol overexpressing TIAM1-HA
The cell cytosol was prepared from HEK293T cells that had been transfected with 
pcDNA-1199-TIAMl vector, encoding for TIAM1-HA, as described in Section 2.8.1. Ten 
pi lysate was first diluted (1:15) in the reaction buffer (25 mM Tris-HCl, pH 7.6, 100 mM 
NaCl, 10 mM MgCk), and then cleared with the 50% glutathione resin for 1 h at 4 °C on a 
rotating wheel, and incubated for 10 min at 37 °C with 50 pM GroPIns4P. Finally, 4 pg 
purified Racl-GST or purified GST (Section 2.8.2), 10 pi 50% glutathione resin and 20 pi 
2 mg/ml BSA (final volume 200 pi) were added to the samples, which were then incubated 
for 1 h at 4 °C on the rotating wheel. The pellets were recovered by centrifugation at 800x 
g  for 6  min at 4 °C, and after 3 washes with the reaction buffer, they were analysed by 
immuno-blotting with the anti-TIAMl antibody (see Section 2.7). The amount of TIAM1- 
HA co-immunoprecipitated with Racl-GST was quantified by the NIH imaging 
programme (densitometric analysis).
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2.11.2 Pull-down assay with purified TIAM1
Two pg of the purified TIAM1 protein (see Section 2.8.3) were incubated for 10 
min at 37 °C with 100 pM GroPIns4P, then 2 pg purified Racl-GST or GST, 10 pi 50% 
glutathione resin and reaction buffer (20 mM Tris-HCl, pH 7.6, 100 mM NaCl, 200 mg/ml 
BSA, 1 mM MgCl2 , 1 mM DTT and 1% Triton X-100) were added to the samples (final 
volume 200 pi). Finally, the samples were incubated on a rotating wheel for 1 h at 4 °C. 
The pellets were recovered by centrifugation at 800x g  for 6  min at 4 °C, and then after 3 
washes with the reaction buffer they were analysed by immuno-blotting with the anti- 
TIAM1 antibody (see Section 2.7). The quantification of the densitometry of the bands was 
performed using the NIH imaging programme.
2.12 Uptake experiments
2.12.1 Cell permeabilisation with tetanolysin
Solutions
1) Tetanolysin solution: Tetanolysin was dissolved in sterile water to a final 
concentration of 1 pg/pl.
2) HGI buffer: 20 mM PIPES, 2 mM NaATP, 4.8 mM Mg(CH3 COO)2, 150 
mM potassium glutamate, 2 mM EGTA, 1 mM DTT (added just before the 
experiment) and KOH to obtain pH 7.0.
Procedure
The NIH 3T3 cells were permeabilised with tetanolysin (Sigma) by a procedure 
adapted from Riese et al. (2002). The cells were detached from the petri dish by scraping, 
then counted, divided into samples of 6  xlO6 cells (to be divided again into samples of 1 . 6  
xlO6 cells for the uptake experiments), and washed with 6  ml/sample HGI buffer. The cells
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were then incubated for 10 min at 37 °C with 2.4 pg tetanolysin, 1 mM DTT and 2 mM 
ATP in HGI buffer and then washed with ice-cold HGI buffer. The level of cell 
permeabilisation was quantified by penetration of Trypan Blue (at 4 mg/ml).
2.12.2 GroPIns4P uptake in cells and binding in to membranes
2.12.2.1 GroPIns4P uptake in intact andpermeabilised cells
The GroPIns4P uptake was performed according to Patton-Vogt and Henry (1998) 
and Berrie et al. (1999). Intact or permeabilised (see Section 2.12.1) NIH 3T3 cells (1.5 
xlO6) were harvested and resuspended in 150 pi growth medium plus 10 mM HEPES, pH
7.5, and incubated with 150 pi growth medium plus [3 H]GroPIns4P (9 xlO4  cpm/sample), 
10 pM GroPIns4P and 10 mM HEPES for 10 min at RT. The samples were then spotted 
onto nitrocellulose filters (0.45 pm cellulose nitrate membrane filters; Whatman), and 
washed three times with a buffer containing HBSS, 2 mg/ml BSA and 10 pM  GroPIns4P 
in a vacuum filtration apparatus. The binding at time 0 was calculated by separately 
spotting cells and [ H]GroPIns4P on the same nitrocellulose filter. The non-specific 
binding to the filters was calculated by spotting the radioactive mixture directly onto the 
filters without the cells, and this was subtracted from the total bound [3 H]GroPIns4P 
obtained for each sample. Each experiment was carried out in quadruplicate. The filters 
were dissolved in Filter Count (Perkin Elmer) and then counted to an error of ±2% in a p- 
scintillation counter (Beckman). The dpm obtained were then converted into total pmols of 
GroPIns4P bound to the sample and plotted. This was done considering the specific 
activity of the [3 H]GroPIns4P, the amount of [3 H]GroPIns4P bound per sample, the ratio 
between the [3 H]GroPIns4P and GroPIns4P, and the concentration of GroPIns4P.
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2.12.2.2 GroPIns4P binding to membranes
The conditions applied in the uptake assay (Section 2.12.4) were used to follow the 
binding of GroPIns4P to membranes. The experiment was performed using the same 
amount of total membrane and plasma membranes that should be present in the cells used 
for the uptake experiment described in Section 2.12.2. The approximate amount of total 
membrane present in a single cell, was calculated by preparing total membranes from a 
known number of cells and then dividing the amount of membrane obtained for the number 
of starting cells. Thus, the theoretical amount of membrane present in a single NIH 3T3 
cell is about 80 pg (amount of proteins). The uptake assay was performed with 1.5 x 106  
cells per sample, and thus the amount of total membrane and plasma membranes would be 
1 2 0  pg proteins and 6  pg proteins respectively (in general, the plasma membrane 
represents 5% of the total membranes; Gettys et al., 1994). The membranes were extracted 
from NIH 3T3 cells following the procedure described in Section 2.9, and the assay was 
performed as described in Section 2.12.2.
2.13 Binding assays
2.13.1 GTPyS binding
The GTPyS binding was performed according to (Wieland et al., 1994). Plasma 
membranes of NIH 3T3 cells (5 pg) untreated and treated with 5 nM PTX for 24 h, were 
incubated for 30 min at 30 °C in a buffer containing 50 mM triethanolammine, pH 7.3, 5 
mM MES, 1 mM EDTA, 5 mM MgCl2, 143 mM NaCl, 0.16% BSA, 10 pM  GTP, and 4 
nM [y 3 5 S]GTPyS (2 xlO5 cpm/sample), in the presence of 50 pM  GroPIns4P or other 
stimuli, including Mas 7 (25 pM), and LPA (10 pM), in a final volume of 100 pi. The non­
specific binding was measured by adding GTPyS to samples to a final concentration of 10 
pM. The reaction was stopped by adding 2.5 ml ice-cold washing buffer (50 mM Tris-HCl,
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pH7.3, 1 mM EDTA and 5 mM MgCk). Then the samples were filtered through 0.45 pm 
filters (cellulose nitrate membrane filters; Whatman) and washed three times with 2.5 ml 
ice-cold wash buffer in a vacuum apparatus. Finally, the filters were collected, dissolved in 
Filter Count (Perkin Elmer) and counted to an error of ±2% in a p-scintillation counter 
(Beckman). The results in the Figures are plotted as percentage increases over the 
untreated samples.
2.13.2 Binding of GroPIns4P to immunoprecipitated TIAM1
Cell cytosols overexpressing different constructs of TIAM1 or its deletion mutants 
that were HA or GFP tagged (see Table 2.1 and Section 2.7.1) were used to 
immunoprecipitate the corresponding fusion proteins through the HA or GFP tags, as 
described in Section 2.7.3. The immunoprecipitates (already attached to Protein A or G 
depending on the tag) were incubated with GroPIns4P for 45 min at 37 °C in a buffer 
containing 25 mM Tris-HCl, pH 7.6, 100 mM NaCl, 10 mM MgC^, GroPIns4P in a range 
of 0.1-50 pM and [3 H]GroPIns4P 0.1 pM (at 9xl0 4 cpm/sample) in a final volume of 100 
pi. Then the samples were centrifuged for 5 min at 3000x g  at 4 °C, washed 3 times with 
the same buffer (25 mM Tris-HCl, pH 7.6, 100 mM NaCl, 10 mM MgCk) and the resin 
was counted on a p-scintillation counter using Ultima Gold scintillation fluid 
(PerkinElmer). The non-specific binding was calculated by immunoprecipitating the wild- 
type cytosol from HEK293T cells with the anti-HA antibody (in the case of the 
immunoprecipitation of TIAM-HA), or by immunoprecipitating GFP from cytosol 
overexpressing GFP with the anti-GFP antibody (in the case of the immunoprecipitation of 
TIAM1-GFP or its deletion mutants).
The Kd values (dissociation constants) for GroPIns4P were calculated using the 
Prism programme, according to the equation: B=(FxBmax)/(Kd+F), where F is the ligand
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that is not bound to the receptor, B is the receptor that has radioligand bound to it, and 
Bmax is the total amount of receptor present (i.e., the maximum number of binding sites).
The following assumptions have to be taken in account for this calculation: i) only a 
small fraction of the radioligand binds; thus, its free concentration is almost identical to the 
total concentration added, ii) There is no cooperativity; thus, the binding of a ligand to one 
binding site does not alter the affinity of the ligand for another binding site, iii) The 
conditions are left to reach equilibrium, iv) The binding is reversible and follows the law of 
mass action.
The Kd for GroPIns4P versus immunoprecipitated TIAM1 value was calculated 
considering only the specific binding seen at the lower pM GroPIns4P concentrations (up 
to 10 pM) because with the increase in the concentration of GroPIns4P to 50 pM, the 
variability of the data through this procedure rendered the values of the specific binding 
difficult to estimate with any significance.
The samples were counted to a ±2% error and the dpm were converted into total 
pmols of GroPIns4P bound. This calculation was as explained in Section 2.12.2.
2.13.3 Binding of GroPIns4P to purified TIAM1-GST and Racl-GST
Purified TIAM1-GST (2 pg) (see Section 2.8.3) or Racl-GST (2 pg) (see Section 
2.8.2) were used instead of the immunoprecipitate in the same binding assay as in Section
1.13.2. The assay buffer, containing 10 pM GroPIns4P and 0.1 pM [3 H]GroPIns4P (9 
xl0 4 cpm/sample), and the times of incubation where the same as those used in Section
2.13.2. However, two different approaches were used to determine if GroPIns4P binds 
directly to TIAM1-GST or Racl-GST:
1) TIAM1-GST was incubated with the assay buffer and then precipitated 
through the glutathione resin, to separate the unbound fraction. The non­
specific binding was calculated by using purified GST instead of TIAM1-
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GST. The resin was counted on a p-scintillation counter using the Ultima 
Gold scintillation fluid (PerkinElmer). The samples were counted to an 
error of ±2% and the dpm converted into total pmols of GroPIns4P bound 
(Section 1.12.2).
2) TIAM1-GST or Racl-GST were incubated in the assay buffer and then 
spotted onto nitrocellulose filters, which were then washed twice using a 
vacuum apparatus, with 25 mM Tris-HCl, pH 7.6, 100 mM NaCl, 10 mM 
MgCl2 , 200 pg/ml BSA. Also in this case, GST was used to evaluate the 
non-specific binding. Finally the filters were collected, dissolved in Filter 
Count scintillation fluid (PerkinElmer) and counted to an error of ±2% in a 
P-scintillation counter. The dpm were converted into total pmols of 
GroPIns4P bound (Section 1.12.2).
2.13.4 Liposome-binding assay.
The GST-PH fusion proteins were expressed in E. coli (BL-21) and purified using 
Glutathione-Sepharose™ 4B beads (Amersham Pharmacia Biotech AB, Sweden). Liposomes 
of defined lipid compositions were generated by co-dissolving the appropriate lipids in 1 : 1  
chloroforrmmethanol containing 0.1% HC1. The lipid mixtures contained 
phosphatidylcholine (PC) alone or in combination with 2% PI4 5 P2  (Kavran et al., 1998). The 
liposomes were prepared by initially drying the lipids under a stream of nitrogen, followed 
by a high vacuum, and then rehydration of the dried mixtures by bath sonication in PBS, to a 
final total lipid concentration of 10 mM. The lipids were subjected to at least 10 cycles of 
freezing (liquid N2 ) and thawing (bath sonication), until optical clarity was achieved. The 
different PH domains were incubated with the liposomes at RT for 15 min, and then they 
were ultracentrifuged at 100,000x g  for 30 min at 4°. After centrifugation, both the 
supernatants and the vesicle pellets were assayed for protein content. Competition assays
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were then performed by Stefania Mariggio (Department of Cell Biology and Oncology; 
Consorzio Mario Negri Sud, Italy), and the ability of the water-soluble 
glycerophosphoinositols to compete with PtdCho/ PI4 5 P2 -lipid vesicles for the binding to PH 
domains was calculated (Kavran et al., 1998).
2.14 Statistical analysis
All experiments are presented as the means of duplicate or triplicate determinations 
that were repeated at least three times. Statistical analysis was carried out using the paired 
Student’s t test, calculated by the “Prism GraphPad” programme.
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CHAPTER 3
SIGNALLING CASCADE INVOLVED IN GLYCEROPHOSPHOINOSITOL 4- 
PHOSPATE INDUCED ACTIN RUFFLE FORMATION.
3.1 Introduction
GroPIns4P can modulate the actin cytoskeleton organization acting at the level of 
the small GTPases of the Rho family: when added exogenously to serum-starved Swiss 
3T3 cells, it stimulates a Racl-dependent rapid formation of membrane ruffles followed by 
RhoA-dependent stress fibres formation. Moreover, GroPIns4P increases the cytosolic 
fraction of GTP-bound Racl and favours its translocation to the plasma membrane, 
without altering its intrinsic GTP-binding or GTPase activity (Mancini et al., 2003). The 
action of GroPIns4P is specific, since under identical conditions GroPIns and 
GroPIns4 ,5 P2  had no measurable effects.
To study the mechanism responsible for the modulation of the actin cytoskeleton 
operated by GroPIns4P, the methodological approaches taken were:
1) Immunofluorescence analysis of the intracellular localization of small 
GTPases involved in actin cytoskeleton remodelling, of other proteins 
involved in their regulation and of the actin cytoskeleton.
2) In vitro assays to study specific enzymatic activities potentially modulated by 
GroPIns4P as well as second messenger production.
3) In vivo imaging of Fluo-3 loaded cells to measure intracellular calcium levels. 
These approaches should allow the understanding of a complex signalling pathway
that is activated upon cell treatment with GroPIns4P and that leads to ruffle formation.
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3.2 GroPIns4P and Racl
3.2.1 General description
The GroPIns4P-dependent Racl activation was investigated in Swiss 3T3 cells 
(Mancini et al., 2003). Exogenously added GroPIns4P induces a rapid translocation of 
Racl-GFP to the plasma membrane and produces a sustained and nearly maximal 
activation of Racl, increasing the GTP-bound fraction of Racl (Mancini et al., 2003). 
GroPIns and GroPIns4,5P2 are also able to increase the amount of GTP-bound Racl in the 
cell, but only transiently and at a concentration a least of 100 pM (Fig. 1.9, Chapter 1) 
(Mancini et al., 2003). GroPIns4P is the only compound able to initiate the signal cascade 
that leads to actin reorganization, thus suggesting that the duration and the extent of Racl 
activation could play an important role in this pathway, as discussed in the introduction 
(Section 1.4.3.1).
Swiss 3T3 cells are not easily transfectable, which makes them unsuitable for 
further investigations into the activity of the glycerophosphoinositols. I therefore tested 
NIH 3T3 cells, which transfect well, for GroPIns4P-dependent ruffle and stress fibre 
formation and GFP-Racl translocation to the plasma membrane. In addition, I examined 
whether the reported ability of GroPIns and GroPIns4,5P2 to transiently activate Racl 
could produce the translocation to the plasma membrane of this small G protein.
3.2.2 GroPIns4P triggers ruffle formation and Racl-GFP translocation to the 
plasma membrane in NIH 3T3 cells
In order to verify whether GroPIns4P could modulate the actin cytoskeleton also in 
NIH 3T3 cells in a way that could be comparable to what is reported for Swiss 3T3 cells 
(Mancini et al., 2003), immunofluorescence experiments of ruffle and stress fibre 
formation were performed. Serum starved NIH 3T3 cells were treated with 50 pM
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GroPIns4P or 10 ng/ml PDGF for different times (from 2 to 30 minutes), stained with 
TRITC-labelled phalloidin for filamentous actin visualization and subjected to blind 
morphological scoring, as described in Section 2.4.3.
Within 2 minutes of addition, GroPIns4P produced a clear increase in membrane 
ruffles (a 2.3-2.5-fold response versus control) both on the dorsal side of the cell and at the 
leading edge of the lamellipodium (Fig. 3.1a). This feature persisted for up to 5 min (1.4 
fold increase) of treatment and then disappeared (Fig. 3.1b). A five min treatment with 
PDGF produced a 3.9-fold increase in the same kind of ruffles and the appearance of 
circular ruffles (or called waves) that are transient, actin-based dorsal membrane structures 
that can provide a structural base for force generation, and which function as indicators of 
cellular transition from a static to a motile state (Buccione et al., 2004) (Fig. 3.1a). The 
different effects of these two compounds underlined a divergence in their mechanism of 
action.
Both Swiss 3T3 and NIH 3T3 cells had a similar time course for GroPIns4P- 
dependent membrane ruffle formation; the appearance of stress fibres was instead delayed 
and less evident in NIH 3T3 cells (within 15-20 min there was a 1.7-fold response over the 
control in stress fibres) when compared to Swiss 3T3 (within 12 min a 3-4-fold response) 
(Mancini et al., 2003) (Fig. 3.1b).
In Swiss 3T3 cells the formation of membrane ruffles was associated with the 
translocation of Racl-GFP to the plasma membrane (Mancini et al., 2003). The same event 
could be followed also in NIH 3T3 cells. Racl GFP tagged was transfected in NIH 3T3 
cells and, after 24 h of serum starvation, 50 pM GroPIns4P or 10 ng/ml PDGF were added 
for different times (as described in Section 2.4.4). Within 2 min of treatment, Racl-GFP 
localised at the plasma membrane and in particular in membrane ruffles and remained 
there for at least 15 min (as showed also for Swiss 3T3 cells). In basal conditions, only 
32% of cells shown a localization of Racl at the plasma membrane, whereas upon 
stimulation with GroPIns4P Racl localised at the level of plasma membrane in the 75% of
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Figure 3.1 - GroPIns4P-dependent ruffle and stress fibre formation in NIH 3T3 
cells, a) Serum starved NIH 3T3 cells were treated with 50 pM GroPIns4P for different 
times (from 2 to 30 min) or 10 ng/ml PDGF for 5 min. Cells were fixed and stained with 
FITC-labelled phalloidin and quantified blind for the extent of ruffle and stress fibre 
formation as described in Section 2.4.3.The results shown are the means (±SD) of three 
independent experiments, each performed in duplicate, b) Representative images of 
GroPIns4P- and PDGF-dependent modification of actin cytoskeleton in NIH 3T3 cells. 
Bar=20 pm
<0.05, **P <0.01, versus control (Section 2.14)
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cells (Fig. 3.2a, b).
The behaviour of these two cell lines is therefore similar, but the NIH 3T3 cells 
have the advantage of being easy transfectable. For this reason these cells were used for the 
investigation of the mechanism of action of GroPIns4P.
3.2.3 GroPIns and GroPIns4,5P2 do not induce the translocation of Racl to the 
plasma membrane.
A treatment with 50-100 pM GroPIns or GroPIns4,5P2 of Swiss 3T3 cells did not 
produce any ruffle formation, despite, these two compounds are able to induce a small 
(50% increase) and transient activation of Racl (if compared with the 100% increase 
produced by GroPIns4P) (Mancini et al., 2003). Even if weak, this Racl activation could 
be sufficient to induce its translocation to the plasma membrane. To test this possibility, 
the extent of Racl-GFP localisation to the plasma membrane upon treatment with GroPIns 
and GroPIns4,5P2 was analysed in NIH 3T3 cells.
The cells, transfected with Racl-GFP and serum starved, were stimulated with 100 pM 
GroPIns or GroPIns4,5P2 for different times (from 2 to 20 min). TRITC-phalloidin was 
used for filamentous actin visualization and the localization of Racl-GFP was analysed by 
confocal microscopy. Short-term treatment with GroPIns or GroPIns4,5P2 (2-5 min) did 
not produce any translocation of Racl-GFP to the plasma membrane. A longer incubation 
(15-20 min), resulted in a partial re-localisation of Racl-GFP to the plasma membrane in 
45-55% of the treated cells (a 1.5-1.6 fold response over the basal level). However, this 
was a weak and delayed effect when compared with that observed upon GroPIns4P 
treatment (Fig. 3.3). These data supported the conclusion that the rapid effect of Racl 
translocation and ruffle formation produced by GroPIns4P cannot be mimicked by other 
similar compounds like GroPIns and GroPIns4,5P2.
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Figure 3.2 - GroPIns4P-dependent translocation of Racl-GFP to the plasma 
membrane in NIH 3T3 cells, a) Sub-confluent NIH 3T3 cells were transfected with 
the pEGFP-Racl construct as described in Section 2.3.4. Twenty-four h after 
transfection, cells were serum starved for 24 h and then were treated with GroPIns4P 
(50 pM) for 2 to 20 min, fixed, and stained with TRITC-labelled phalloidin. The 
percentage of cells showing plasma membrane localisation of Racl was quantified 
blind as described in Section 2.4.4. The graph represents the mean (±SD) of three 
independent experiments, each performed in duplicate, b) Localisation of Racl-GFP 
and actin in GroPIns4P-induced membrane ruffles. Bar=20 pm 
<0.05, ** P <0.01, ***P <0.001, versus control (Section 2.14)
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Figure 3.3 - Quantification of GroPIns and GroPIns4,5P2-dependent Racl-GFP 
translocation to the plasma membrane. Sub-confluent NIH 3T3 cells were 
transfected with the pEGFP-Racl construct as described in Section 2.3.4. Twenty- 
four h after transfection, cells were serum starved for 24 h and then were treated with 
GroPIns or GroPIns4,5P2 (100 jiM) for 2 to 20 min, fixed and stained with TRITC- 
labelled phalloidin. The amount of cells showing plasma membrane localisation of 
Racl was quantified blind as described in Section 2.4.4. The graph represents the 
mean (±SD) of two independent experiments, each preformed in duplicate. *P<0.05, 
**P<0.01, versus control (Section 1.14).
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3.2.4 Conclusion
When exogenously added to Swiss 3T3 and NIH 3T3 cells, GroPIns4P produces a 
sustained activation of Racl, followed by an increase of 2.3-fold versus the control of 
membrane ruffles. These features identify a site of actin polymerization and are associated 
with cell protrusion (linear ruffles at the leading edge of lamellipodium), macropinocytosis 
or receptor internalization (dorsal ruffles or waves) (see Section 1.2.2; Buccione et al., 
2004). The GroPIns4P-dependent activation of Racl also results in both an increase in 
GTP-bound Racl and in its translocation to the plasma membrane. These changes can be 
easily followed both in Swiss 3T3 (Mancini et al., 2003) and in NIH 3T3 cells. In contrast 
GroPIns and GroPIns4,5P2 do not produce any increase in membrane ruffle formation and 
even if they can generate a weak and transient activation of Racl, this is not enough to give 
a significant stimulation that can cause a rapid and sustained translocation of Racl to the 
plasma membrane, which is necessary for ruffle formation.
3.3 TIAM1 is involved in GroPIns4P-dependent Racl activation and ruffle 
formation.
3.3.1 General description
The activation of Racl implies its GDP/GTP exchange, catalyzed by a specific 
GEF. Many different GEFs specific for Racl exist in nature (TIAM1, VAV1-2, PIX, 
STEF), each one expressed in different cell type. One of the most studied and well 
expressed both in Swiss 3T3 and NIH 3T3 cells is TIAM1. The gene encoding for TIAM1 
was originally identified in T-lymphoma cells as an invasion and metastasis-inducing gene 
(Habets et al., 1994), and the function associated to it was the exchange activity specific 
for Racl. This protein contains two PH domains, one at the N-terminus that binds
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PI3,4,5P3 and is important for its plasma membrane translocation, and one at the C- 
terminus that cooperates with the catalytic Dbl homology domain in enhancing the 
GDP/GTP exchange of Racl. Plasma membrane-translocation of TIAM1 is required for 
Racl-dependent membrane ruffling and also JNK activation in NIH 3T3 cells (Michiels et 
al., 1997). TIAM1 activity is also modulated by phosphorylation, and in particular, 
CaMKII-dependent phosphorylation is important for its plasma membrane translocation 
and enhances its exchange activity (Fleming et al., 2000) (see Section 1.2.3.2). The 
involvement of TIAM1 in Racl activation and ruffle formation, together with its high 
expression levels both in Swiss and NIH 3T3 cells, supported the hypothesis that TIAM1 
could be involved in the pathway activated by GroPIns4P that leads to Racl activation. To 
see if this is the case, immunofluorescence experiments in NIH 3T3 cells transfected with 
TIAM1-GFP were performed.
3.3.2 GroPIns4P induces the translocation of TIAM1 to the plasma membrane
TIAM1 is a cytosolic protein that translocates to the plasma membrane upon 
activation. Once at the plasma membrane it interacts with Racl and catalyzes GDP/GTP 
exchange (as discussed in Section 1.2.3.2). In order to see if  GroPIns4P could induce the 
translocation of TIAM1 to the plasma membrane, immunofluorescence experiments were 
preformed. NIH 3T3 cells were transfected with pEGFP-C1199-TIAMl, a construct that 
encodes for a GFP-tagged mutant of TIAM1 that lacks the N-terminal myristoylated 
region, but that keeps the same behaviour of the wild type protein (Michiels et al., 1997). 
For brevity the expressed protein is referred to throughout as TIAM1-GFP. After 
transfection, the cells were serum starved and treated with 50 pM GroPIns4P or 10 ng/ml 
PDGF for different times. The samples were analysed for the extent of C1199-TIAM1- 
GFP (henceforth referred as TIAM1-GFP for brevity) translocation and quantified in a 
blind fashion on a laser control scanning microscope (LSM510) with a 63 x objective (as
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described in Section 2.4.4). Within 2 minutes of stimulation, GroPIns4P produced a 
translocation to the plasma membrane of TIAM1-GFP in 55% of transfected cells (a 2.5 
response as compared to untreated samples). At 10 minutes TIAM1 was redistributed in 
the cytosol (Fig. 3.4 a). Similarly to Racl, also TIAM1 was found associated with 
membrane ruffles, as shown in Figure 3.4b. This result was in line with the previous 
observations that GroPIns4P induces Racl-GFP translocation to the plasma membrane in 
the same time frame (Mancini et al., 2003) and supported the hypothesis that GroPIns4P 
needs an active TIAM1 to activate Racl. The extent of TLAM1 translocation to the plasma 
membrane mediated by GroPIns4P was comparable to that of PDGF, which caused a 2.6 
fold response (Fig. 3.4a).
In parallel, the effect of GroPIns on TIAM1-GFP translocation to the plasma 
membrane was analysed. The experiment was performed in NIH 3T3 cells transfected with 
TIAM1-GFP and then treated with GroPIns. The effect of GroPIns was compared with that 
of GroPIns4P. Upon treatment with GroPIns, no significant translocation of TIAM1 to the 
plasma membrane was observed (Fig. 3.5).
The data confirmed that the mechanism of action of GroPIns4P is unique and 
cannot be mimicked by other similar compounds like GroPIns.
3.3.3 TIAM1 and Racl co-Iocalize at the plasma membrane upon GroPIns4P 
treatment.
The direct interaction of TLAM1 and Racl at the plasma membrane favours the 
activation of Racl and consequently ruffle formation (Mertens et al., 2003). The effect of 
GroPIns4P at the level of Racl and TIAM1 activation had been followed independently by 
immunofluorescence experiments (as previously described), but there was no direct proof 
that Racl and TIAM1 could co-localize at the plasma membrane upon treatment with 
GroPIns4P. To see if this was the case, immuno-fluorescence assays in NIH 3T3 cells co-
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Figure 3.4 - GroPIns4P-dependent translocation of TIAMT1-GFP to the plasma 
membrane, a) Time-course of stimulation with 50 pM GroPIns4P in NIH 3T3 cells. 
Sub-confluent NIH 3T3 cells were transfected with the pEGFP-cl 199-TIAM1 
construct as described in Section 2.3.4. Twenty-four h after transfection, cells were 
serums starved for 24 h and then were treated with GroPIns4P (50 pM) for 2 to 20 
min or 10 ng/ml PDGF for 5 min, fixed, and stained with TRITC-labelled phalloidin. 
The percentage of cells showing plasma membrane localisation of T1AM1 was 
quantified blind as described in Section 2.4.4. The bars show the means (±SD) of four 
independent experiments, each performed in duplicate. *P<0.05, **P<0.01, 
***P<0.001 (Section 1.14).
b) Localisation of TIAM1-GFP and actin in GroPIns4P-induced membrane ruffles. 
Bar=20 pm
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Figure 3.5 - Effect of GroPIns in TIAM1-GFP translocation to the plasma 
membrane. Time-course of stimulation with GroPIns and GroPIns4P in NIH 3T3 
cells. Sub-confluent NIH 3T3 cells were transfected with the pEGFP-cl 199-TIAM1 
construct as described in Section 2.3.4. Twenty-four h after transfection, cells were 
serum starved for 24 h and then were treated with GroPIns4P (50 pM) or GroPIns 
(100 pM) for 2 to 10 min, fixed and stained with TRITC-labelled phalloidin. The 
percentage of cells showing plasma membrane localisation of TIAM1 was quantified 
blind as described in Section 2.4.4. The bars show the means (± SD) of two 
independent experiments, each performed in duplicate. **P<0.01, ***P<0.001 
(Section 1.14).
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transfected with pEGFP-Racl and pcDNA-C1199-TIAMl were performed. The two 
constructs encodes for Racl-GFP and C1199-TIAM1-HA (henceforth referred as TIAM1- 
HA for brevity) respectively. GroPIns4P was able to induce the translocation of both Racl- 
GFP and TIAM1-HA to the plasma-membrane and the two proteins co-localised in the 
same membrane structures within 2 min of treatment (Fig. 3.6). This co-localization 
supported the idea that TIAM1 could be the exchange factor activated by GroPIns4P for 
stimulating Rac 1 -dependent ruffle formation.
3.3.4 Effect of GroPIns4P on the PH-domain deleted mutants of TIAM1
The localization of TIAM1 at the membrane depends on the interaction of its N- 
terminal PH domain with PI3,4,5P3 and PI4,5P2. A deletion mutant that lacks this PH 
domain (APHn-TIAMl-GFP) is not able to translocate to the plasma membrane (Fleming 
et al., 2000). The C-terminal PH domain of TIAM1 cooperates with the dbl homology 
(DH) domain in the interaction between Racl and TIAM1, but it is not important for its 
translocation to the plasma membrane (Fleming et al., 2000). In order to understand if the 
absence of one or both PH domains of TIAM1 could affect the ability of GroPIns4P to 
translocate TIAM1 to the plasma membrane, the PH-domain-deleted mutants of TIAM1 
were overexpressed and analysed in the immunofluorescence assay. Those mutants that 
selectively lacks the N-terminal PH domain (APHn-TIAMl), the C-terminal PH domain 
(APHc-TIAMl) or both (APH-TIAM1) were expressed in vectors that contain the GFP tag 
(Fig. 3.7a). PDGF was used in this experiment to follow the correct localisation of the 
constructs (Fleming et al., 2000).
The absence of the N-PH domain resulted in a loss of the ability of TIAM1 to 
translocate to the plasma membrane both in PDGF and in GroPIns4P-treated samples (Fig 
3.7b). As expected, the APHc-TIAMl-GFP was able to translocate to the plasma 
membrane upon treatment with GroPIns4P but, if  compared with the full length TIAM1, it
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Figure 3.6 - Co-localisation of Racl and TIAM1 at the plasma membrane. Sub- 
confluent NIH 3T3 cells were transfected with the Racl-GFP and TIAM1-HA 
construct as described in Section 2.3.4. Twenty-four h after transfection, cells were 
serum starved for 24 h and then were treated with GroPIns4P (50 pM) 2 min, fixed 
and stained with Ab-anti HA (Babco). The plasma membrane localisation of TIAM1 
and Racl was analysed by confocal microscopy (as described in Section 2.4.4). The 
pictures are representative of three independent experiments. Bar=20 pm
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Figure 3.7 - Sub-cellular localisation of PH-domain-deleted mutants of TIAM1.
Scheme of the construct overexpressing TIAM1 deleted mutants, GFP tagged (a). 
Sub-confluent NIH 3T3 cells were transfected with the pEGFP-APHn TIAM1 (b); 
APHc-TIAMl (d) APH-TIAM1 (c) as described in Section 2.3.4. Twenty-four h after 
transfection, cells were serum starved for 24 h and then were treated with GroPIns4P 
(50 pM) for 2 min (d) and 5 min (b, c and d), fixed, and stained with TRITC- 
phalloidin. The plasma membrane localisation of TIAM1 was analysed by confocal 
microscopy (as reported in Section 2.4.4). The pictures are representative of two 
independent experiments. Bar=20 pm
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needed at least 5 min of stimulation with GroPIns4P to localize to the plasma membrane. 
PDGF, applied for 2 to 10 min, was also able to induce the translocation of the C-PH 
domain-deleted mutant of TIAM1 to the plasma membrane (Fig. 3.7d). The behaviour of 
the APH-TIAM1-GFP was similar to the APHn-TIAMl: it was always cytosolic and the 
stimulation with GroPIns4P or PDGF did not produce any changes in its localisation (Fig. 
3.7c).
3.3.5 The membrane translocation of TIAM1 induced by GroPIns4P is inhibited by 
the Ca2+/calmodulin kinase II inhibitor KN-93
The effect of GroPIns4P on TIAM1 translocation to the plasma membrane was 
comparable to that of PDGF (Fig. 3.4a). It is well known that PDGF activates TIAM1, 
inducing its translocation to the plasma membrane as well as an increase in Racl-GTP and 
membrane ruffling, in a CaMKII-dependent way (Buchanan et al., 2000; Fleming et al.,
1999). This kinase phosphorylates TIAM1 on threonine residues and this phosphorylation 
favours its translocation to the plasma membrane (see Section 1.3.4) (Buchanan et al.,
2000). To see if this kinase could be involved in the GroPIns4P-dependent activation of 
TIAM1, KN-93, a CaMKII specific inhibitor that binds the Ca2+/CaM binding site of the 
enzyme so preventing its activation (see Figure 1.3.4b; Sumi et al., 1991), was applied to 
NIH 3T3 cells before performing immunofluorescence analysis.
The cell were treated for 24 h with medium that contained KN-93 (20 pM) and 
lacked serum, before the addition of GroPIns4P. The experimental condition used were the 
most suitable to obtain a complete blockage of CaMKII in the cells as reported in Fleming 
et al. (1998). Treatments with 50 pM GroPIns4P for 2 to 10 min and 10 ng/ml PDGF for 5 
min were performed and the samples were analysed for the extent of TIAM1-GFP 
translocation as described in Section 2.4.4
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The translocation of TIAM1-GFP to the plasma membrane induced by GroPIns4P 
was completely prevented by the presence of the KN-93 as shown in Figure 3.8a,b. This 
inhibition was comparable with that observed in the samples treated with PDGF in the 
presence of KN-93. CaMKII is therefore involved in GroPIns4P-dependent TIAM1 
translocation to the plasma membrane.
3.3.6 Conclusion
GroPIns4P affects TIAM1 translocation to the plasma membrane. TIAM1-GFP 
translocates to the plasma membrane after 2 minutes of stimulation with GroPIns4P and at 
10 minutes it starts to redistribute in the cytosol. This event is visible in parallel with the 
translocation of Racl to the plasma membrane and precedes ruffle formation. Treatment 
with GroPIns4P also produces a co-localization of Racl and TIAM1 to the plasma 
membrane thus confirming the hypothesis that the translocation of Racl and its exchange 
factor TIAM1 could be a key point in understanding the mechanism by which GroPIns4P 
produces an increase of membrane ruffling. GroPIns4P-dependent TIAM1 translocation 
requires the N-terminal PH domain. The inhibition of CaMKII by its specific inhibitor KN- 
93, prevents the translocation of TIAM1 to the plasma membrane induced by GroPIns4P, 
thus suggesting that this enzyme is an important effector for GroPIns4P.
3.4 GroPIns4P increases Ca2+/calmoduiin kinase II activity
3.4.1 General description
CaMKII is an oligomeric protein comprised of twelve 50-60-kDa subunits arranged 
as two stacked hexameric rings. The various CaM Kinase II subunits are characterise by an
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Figure 3.8 - Effect of GroPIns4P on TIAM1-GFP localisation in the presence and 
absence of KN-93. a) Sub-confluent NIH 3T3 cells were transfected with the pEGFP- 
cll99-TIAMl construct as described in Section 2.3.4. Twenty-four h after 
transfection, cells were serum starved for 24 h and treated in parallel with KN-93 (20 
pM), then were treated with GroPIns4P (50 pM) for 2 to 10 min or 10 ng/ml PDGF 
for 5 min, fixed and stained with TRITC-labelled phalloidin. The percentage of cells 
showing plasma membrane localisation of TIAM1 was quantified in blind as 
described in Section 2.4.4. The bars show the means (±SD) of four independent 
experiments, each performed in duplicate. *P<0.05, **P<0.01, versus control 
(Section 1.14). b) Localisation of TIAM1-GFP and actin in GroPIns4P-induced 
membrane ruffles, in the presence and absence of KN-93. Bar=20 pm
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N-terminal catalytic region, a central regulatory domain containing an auto-inhibitory
2+domain, a Ca /CaM (calcium calmodulin complex) binding motif, a variable sequence and 
the C-terminal subunit association domain (Morris and Torok, 2001). The binding of the 
Ca2+/CaM complex at the Ca2+/CaM binding site allows an opening of the conformation of 
this kinase that exposes the catalytic site. The auto-phosphorylation that follows leads to a 
permanent activation of the kinase also in the absence of Ca2+ (for further information see 
Section 1.3.4 of the introduction and Figure 1.3.4 b).
The presence of active CaMKII is important for GroPIns4P-dependent translocation 
of TIAM1 to the plasma membrane. In order to see if  GroPIns4P can activate this kinase, 
CaMKII activity assays were performed in NIH 3T3 cells.
3.4.2 GroPIns4P increases the Ca2+/caImoduIin kinase II activity
The CaMKII activity assay (kit from upstate) monitors the ability of the CaMKII 
present in a cell lysate to phosphorylate the autocamtide-2 substrate; this is a peptide 
corresponding to the auto-phosphorylation sequence of CaMKII. Intact NIH 3T3 cells were 
treated with 50 pM GroPIns4P or 10 ng/ml PDGF, lysed in a buffer that does not contain 
Ca2+ (ADBI) and then tested for CaMKII activity as described in Section 2.6.1 This 
procedure allows the measurement of the stimulus-dependent kinase activation. The fact 
that the kinase assay was performed in the absence of Ca2+ means that it was the proportion 
of auto-phosphorylated CaMKII in the lysate that was assessed. The level of maximal 
activation was evaluated by lysing the cells with a buffer containing 2 mM free Ca2+
  94-
(ADBII in Section 2.6.1). This Ca concentration caused the activation of all the CaMKII 
enzymes present in the cell lysate, thus allowing the calculation of the maximal CaMKII 
activation level. The extent of CaMKII activation upon stimulation was expressed as 
percentage of the maximum (as described in Section 2.6.1).
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GroPIns4P produced a rapid (within 90 sec) and transient increase of CaMKII 
activity: the percentage of activation expressed as a percentage of maximal activity was 
13% in basal conditions and 24% after GroPIns4P stimulation (a 1,7-fold response over the 
basal). Within 5 min the level of CaMKII activation went back to the basal condition. 
PDGF (10 ng/ml) produced a 1,8-fold response in CaMKII activity versus the control 
within 150 sec of treatment (Fig. 3.9).
Ruffle formation can be visualised after a 2 min treatment with GroPIns4P and the 
activation of the CaMKII after 1 min and 30 sec; thus these two events could be considered 
as two sequential steps of the same pathway. The GroPIns4P-dependent activation of the 
CaMKII could be the starting point for TIAMl/Racl activation and ruffle formation.
3.4.3 CaMKII activity assay with cell lysates and purified CaMKII
The GroPIns4P-dependent CaMKII activation represented above was observed in 
intact cells. The molecular mechanism involved remained to be identified. Several 
possibilities could be taken into consideration: a direct interaction between GroPIns4P and 
the kinase; the involvement of other proteins (like PLC) that could be activated by 
GroPIns4P and consequently favour an increase in [Ca2+]j that allowed the activation of the 
kinase; an extracellular action of GroPIns4P via receptor activation that initiates a 
signalling cascade in the cell.
If GroPIns4P acts like an agonist via a receptor, it should induce an increase in 
[Ca2+]i that leads to CaMKII activation (Braun and Schulman, 1995). In a cell lysate, the 
Ca2+ stores are destroyed, thus it is not possible to create a signalling event due to agonist 
stimulation that triggers the release of Ca2+ from ER. To see if GroPIns4P can interact with 
a cell surface receptor, it was added directly to the cell lysate; under this condition the 
compound should be active only if it acts directly on the kinase and not through a receptor- 
dependent signalling. The cells were lysed in ADBI buffer (without Ca2+) and then treated
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Figure 3.9 - GroPIns4P-dependent activation of CaMKII. NIH 3T3 cells were 
serum-starved for 20 h, treated with 50 pM GroPIns4P for 90, 150 or 300 sec, or 
PDGF for 150 sec and 300 sec, then lysed in a Ca2+-free buffer (see Section 1.6.1). 
The cell lysate obtained in this way was used for the CaMKII activity assay. The 
extent of CaMKII activation is expressed as percentage of the maximal activation 
obtained when the cells were lysed in the presence of 2 mM free-Ca2+. The bars are 
the means (±SD) of three independent experiments, each performed in duplicate. *P 
<0.05, **P <0.01, versus control (Section 1.14).
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with GroPIns4P for different times at 37 °C, and subjected to the CaMKII activity assay. 
The activity of CaMKII was not affected by GroPIns4P when the treatment was done in 
NIH 3T3 cell lysate (Fig. 3.10a). This data indicated that GroPIns4P could act at the level 
of a membrane receptor or via an intracellular target that initiates a signalling pathway, 
which is impaired when the cells are lysed.
The above experiment was performed by lysing the cells in a buffer without Ca2+,
94-but it could not be excluded that the Ca is important for the activity GroPIns4P. Thus a 
second set of experiments was performed by applying three different Ca2+ concentrations: 
without free Ca2+ (to evaluate the basal level), 0.5 pM free Ca2+ (an intermediate 
concentration in which the kinases present in the cell lysate are partially activated; Fig. 
3.10b) and 2 mM free Ca2+ (to evaluate the maximal level of kinase activation) (Fig. 
3.10c). In all these conditions GroPIns4P was not effective, however this data suggested 
that a direct interaction between GroPIns4P and CaMKII is probably not the mechanism 
involved in the kinase activation pathway.
In order to confirm that GroPIns4P does not activate the kinase by direct 
interaction, the activity assay was performed with purified CaMKII instead of cell lysate. 
The purified enzyme was pre-incubated with GroPIns4P at 30 °C for 10 min prior to 
performing the activity assay: no effect of GroPIns4P was observed, thus excluding a 
direct activation of the kinase under these conditions (Fig. 3.11).
3.4.4 Conclusion
GroPIns4P produce an increase in CaMKII activity only when added to intact cells. 
This activation is lost both when GroPIns4P is added directly to cell lysates or to the 
purified kinase. These data suggests that GroPIns4P does not act directly on the kinase but 
that there is another element involved in a step upstream of this activation. Indeed,
145
-  e
1 »  
B eM os «
o .5
10
8
6
4
2
0
90 150 300 150 300 Time (min)
control GroPIns4P (50 fiM) PDGF (10 ng/ml)
b) 80
70
60
50<*> oT3 1—15 *
£&30
o ,W 20 
1 10 
£ o
rfi
1 0.5 2 [Ca2+ ](mM)
c) 25
U
O'
20
5  s-  a is a <sS w*scss
*•1 o
10
•5 5
0 500
control
0 500 0 500 [Ca2+ I(mM)
GroPIns4P 
(50 \ i M )
PDGF 
(10 ng/ml)
Figure 3.10 - CaMKII activity assay with cell lysate. NIH 3T3 cells were lysed in 
assay buffer ADBI (see Section 2.6.1), then the lysate were incubated at 37 °C with 
50 (iM GroPIns4P or 10 ng/ml PDGF prior to performing the CaMKII activity assay,
a) The experiment was performed in a Ca2+ free assay buffer and the samples were 
treated for different times (from 90 sec to 5 min) with GroPIns4P or PDGF. b) Basal 
CaMKII activity at 3 different Ca2+ concentrations (0 Ca2+, 500 nM or 2 mM); the 
CPM represents the amount of [3 2P]phosphate attached to the substrate, c) The cells 
were lysed in buffers with three different free Ca2+ concentrations (0 Ca2+, 500 nM or 
2 mM), then were treated for 90 sec with GroPIns4P or PDGF. The values are 
reported as percentage of maximal activation that is evaluated when the concentration 
of Ca2+ is maximal (2 mM). The bars are the means (±SD) of two independent 
experiments, each performed in duplicate.
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Figure 3.11 - CaMKII activity assay with purified CaMKII. The activity of 
purified CaMKII was tested by using the assay kit (Section 2.6.1). The effect of 
GroPIns4P on the kinase was evaluated by incubating the compound at 50 pM 
concentration with the CaMKII for 10 min at 30 °C prior to performing the activity 
assay. The bars are the means (±SD) of two independent experiments, each performed 
in triplicate.
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GroPIns4P could be a ligand for a specific (still unknown) receptor, or it could activate an 
intracellular target that could lead to CaMKII activation, perhaps by increasing the [Ca ]i.
3.5 Effect of intracellular Ca2+chelation
3.5.1 CaMKII activity assay in the presence of BAPTA
O I
The activation of CaMKII involves an increase in [Ca ]i that, once complexed with 
calmodulin, interacts with CaMKII allowing conformational changes that favour the auto­
phosphorylation of the enzyme and consequently its activation (Braun and Schulman, 
1995). It could be hypothesized that GroPIns4P activates the kinase by modulating the 
[Ca2+]i concentration. In order to see whether changes in [Ca2+]j are involved in 
GroPIns4P-dependent activation of CaMKII, the CaMKII activity assay was performed in 
the presence of BAPTA-AM, an intracellular calcium chelator. Twenty pM BAPTA-AM 
(a concentration suitable to cause a complete blockage of CaMKII activity; Fleming et al., 
1998) was added to NIH 3T3 cells 30 min before stimulation, to allowed its incorporation 
inside the cells. The treatment with GroPIns4P was performed for 90 sec (enough to see an 
increase in CaMKII activity) and compared with PDGF treatment, which is known to 
activate CaMKII by increasing [Ca2+]i (Fleming et al., 1998) (see Section 2.6.1).
GroPIns4P, as well as PDGF, were not able to activate the kinase when the 
intracellular calcium was chelated (Fig. 3.12). From these data it was clear that GroPIns4P
94-needs [Ca ]i to activate the kinase.
3.5.2 TIAM1 translocation to the plasma membrane in the presence of BAPTA.
As described above, TIAM1-GFP over-expressed in NIH 3T3 translocates to the 
plasma membrane upon stimulation with GroPIns4P, and this translocation is blocked by
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Figure 3.12 - CaMKII activity assay in the presence or absence of BAPTA. NIH
3T3 cells were serum-starved for 24 h and pre-incubated 30 min with BAPTA (20 
pM) before treatment with GroPIns4P (50 pM) for 90 sec or PDGF (10 ng/ml) for 150 
sec. The cells were then lysed in a Ca2+-free buffer (as described in Section 2.6.1), 
and the cell lysate was tested for CaMKII activity. The extent of CaMKII activation is 
expressed as a percentage of the maximal activation obtained when the cells were 
lysed in the presence of 2 mM free-Ca2+. The bars are the means (±SD) of three 
independent experiments, each preformed in duplicate. *F*>0.07 **P<0.05, versus 
samples without BAPTA (Section 1.14).
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the CaMKII-inhibitor KN-93. Moreover, NIH 3T3 cells treated with GroPIns4P shows an 
increase in the CaMKII activity and this increase does not occur when [Ca2+]i is chelated 
by BAPTA. Taken together, this data suggested that the GroPIns4P-dependent TIAM1 
translocation to the plasma membrane requires an increase in [Ca2+]j concentration that in 
turn activates the CaMKII. However, there was no direct proof that [Ca2+]j was important 
for the GroPIns4P-dependent translocation of TIAM1 to the plasma membrane. To test this 
possibility directly, immuno-fluorescence experiments were performed using NIH 3T3 
cells transfected with TIAM1-GFP and treated with BAPTA-AM before stimulation with 
GroPIns4P. The cells were treated with GroPIns4P for 2 to 5 min and then the samples 
were analysed for the extent of TIAM1-GFP translocation (see Section 2.4.4).
In line with initial observations (figure 3.13), in the presence of the calcium 
chelator, GroPIns4P was not able to induce TIAM1-GFP translocation to the plasma 
membrane. The Figure 3.13 shows the quantification of the extent of TIAM1 translocation 
to the plasma membrane in the presence and absence of BAPTA (3.13a), also with two 
representative images of cells (3.13b). This treatment also prevented the membrane 
ruffling (3.13b).
3.5.3 Conclusion
The chelation of [Ca2+]i completely abolished the effects of GroPIns4P by both 
preventing the CaMKII activation and the translocation of TIAM1 to the plasma 
membrane. This observation supported the idea that GroPIns4P needs free [Ca2+]j for its 
activity. A possible model that could explain the action of GroPIns4P could be that 
treatment with GroPIns4P produces an increase in [Ca2+]j that activates CaMKII, which 
phosphorylates TIAM1 favouring its translocation to the plasma membrane. Thus, by
94-chelating the [Ca ] i ,  these events are impaired.
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Figure 3.13 - Effect of BAPTA on GroPIns4P-dependent TIAM1 translocation to 
the plasma membrane, a) Sub-confluent NIH 3T3 cells were transfected with the 
pEGFP-cll99-TIAMl construct as described in Section 2.3.4. Twenty-four h after 
transfection, cells were serum starved for 24 h and then were treated with 20 jiM 
BAPTA for 30 min prior to being stimulated with GroPIns4P (50 pM) for 2 or 5 min. 
After fixation, cells were stained with TRITC-labelled phalloidin. The percentage of 
cells showing plasma membrane localisation of TIAM1 was quantified in blind as 
described in Section 2.4.4. The bars are the means (±SD) of two independent 
experiments, each performed in duplicate. ***P<0.001, versus control (Section 1.14). 
b) Localisation of TIAM1-GFP and actin in GroPIns4P-induced membrane ruffles, in 
the presence and absence of BAPTA. Bar=20 pm
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3.6 GroPIns4P modulates the intracellular Ca2+ concentration
3.6.1 General description
The data described above suggested that the [Ca2+]j could be the key element in 
GroPIns4P-dependent Racl/TIAMl activation and ruffle formation. GroPIns4P could 
activate CaMKII by increasing the concentration of [Ca2+]j. For this reason, cell imaging 
was performed in NIH 3T3 cells labelled with Fluo3-AM, a dye that fluoresces upon Ca2+- 
binding. Cells were imaged using an Olympus 1X70 microscope equipped with a TILL 
Photonics imaging system. After loading with the dye, NIH 3T3 cells were treated with 
GroPIns4P and the change in [Ca2+]i levels measured as an increase in fluorescence (as 
described in Section 2.5). This technique allowed the measurement of any rapid and
O i
transient [Ca ]i variation within single living cell.
3.6.2 GroPIns4P increases intracellular Ca2+ levels
NIH 3T3 cells were plated in 100 mm dishes, and the following day were loaded 
with Fluo3-AM for 30 min in a HEPES-buffered saline solution and then placed on the 
stage of microscope (as described in Section 2.5.1). The live imaging was performed by 
taking two sequential movies: a first one taken each 200 ms for 2 min (to monitor any
o i
rapid [Ca ]* variation) and a second one taken each sec for 6 min, to see what happened 
within 8 min from the stimulation. So that the basal level of fluorescence at the initial state 
was known, the treatment with GroPIns4P (50 pM) was performed 30 sec after the 
beginning of the movie. In each time lapse movie, the increase in fluorescence obtained 
upon stimulation was represented by a gradual change in colour (from blue to red as 
minimal and maximal fluorescence level, respectively) (Fig. 3.14 a). Each cell was selected 
and the fluorescence of each frame calculated by the TILL Photonics imaging system. The
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background signal was determined from the average of three different areas adjacent to the 
cell. The fluorescence values, after background subtraction, were then plotted as an 
increase in fluorescence per second.
For each experiment a series of controls were performed: PDGF (10 ng/ml) and 
ATP (100 pM) were added for the receptor-induced [Ca2+]j increase, and ionomycin (10
94-pM) for ionophores-mediated Ca entry (and to obtain the maximal calcium level). In 
each experiment NIH 3T3 cells were treated with GroPIns4P and then washed with buffer
94“in order to allow the [Ca ]i to return to the physiological concentration (see Section 2.5.1). 
Other stimuli were then given to evaluate the level of [Ca2+]i increase upon receptor- 
dependent stimulation (PDGF and ATP), or the maximal [Ca2+]i increase obtained with 
non-physiological stimuli (ionophores). These effects were then compared with that 
obtained upon treatment with GroPIns4P. For each sample, from 5 to 12 cells were 
monitored for at least 8 min.
[Ca2+]i can be estimated from measurements of the Ca2+ indicator fluorescence at
94“ 9 1maximal and minimal [Ca ]i (Fmax and Fmin), obtained by adding ionophores and Ca 
chelators respectively. The single wavelength measurements, performed with the Fluo3- 
AM (a nonratiometric Ca2+ indicator), do not allow the [Ca2+]i to be calculated. Fmax and 
Fmin cannot be obtained unless the dye concentration is precisely estimated or in vivo 
calibration is performed in the same cell. The estimation of fluorescence intensity of such 
nonratiometric Ca2+ indicators has been often reported not as [Ca2 +]i, but as the pseudoratio 
(AF/F) indicated by the following formula: AF/F0=[(F-F0)/(F0-B)] where F is the maximal 
level of fluorescence obtained upon stimulation, F0 is the fluorescence at the basal 
condition and B is the background (Klepeis et al., 2001; Takahashi et al., 1999). Apart 
from dye saturation, AF/F0 is thought to approximately reflect the [Ca2+]i if  there is no 
change in dye concentration, intracellular environment or path length (Svoboda et al., 
1997) (See Section 2.5.2).
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Figure 3.14 -  Till photonics live imaging of fluo3-AM loaded NIH3T3 cells. Cells 
were incubated with 4 pM fluo3-AM for 30 min at 37 °C. After two washes in 
HEPES-buffered saline solution, the cells were positioned on the stage of a Till 
Photonic microscope (as described Section 2.5.1). For each experiment, the cells were 
scanned for 30 s to establish a base-line fluorescence reading before the sequential 
addition of the stimuli. All incubations were carried out while continuously scanning 
the cells every 2 0 0  ms for two min (first movie) and each second for 6  min (second 
movie) (as explained in Section 2.5.1). a) Selected frames from the time lapse movie 
obtained upon 50 pM GroPIns4P stimulation. The following plots represents the 
kinetics of [Ca2+]j increase caused by 50 pM GroPIns4P (c), 100 pM ATP (d), 10 
ng/ml PDGF (e), 10 pM ionomycin (f) and 100 pM GPI (g). The effect of HEPES 
buffer addition is represent in b . The arrows indicate the time point in which the 
stimulus was given to the cell. Each plot represents the behaviour of two cells (pink 
and blue)
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In order to quantify the effect of GroPIns4P and compare it with the other stimuli, 
the fluorescence variation was calculated as the pseudoratio AF/F. The Lag phase (Time 
between the stimulation and the increase of Ca2+), the time of stimulation (duration of the 
stimulus) and the percentage of responsive cells were also measured (Table 3.1).
The treatment with GroPIns4P (50 pM), produced a AF/F of 1.08±0.14 in 
approximately 58% of the cells analysed per sample (Fig. 3.14 c, Table 3.1). The Ca2+ 
increase obtained was rapid (within 25 sec) and transient (the [Ca2+]i increase persisted for 
30-50 sec); then the intracellular calcium concentration went back to the basal level. Figure 
3.14 a shows selected frames from the time lapse movie obtained upon GroPIns4P 
stimulation. GroPIns4P was also active at lower concentration than 50 pM, but the stimuli 
were given to the cells at a concentration suitable for obtaining the highest response 
(according to Mancini et al., 2003).
ATP was applied to the cells in a range of concentration from 1 to 100 pM , to identify the 
condition that caused the maximal cellular response. Thus, 100 pM ATP was used 
routinely in all subsequent experiments. The treatment with ATP caused a AF/F of 
1.52±0.09 in the 82% of the cells, a few seconds after its addition, then there was a 
prolonged oscillation in [Ca2+]j (Fig. 3.14 d Table 3.1). The effect of PDGF (10 ng/ml) was 
similar to GroPIns4P for the AF/F (0.94±0.08) and for the number of responsive cells per 
sample (65%), whereas, the appearance of the Ca2+ spike was delayed (100-120 sec after 
the treatment) and more prolonged (100 sec) (Fig. 3.14 e, Table 3.1). Ionomycin produced 
a AF/F of 1.33±0.16 in the 96% treated cells. It showed the same rapid Ca2+ increase as 
seen in ATP-treated cells, but the rise was more sustained (250 sec) (Fig. 3.14 f, Table 
3.1). Upon stimulation with ATP and ionomycin the level of fluorescence reached the 
saturation, thus the AF/F0 value could not be considered proportional to the increment in 
[Ca2 +]j. In fact, the formula used to calculate the AF/F0 can approximately reflect the
o i
[Ca ]j variation only when the increase in fluoresce does not reach saturation
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AF/F0 LAG
PHASE
00
TIME OF 
STIM (s)
% OF 
CELLS
Control 0.06 ±0.16 2.5 ± 8
GroPIns4P 1.08 ±0.14*** 25 ± 4 45 ±16 58 ± 3
PDGF 0.94 ±0.08*** 122 ± 16 247 ±112 65 ± 9
ATP 1.52 ±0.09*** 8 ± 1 115 ± 7 82 ± 3
Ionomycin 1.33 ±0.16*** 18 ± 3 249 ±13 96 ± 1
GPI 0.06 ±0.03 0
Table 3.1 - Quantification of the [Ca2+]j increase. The effect of GroPIns4P (50 (iM), 
ATP (100 pM), PDGF (10 ng/ml), ionomycin (10 pM) and GroPIns (100 pM) in 
increasing [Ca2+]j levels was calculated as changes in fluorescence relative to the base 
line [pseudo ratio: AF/F0=(F-F0)/(F0-B)]. Lag phase (time between the stimulation 
and the increase of Ca2+), the time of stimulation (duration of the stimulus) and the 
percentage of responsive cells were also measured (as described in Section 1.5.2). The 
number of responsive cells is given as percentage of the total number analysed per 
sample. ATP, PDGF and ionomycin were used as positive controls. The numbers 
represents the mean (±SE) of at least 10 independent experiments for GroPIns4P and 
of 5-8 experiments for the other stimuli. ***P<0.001, versus control (Section 1.14).
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(Svoboda et al., 1997). In the case of GroPIns4P and PDGF, the increase in fluorescence 
did not reach the saturation, thus the values of AF/FO calculated could reflect the real 
changes in [Ca2+]i.
Comparing the effect of GroPIns4P with the other stimuli, it was clear that the 
extent of [Ca2+]i increase produced by GroPIns4P was high enough to activate a signalling 
pathway, similar to PDGF treatment. On the other hand, the kinetics were different, as 
suggested by the divergence in the duration of the [Ca2+]i rise and the time of response. 
GroPIns (100 pM) was also tested for the ability to increase the [Ca2+]i but it was not 
active (Fig. 3.14 g, Table 3.1).
The rapid and transient increase in [Ca2+]i produced by GroPIns4P could be 
considered as an early event that allowed CaMKII activation and TIAM1 translocation to 
the plasma membrane.
3.6.3 Characterization of GroPIns4P-dependent Ca2+ increase
The results described above led me to perform experiments aiming at elucidating 
the mechanism by which GroPIns4P increases the intracellular calcium concentration. In 
order to see if the increase in [Ca2+]i depends on the liberation of Ca2+ from the 
intracellular stores, the same experiment was performed in a Ca2+-free buffer containing 1 
mM EGTA (as described in Section 2.5.1; Klepeis et al., 2001). In the absence of
94-extracellular Ca it was possible to create an inverse gradient that favoured the exit of
94-[Ca ]i (more concentrated inside) from the cell. In this condition, all the signals that 
caused the opening of Ca2+ channels or that mimic these channels by creating pores on the 
plasma membrane (ionomycin), instead of increasing [Ca2+]i, produces a complete Ca2+ 
depletion. Whereas agonists like ATP and PDGF that produce and increase in [Ca2+]i by 
acting at the level of intracellular stores, are still active (Kuriyama et al., 1991; Ryu et al., 
2003).
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The treatment with GroPIns4P caused an increase in [Ca2+]i levels also in the 
presence of EGTA, and so the action of GroPIns4P should not lead to the influx of 
extracellular Ca2+, but is likely to activate the liberation of Ca2+ from intracellular stores 
(endoplasmic reticulum-ER) (Fig. 3.15 a, Table 3.2). In the same experiment, treatment 
with ionomycin (10 pM) caused a complete depletion of [Ca2+]i (Fig. 3.15).
The release of Ca2+ from the ER can be controlled by [Ca2+]j itself or by a variety of 
messengers and molecules such as IP3 , cyclic ADP ribose (cADPR), nicotinic acid adenine 
dinucleotide phosphate (NAADP) and sphingosine-1-phosphate (SIP) that either stimulate 
or modulate the release channel from the internal stores (Berridge et al., 2003). The 
possible involvement of IP3 in the GroPIns4P-dependent pathway was analysed. Many 
stimuli such as growth factors, cytokines, and hormones can function through 
phospholipase C (PLC) to generate IP3 , which in turn stimulates the release of Ca2+ by 
acting at the level of IP3 receptors at the ER (see Section 1.3.1). GroPIns4P could act at the 
PLC level generating IP3 from PI4 ,5 P2  or directly at the level of the IP3 receptor at the ER.
A specific inhibitor of PLCs (U-73122) was applied to the cells at a concentration 
of 5 pM, in order to completely prevent their activation (Bleasdale et al., 1990). In this 
way, the possible action of GroPIns4P at the level of these enzymes was tested. The result 
was a complete inhibition of GroPIns4P-dependent [Ca2+]j rise (Table 3.2).
The inactive analogue of U-73122 (U-73443) was also tested in the assay and, as 
expected, the GroPIns4P-dependent [Ca2+]i release was not blocked (Table 3.2). Thus, 
GroPIns4P acts at the intracellular level to produce an increase of [Ca2+]i and a PLC is 
involved in the GroPIns4P-dependent pathway of [Ca2+]j mobilisation. Under the same 
inhibitory conditions, ATP and PDGF were also not able to increase the [Ca2+]i (Table 2).
PLCs can be activated by several mechanisms: PLCp is activated by interaction 
with G a or py subunits of heterotrimeric G-proteins, upon G-protein coupled receptor 
(GPCR) activation, whereas the PLCy is tyrosine phosphorylated upon activation of
tyrosine kinase receptors (RTK) (Rebecchi and Pentyala, 2000); see also Section 1.3.3).
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Figure 3.15 - Till photonics live imaging of fluo3-AM loaded NIH 3T3 cells.
Cells were incubated with 4 pM fluo3-AM, for 30 min at 37 °C. After two washes in 
HEPES-buffered saline solution, the cells were positioned on the stage of a Till 
Photonic microscope (as described in Section 2.5.1). For each experiment, the cells 
were scanned for 30 sec to establish a base-line fluorescence reading before the 
sequential addition of the stimuli. All incubations were carried out while 
continuously scanning the cells every 2 0 0  msec for two min (first movie) and each 
second for 6  min (second movie) (as explained in methods). The plots represents the 
kinetics of [Ca2+]j increase caused by 50 pM GroPIns4P (a) or 10 pM ionomycin (b) 
in the presence of 1 mM EGTA. The arrows indicate the point in which the stimulus 
was given to the cell. Each plot represents the behaviour of two cells (pink and blue)
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AF/F0 LAG
PHASE
(s)
TIME 
OF 
STIM (s)
% OF 
CELLS
EGTA
GroPIns4P
0.94 ± 0.13*** 19 ± 5 75 ±17 81 ± 6
U-73122
GroPIns4P
0.05 ± 0 .0 1 0 0 0
U-73122 PDGF 0.08 ± 0.06 0 0 0
U-73122 ATP 0.07 ±0.10 0 0 0
U-73443
GroPIns4P
1.1 ±0.3 20 ± 4 13 ± 9 56 ± 6
Genistein
GroPIns4P
0.29 ± 0.06 54 ±15 138 ± 23 22 ±16
Genistein PDGF 0.19 ± 4 7 ± 2 70 ± 2 5 ± 3
Genistein ATP 1.16 ± 0.23*** 6 ± 1 69 ±11 78 ± 5
SU6656 /PP2 
GroPIns4P
0.03 ± 4 0 0 0
SU6656/PP2
PDGF
0.08 ± 4 0 0 0
SU6656/PP2 ATP 0.75 ± 0.3*** 6 ± 1 80 ± 1 1 90 ± 5
Table 3.2 - Effect of inhibitors in GroPIns4P-dependent [Ca2+]; increase. The
[Ca2+]j was calculated as changes in fluorescence relative to the base line [pseudo ratio: 
AF/F0=(F-F0)/(F0-B)]. The lag phase (time between the stimulation and the increase of 
[Ca2+];), the time of stimulation (duration of the stimulus) and the percentage of 
responsive cells were also measured (as described in Section 2.5.2). The number of 
responsive cells is given as percentage of the total number analysed per sample. The 
inhibitors used are EGTA (ImM), U-73122 (5pM), genistein (10 pM) and SU6656 or 
PP2 (10 pM). ATP (100 pM), and PDGF (10 ng/ml) were used as positive controls. 
The numbers represents the mean (±SE) of 6  different experiments. * * *P<0.001, versus 
control (Section 1.14).
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GroPIns4P could act at different levels, via a receptor, directly on PLC, on heterotrimeric 
G-proteins or on a tyrosine kinase.
Using genistein, an inhibitor of receptor and non-receptor tyrosine kinases, it was 
possible to prevent the GroPIns4P-induced increase in [Ca2+]i (Table 3.2). NIH 3T3 cells 
were treated for 30 min with 10 pM genistein (a concentration suitable to obtain a 
complete blockage of cellular tyrosine kinases; Akiyama et al., 1987) before stimulation 
with 50 pM GroPIns4P. The specificity of the inhibitor was assessed by treating the cells 
with PDGF, which activated RTK, and ATP which is an agonist of GPCR. As expected,
O I
the PDGF did not induced any [Ca ]i rise whereas ATP was still active in the presence of 
genistein (Table 3.2). This data indicated that the action of GroPIns4P is through a 
phosphorylation-dependent signal and probably could involve a PLCy, known to be 
activated upon tyrosine kinase-dependent phosphorylation (Rhee, 2001).
The identification of the tyrosine kinase that could be activated by GroPIns4P was 
achieved by using a set of specific inhibitors. The addition of SU6656 or PP2 (Src family 
kinases specific inhibitors) at a concentration of 10 pM (suitable to have a specific 
inhibition of Src family kinases; Bain et al., 2003) completely prevented the increase in 
[Ca2+]i levels produced by the stimulation with GroPIns4P in NIH 3T3 (Table 3.2). In the 
same assay, ATP was still able to increase the [Ca2+]i thus confirming that the inhibitor has 
a specific effect; whereas the PDGF pathway was completely blocked (Table 3.2), the Src 
family kinases could be a good candidate as target for GroPIns4P. It remained to be 
determined if  there was a direct activation of the kinase by GroPIns4P or whether there 
was another unknown element that could mediate the GroPIns4P-dependent Src family
I
kinase activation and [Ca ]j increase.
3.6.4 Conclusion
GroPIns4P is able to induce a rapid and transient increase in [Ca2+]j concentration
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acting at the intracellular level. Using PLC inhibitors like U-73122 the effect of GroPIns4P 
was blocked, thus implying that a PLC is involved in the GroPIns4P-dependent pathway of 
[Ca2+]i mobilisation. The GroPIns4P-dependent increase in [Ca2+]i was also prevented by 
the addition of Genistein, a tyrosine kinase inhibitor. This data suggests that PLCy could be 
involved in this pathway. Among the tyrosine kinases, the Src family o f tyrosine kinases is 
the best candidate as mediator o f GroPIns4P activity.
3.7 GroPIns4P increases IP-* concentration in cells
3.7.1 General description
The GroPIns4P-dependent increase in [Ca2+]i involves the action of a PLC and a 
tyrosine kinase since inhibitors of these enzymes cause a block in its activity. To confirm 
the involvement of a PLC in the GroPIns4P-dependent [Ca2+]i increase, the intracellular 
concentration of IP3 was measured. Intact cells or lysates o f NIH 3T3 cells were treated 
with 50 pM GroPIns4P and the intracellular concentration o f IP3 measured using an IP3 
assay kit (see Section 2.6.3).
3.7.2 GroPIns4P increases IP3 production both in intact and lysed NIH 3T3 cells
After treating NIH 3T3 cells with GroPIns4P, the IP3 was extracted by the 
perchloric acid method (see Section 2.6.3). Then, the “D-myo-Inositol 1,4,5-trisphosphate 
(IP3) [3H] Biotrak assay system” from Amerhsham was used to determine the 
concentration of IP3 . Stimuli like thrombin (5U/ml), PDGF (lOng/ml) or ATP (lOOpM) 
were used to asses the viability of the assay (as described in Section 2.6.3).
The quantification of IP3 provided by the kit is based on competition between [3H] 
IP3 (the tracer) and unlabelled IP3 produced by the samples for the interaction with a
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binding protein, prepared from bovine adrenal cortex. Since the binding protein for IP3 was 
also able to bind the GroPIns4P with an affinity 5000-times lower than that o f IP3 , this 
generated a potential source o f error. This figure was obtained by performing a competition 
binding assay between IP3 and an increasing concentration o f GroPIns4P. The 
concentration of GroPIns4P added to the sample was 50 pM in a volume o f 200 pi, which 
corresponds to 4 nmol, and the amount o f IP3 produced by stimulation ranges from 0.2 to 7 
pmol, thus the non specific binding of GroPIns4P to the resin could partially compete with 
the IP3 , therefore altering the calculation of the IP3 concentration. For this reason, the 
GroPIns4P-dependent increase in IP3 was compared with an untreated sample to which the 
same amount o f GroPIns4P as used for the stimulation was added just for the 
quantification step.
In intact cells, a 15% increase in IP3 upon 2 min o f treatment with GroPIns4P could 
be identified; this effect was comparable with that obtained with PDGF (25% increase), 
whereas ATP and thrombin produced a higher increase in IP3 (70 and 100%, respectively), 
as shown in Figure 3.16. This data confirmed that the Ca2+ increase produced by 
GroPIns4P in NIH 3T3 cells is due to the activation o f a PLC.
The increase was even higher using cell lysates; in this case the cells were 
harvested and subjected to mechanical lysis (as described in Section 2.6.3) before being 
stimulated with the various stimuli. After 5 min of treatment with GroPIns4P, a 20% 
increase in IP3 was seen and by increasing the time of incubation to 15 min an 80% 
increase could be observed (Fig. 3.17). Even if  the GroPIns4P-dependent increase in IP3 
concentration was seen in cell lysates as well as in whole cells, it could not be excluded 
that a potential action of GroPIns4P was via receptor, since the mechanical lysis did not 
uncouple receptors from their related PLCs. This was demonstrated by the increase in IP3 
concentration induces by thrombin (from 40% after 5 min to 150% within 15 min), an 
agonist o f PAR family receptors (GPCR), in the same lysate used for the previous 
experiments (Fig.3.17).
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Figure 3.16 - Quantification of IP3  production in intact cells. NIH 3T3 were treated 
with 50 pM GroPIns4P, 10 ng/ml PDGF, 100 jiM ATP or 5 IU/ml Thrombin for 
different times at 37 °C. The reaction was stopped by adding 20% perchloric acid and 
the samples were left 20 min on ice. Then the samples were collected, centrifuged and 
the pH adjusted to 7.0 with KOH. After a second centrifugation step the samples were 
ready to be measured by a kit (as described in Section 2.6.3). The columns represent 
the average of at least 4 different experiments calculated as increase over basal 
(control); the bars represent the SD. The specific basal level for GroPIns4P is the 
untreated sample with GroPIns4P added immediately before IP3 measurement. 
*^<0.05, **P<0.01, versus control (Section 1.14). Each P value for GroPIns4P- 
treated samples was calculated in respect to their specific basal level.
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Figure 3.17 - Quantification of IP3 production in cell lysates. NIH 3T3 were lysed 
and then treated with 50 pM GroPIns4P, 10 ng/ml PDGF or 5 U/ml Thrombin for 
different times at 37 °C. The rest of the assay was similar to the experiment 
performed with intact cells (Fig. 3.16). The columns represent the average of at least 4 
different experiments calculated as increase over basal (control); the bars represents 
the SD. The specific basal level for GroPIns4P is the untreated sample with 
GroPIns4P added immediately before IP3 measurement.
*P<0.05, **P<0.01, versus control (Section 1.14). Each P value for GroPIns4P- 
treated samples was calculated in respect to their specific basal level.
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3.7.3 GroPIns4P acts through PLCy for IP3 production
In order to understand which PLC could be involved in GroPIns4P-dependent IP3 
increase, the same IP3 assay was performed blocking selectively the PLCp or y with 
specific antibodies (Ferry et al., 2001): NIH 3T3 cell lysates were incubated with 
GroPIns4P for 15 min at 37°C in the presence or absence of 20 pg/ml of anti-PLCp and 
anti-PLCy antibody (the same concentration used in Ferry et al., 2001). The selectivity of 
the antibodies was assessed by treating the lysates with thrombin: this agonist was 
selectively blocked only by the anti-PLCp-Ab that is coupled with the PAR family of 
GPCR, whereas the anti-PLCy-Ab was ineffective (Fig, 3.18a).
The GroPIns4P-dependent increase in IP3 was completely prevented by the 
presence of the anti-PLCy-Ab and partially by the antibody for PLCp. As shown in figure 
3.18 b the GroPIns4P-dependent increase in IP3 was 80% in normal conditions and 40% 
when the PLCp was inhibited, whereas no increase in IP3 production was observed in the 
absence of PLCy activity. This set of experiments showed that PLCy is the most 
responsible for the GroPIns4P-dependent IP3 production. In contrast, PLCp gives only a 
partial contribution. Thus GroPIns4P should activate the PLCy, probably via 
phosphorylation. In fact, the inhibition of GroPIns4P dependent increase in [Ca2+]i 
generated by genistein and Src family kinases inhibitors indicated that there is a kinase 
involved in the pathway.
3.8 GroPIns4P and Src family kinases
3.8.1 General description
The inhibition of Src family kinases completely impaired the GroPIns4P-induces
o  1
[Ca ]j increase in NIH 3T3 cells. This data strongly suggested that GroPIns4P can activate
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Figure 3.18 - Quantification of IP 3 production in the presence of anti-PLCpl and 
anti-PLCyl antibodies. NIH 3T3 cell lysate was incubated with anti-PLCp 1 and 
anti-PLCyl antibodies (20 pg/ml) as described in Section 2.6.3, then treated with 5 
IU/ml thrombin (a) or 50 pM GroPIns4P (b) for 15 min. The rest of the assay was 
similar to the experiment performed with intact cells (Fig. 3.16). The columns 
represent the average of three independent experiments represented as increase over 
basal (control); the bars represents the SD. The specific basal level for GroPIns4P is 
the untreated sample added with GroPIns4P immediately before the IP3 measure. 
*P<0.05, ***P<0.001, versus control (Section 1.14). Each P value for GroPIns4P- 
treated samples was calculated in respect to their specific basal level.
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Src kinases, but there was no direct proof that a treatment with GroPIns4P leads to an 
increase in active Src kinases in the cells. These enzymes, when active, are phosphorylated 
at Tyr416 (Roskoski, 2004) (see Section 1.3.5). Thus, the amount of active Src kinases 
present in the cells was followed with a specific antibody that exclusively recognises p- 
Tyr416 (from Upstate) both by immunofluorescence and western blotting. This antibody 
was not selective for the three ubiquitously expressed isoforms of the Src family (Src, Fyn 
and Yes; see Section 1.3.5).
3.8.2 GroPIns4P activates Src kinases and induces their translocation to the plasma 
membrane both in Human Fibroblasts and NIH 3T3 cells
When Src kinases are activated, they undergo conformational changes that allowed 
the autophosphorylation of Tyr416 and favour their interaction with many different 
substrates (see Section 1.3.5). The formation of lamellipodia and ruffles also implies the 
activation of Src kinases and their translocation at the level of plasma membrane, which is 
visible by immunofluorescence as an increase in the staining of p-Src at the tip of 
lamellipodia and ruffles (Timpson et al., 2001).
We took advantage of human fibroblasts, a cellular system in which the conditions 
for following the activation of endogenous Src family kinases both by 
immunofluorescence and western blotting have been well established in a laboratory in this 
department (Sallese’s lab. unpublished data). The cells were treated with 50 pM 
GroPIns4P or 10 ng/ml PDGF and then stained for p-Src with a specific antibody, and for 
actin with FITC- phalloidin. Within 2 min of treatment with GroPIns4P or performing a 5 
min treatment with PDGF, an increase in lamellipodia and ruffles was visible in human 
fibroblast cells and p-Src localised at the tip of lamellipodia (Fig. 3.19 a). In parallel, an 
increase in p-Src level was observed also by western blotting. Human fibroblasts were 
treated with GroPIns4P and PDGF, then the cells were lysed and the amount of active
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Figure 3.19 - GroPIns4P-dependent Src family kinases activation, a) Human 
fibroblasts were treated with 50 pM GroPIns4P or 10 ng/ml PDGF, fixed and then 
stained for p-Src with a specific antibody and for actin with TRITC-phalloidin (as 
described in Section 2.4.4). Bar=20 pm b) After stimulation, the same cells were lysed 
and the amount of active (phosphorylated) Src analysed by western blotting with the 
anti-p-Src antibody (see Section 2.6.5). c) NIH 3T3 were treated with 50 pM 
GroPIns4P or 10 ng/ml PDGF. The cells were lysed and the amount of active 
(phosphorylated) Src analysed by western blotting (see Section 2.6.5). 
a-b were preformed in collaboration with Teodoro Pulvirenti from the Sallese’s 
laboratory (our department)
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(phosphorylated) Src analysed by western blotting using the anti-p-Src antibody (as 
described in Section 2.6.5). GroPIns4P double the amount of p-Src in the cells (Fig. 3.19b). 
The band of p-Src that was modulated by GroPIns4P was of 50 kDa and therefore 
corresponded to the Src isoform of Src family.
The same approaches were tested in NIH 3T3 cells, but unfortunately the Ab anti p- 
Src does not work for immunofluorescence in this cell system, because it generated too 
much non-specific binding. In contrast with the western blot approach it was possible to 
follow a strong increase in p-Src upon treatment with GroPIns4P also in NIH 3T3 cells 
(Fig. 3.19 c). However, in this case the p-Src band corresponded to a protein that is at least 
6 6  kDa, whereas p-Src was at 50 kDa in human fibroblasts. Looking at the other isoforms 
of Src, Yes has a molecular weight of 6 6  kDa, and with an anti-Yes antibody it was 
possible to confirm that the band recognised by the Ab anti p-Src and that appears to be 
modulated by GroPIns4P, corresponded to Yes in NIH 3T3 cells (Fig. 3.19 c).
These data confirmed the initial hypothesis that GroPIns4P can activate Src family 
kinases and this activation could also be associated with [Ca2+]i increase and, consequently 
ruffle formation.
3.9 Effect of different inhibitors on GroPIns4P-dependent ruffle formation
3.9.1 General description
The pathway elucidated so far shows that the translocation of TIAM1 to the plasma 
membrane depends on an increase in [Ca2+]i that leads to the activation of the CaMKII, a 
kinase that phosphorylates TLAM1, allowing its activation. In turn, TIAM1 is able to 
activate Racl, favouring the formation of membrane ruffles. All those events can be 
mediated by GroPIns4P.
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While it was shown that the [Ca2+]i increase and the translocation of TIAM1 are 
impaired when one element of the pathway is blocked with specific inhibitors (KN-93 for 
CaMKII, U-73122 for PLCs, SU6656 and PP2 for Src kinase), there was no parallel 
experimental evidence that those inhibitors prevented the GroPIns4P-induced membrane 
ruffle formation. For this reason the ability of GroPIns4P to induce membrane ruffling in 
NIH 3T3 cells treated with U-73122, KN-93 and SU6656 was analysed.
3.9.2 U-73122 prevents the GroPIns4P-dependent ruffle formation
Serum starved NIH 3T3 cells were subjected to 10 min treatment with 5 pM U- 
73122 before stimulation with 50 pM GroPIns4P (2 min, enough to follow ruffle 
formation) or 10 ng/ml PDGF (5 min stimulation). The extent of ruffle formation was 
analysed as for the other experiments and quantified in blind conditions (as described in 
Section 2.4.3).
The inhibition of PLCs reduced both the GroPIns4P- and PDGF-dependent ruffle 
formation by 70 % (from 2.5-fold response in normal condition to 1.45-fold response in the 
presence of the inhibitor). A residual 30% activity was still present also upon treatment 
with U-73122 (Fig. 3.20). The ability of PDGF to induce membrane ruffles was also 
strongly reduced by U-73122; it produces a 3.8-fold increase in ruffle under normal 
conditions and a 2-fold increase in the presence of the inhibitor (Fig. 3.20). To verily that 
the effect of the inhibitor was specific, the inactive analogue (U-73343) was also used. 
Treatment with 5 pM U-73343 (the same concentration used for U-73122) did not prevent 
the formation of membrane ruffles induced by GroPIns4P and PDGF (Fig. 3.20). The 
blockage of PLCs implies that that the increase of [Ca2+]i produced by GroPIns4P is 
prevented. Under these conditions also ruffle formation is strongly reduced. Together these
» • 94-two observation implies that the [Ca ]i increase is an important event that precedes the 
signalling pathway that leads to GroPIns4P-dependent ruffle formation. In the figure 3.20b,
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Figure 3.20 - Effect of PLCs inhibitors in GroPIns4P-dependent ruffle formation.
Serum starved NIH 3T3 cells were incubated with 5 pM U-73122 or U-73343, and 
then treated with 50 pM GroPIns4P for 2 min or 10 ng/ml PDGF for 5 min. Cells 
were fixed and stained with TRITC-labelled phalloidin and quantified blind for the 
extent of ruffle formation as described in Section 2.4.3 The results shown are average 
(±SD) of three independent experiments, each performed in duplicate. *JP<0.05 
**P<0.01 ***/><0.001, versus control (Section 1.14). b) Representative images of 
GroPIns4P-dependent modification of the actin cytoskeleton in the presence and 
absence of U-73122, in NIH 3T3 cells. Bar =20 pm
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two representative images of cells treated with GroPIns4P (50 pM) in the presence and 
absence of U-73122 (5 pM) are shown.
3.9.3 KN-93, PP2 and SU6656 prevent the GroPIns4P-dependent ruffle formation
To test the involvement of CaMKII and Src kinases in GroPIns4P-dependent ruffle 
formation, serum starved NIH 3T3 were treated with CaMKII (KN-93) or Src (PP2 and 
SU6656) inhibitors prior to being incubated with 50 pM GroPIns4P (2 min), PDGF 10 
ng/ml (5 min) or 10 pM PMA (Phorbol 12-Myristate 13-Acetate) (5 min).
KN-93 completely prevented ruffle formation induced both by GroPIns4P and 
PDGF (Fig. 3.21). PMA, which binds to and activates protein kinase C causing Racl 
activation and ruffle formation in a CaMKII-independent way (Ridley and Hall, 1992), was 
still active also in the presence of KN-93. The two inhibitors of Src gave a significant but 
not complete inhibition (Fig. 3.21) both for GroPIns4P and PDGF-dependent ruffle 
formation (70% decrease).
As shown in figure 3.21, under normal conditions GroPIns4P caused a 2.5-fold 
increase versus the control in membrane ruffles, PDGF a 3.6-fold increase and PMA a 1.7- 
fold increase. Upon treatment with KN-93, the GroPIns4P effect was completely blocked 
and PDGF could induce only a 1.5-fold increase in ruffles, whereas PMA was still able to 
induce a 1.7-fold increase. On the other hand, the treatment with Src inhibitors caused only 
a 1.5-fold increase in ruffles upon GroPIns4P treatment and a 2-fold increase upon PDGF 
treatment.
This result indicated that CaMKII plays a fundamental role in the GroPIns4P- 
dependent ruffle formation, whereas blocking Src kinases lead to incomplete inhibition. 
There was still a 30% residual activity that could be explained by a possible incomplete 
blockage of the kinase produced by the inhibitor. However, the [Ca2+]j increase induced by 
GroPIns4P was completely prevented by the same concentration of inhibitors used for the
173
4></)«os-o#S3
5
450
400
350
300
250
200s
3
C* 150
100
50
0
GroPIns4P
PDGF
PMA
**
* *
* *
KN-93 
(20 (J.M)
I 1
** 
* r i
f
SU6656 
(10 gM)
I
+ - 
-  +
PP2 
(10 pM)
I * * j
ri
+ - 
-  +
Figure 3.21 - Effect of CaMKII and Src inhibitors in GroPIns4P-dependent ruffle 
formation. Serum starved (24 h) NIH 3T3 were treated with KN-93 (24 h) or Src 
inhibitors (PP2 and SU6656) (15 min) and then incubated with 50 pM GroPIns4P (2 
min), PDGF 10 ng/ml (5 min) or 10 pM PMA (5 min). The cells were then fixed and 
stained with TRITC-labelled phalloidin and quantified blind for the extent of ruffles 
formation as described in Section 2.4.3. The results shown are the means (±SD) of 
three independent experiments, each performed in duplicate .* /^ .05 **P<0.01, versus 
control (Section 1.14).
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assay of ruffle formation. In addition, by blocking both the PLCs and Src kinases, the same 
70 % inhibition could be obtained. Probably, beside Src, there is another element able to 
influence the pathway of GroPIns4P-dependent ruffle formation acting the level of 
CaMKII.
3.9.4 GroPIns4P is not able to induce ruffle formation in SYF cells (deficient for 
Src, Fyn and Yes)
In order to confirm the involvement of Src kinases in GroPIns4P-dependent ruffle 
formation by a different approach, a cell line which lacked Src, Fyn and Yes (SYF cells) 
was used. This cell line was derived from mice in which Src, Fyn and Yes have been 
knocked out, which displays severe developmental abnormalities and lethality by E9.5. 
PDGF-dependent chemotaxis and cell cycle progression is not altered in this cell line, 
whereas integrin-dependent cell motility in a wound healing assay is retarded (Klinghoffer 
et al., 1999).
In principle, if the Src family kinases are important in the pathway that is activated 
by GroPIns4P to produce membrane ruffles, in the knock out fibroblasts this compound 
should not be active. On the other and, if Src kinases are not the only tyrosine kinase 
family activated by GroPIns4P and Src activity could be replaced by other kinases, 
GroPIns4P should be able to induce ruffles also in this knock out system. This is the case 
for PDGF, which is still active in the absence of Src, Fyn and Yes (Klinghoffer et al., 
1999).
Serum starved SYF cells were treated with GroPIns4P (50 pM) for different times 
(2 to 10 min), PDGF (10 ng/ml) for 5 min or PMA (10 pM) for 5 min, then were fixed and 
stained with TRITC-phalloidin for actin visualization (see Sections 2.4.2 and 2.4.3). 
GroPIns4P was not able to induce ruffles formation in SYF cells, whereas the membrane 
ruffle were still formed upon treatment with PDGF or PMA (Fig. 22a,b). This data
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Figure 3.22 - GroPIns4P-dependent ruffle formation in SYF cells, a) SYF cells 
were serum starved for 12 h in DMEM, 0.1 % foetal bovine serum; then were treated 
with 50 pM GroPIns4P for different times (from 2 to 30 min), 10 ng/ml PDGF for 5 
min or 10 pM PMA for 5 min. Cells were fixed and stained with TRITC-labelled 
phalloidin and quantified blind for the extent of ruffles formation as described in 
Section 2.4.3. The results shown are means (±SD) of two independent experiments, 
each performed in duplicate. **/* <0.01 ***P <0.001, versus control (Section 1.14). 
b) Representative images of GroPIns4P- and PDGF-dependent modification of the 
actin cytoskeleton in SYF cells. Bar=20 pm
PDGF
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suggested that Src is a key element for the activity of GroPIns4P.
In support of these data, the transfection of c-Src in SYF cells restored their ability 
to from ruffles upon GroPIns4P treatment (Fig. 3.23). In this case, the cells were 
transfected with an expression vector for c-Src, then starved and treated with GroPIns4P 
(50 pM) or PDGF (10 ng/ml). The extent of ruffle formation was quantified by observation 
of the transfected cells. GroPIns4P as well as PDGF, induced a 2.5-fold increase versus 
control of membrane ruffles as shown in figure 3.23. If the effect of GroPIns4P was 
restored by the expression of c-Src, the effect of PDGF was not increased upon 
transfection, thus indicating that its receptor is coupled with another TyrK in this cell 
system.
3.9.5 Conclusion
In NIH 3T3 cells the inhibition of PLCs, as well as Src family kinases inhibition, 
prevents the increase in [Ca2+]i and consequently produces a 70% inhibition of GroPIns4P- 
dependent ruffle formation. This data supported the idea that GroPIns4P activates a 
signalling pathway that, starting from the increase in [Ca2 +]j, leads to ruffle formation. The 
inhibition of CaMKII completely impaired the GroPIns4P-dependent ruffle formation, thus 
confirming the fundamental role of this kinase in the pathway. The data also demonstrated 
that the Src/Ca2+/CaMKII pathway is strongly required by GroPIns4P to produce ruffle 
formation. Both the inhibition of PLCs and of Src kinases cause a large, but not complete, 
blockage of ruffle formation. To explain the presence of this residual activity we could 
argue that CaMKII maintains a residual basal activity also after starvation, thus, GroPIns4P 
could allow the phosphorylation of TIAM1 and the consequent ruffle formation by 
modulating the activity of the kinase in another way, without increasing [Ca2 +]i, for 
example by favouring the interaction of TIAM1 and CaMKII or the formation of protein 
complex that allowed the tethering of TIAM1 and Racl to the plasma membrane.
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Figure 3.23 - GroPIns4P-dependent ruffle formation in SYF cells overexpressing 
Src. a) SYF cells were transfected with the pSM-c-Src construct as described in 
Section 2.6.5. Twenty four h after transfection, cells were serum starved for 12 h in 
DMEM, 0.1 % foetal bovine serum then were treated with 50 pM GroPIns4P for 2 
min or 10 ng/ml PDGF for 5 min. Cells were then fixed and stained with the anti-c- 
Src ab (green) and TRJTC-labelled phalloidin (red) and quantified blind for the extent 
of ruffle and stress fibre formation. The results shown are the means (±SD) of two 
independent experiments, each performed in duplicate. **P<0.01, ***P<0.001, 
versus control (Section 1.14). b) Representative images of GroPIns4P- and PDGF- 
dependent modification of the actin cytoskeleton in SYF cells transfected with Src. 
Bar=20 pm
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The importance of Src kinases for GroPIns4P activity was clearly demonstrated using SYF 
cells. In this case the absence of three isoforms of Src family kinases completely prevents 
the GroPIns4P-dependent ruffle formation; thus suggesting that in SYF cells Src kinases 
are fundamental for the activity of this compound.
3.10 Final discussion
The pathway that I am proposing is initiated by GroPIns4P, that activates a member 
of the Src family kinases (potentially Yes in NIH 3T3). This kinase then phosphorylates 
PLCyl allowing its activation and consequent IP3 production and Ca2+ increase. This event 
triggers the activation of CaMKII that phosphorylates TIAM1, facilitating its translocation 
to the plasma membrane and enhancing its exchange activity versus Racl. This small 
GTPase is also translocated to the plasma membrane upon treatment with GroPIns4P and, 
even if  it is not clear, it is possible to hypothesise that the Ca2+ increase could facilitate this 
event. It has been shown that a Ca -dependent activation of PKC can disrupt the Racl- 
GDI complex via phosphorylation of GDI. This event favours the translocation of Racl to 
the plasma membrane and consequently its interaction with GEFs (Price et al., 2003); see 
Sections 1.2.3 and 1.2.3.1). Once activated at the level of plasma membrane, Racl can lead 
to the formation of membrane ruffles (Fig. 3.24).
Besides Src kinases there could be also another unknown target of GroPIns4P, able 
to cause ruffle formation, even if only at a low level, when Src kinases are inhibited. In 
normal conditions Src kinases and the other unknown element are both activated by 
GroPIns4P and this leads to the maximal effect that is 2.5-fold increase in ruffles versus 
the basal (Fig. 3.22). In the absence of active Src kinases, GroPIns4P induces only a 1.45- 
fold increase in ruffles that could correspond to the activation of the unknown target. In the 
case of SYF cells the absence of Src family kinases (Src, Fyn and Yes) completely 
abolished the GroPIns4P-dependent ruffle formation. This data also supports the idea that
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Src kinases represent one of the main targets for GroPIns4P. In this case, however, the 
inhibition is complete and the transfection of c-Src, upon GroPIns4P treatment, cause a 
huge rescue of ruffle formation, which, in extent resembles the effect of PDGF. In 
fibroblasts, on the other hand, this growth factor is more active than GroPIns4P. Probably 
in SYF cells the second unidentified pathway is not present and the absence of Src 
completely abolishes the GroPIns4P-dependent ruffles formation.
It remains unclear how Src kinases can be activated by GroPIns4P. Src kinases are 
regulated by alternative phosphorylation/de-phosphorylation events: the chief
phosphorylation sites of Src kinases include tyrosine 416, phosphorylation of which, 
results in activation via autophosphorylation, and tyrosine 527 that results in the inhibition 
of phosphorylation by C-terminal Src kinase (CSK). Protein-tyrosine phosphatases such as 
PTPa, Shpl, Shp2 and several other transmembrane enzymes, can remove the inhibitory 
phosphate from Src kinases causing their activation (see Section 1.3.5). GroPIns4P could 
directly interact with a Src kinase favouring its autophosphorylation on tyrosine 416 or 
alternatively activate a phosphatase that de-phosphorylates the tyrosine 527. It cannot be 
excluded that GroPIns4P could lead to the inhibition of CSK.
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Figure 3.24 - Schematic representation of the pathway elucidated in Chapter 3.
GroPIns4P activates a member of the Src family kinases (potentially Yes in NIH 3T3), 
this kinase phosphorylates PLCyl allowing its activation and the consequent IP3 
production and [Ca2+]j increase. This event causes the activation of CaMKII that 
phosphorylates TIAM1, facilitating its translocation to the plasma membrane and 
enhancing its exchange activity versus Racl. Once activated at the level of plasma 
membrane, Racl can lead to the formation of membrane ruffles.
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CHAPTER 4
AN ALTERNATIVE MECHANISM OF ACTION OF GroPIns4P
4.1 Introduction
The pathways elucidated in Chapter 3 explain how exogenously added GroPIns4P 
induces ruffle formation in Swiss and NIH 3T3 cells. Its action involves CaMKII, which 
phosphorylates TIAM1, allowing the translocation of TLAM1 to the plasma membrane, 
where it can interact with and activate Racl, which is responsible for ruffle formation. 
CaMKII is activated by GroPIns4P through a Src-dependent increase in [Ca2 +]j. However, 
this increase can only partially explain GroPIns4P-dependent ruffle formation, as there is a 
residual response to GroPIns4P stimulation when Src kinases are blocked or a [Ca2+]j 
increase is prevented (see Section 3.9).
Some important questions arise from these data: How does GroPIns4P activate Src 
kinases? Is their interaction direct or via a receptor-dependent process? What is the 
unknown Src-independent element that is involved in membrane ruffling produced by 
GroPIns4P?
To identify the specific targets of GroPIns4P, and in this way to elucidate the 
mechanisms by which this compound activates Src kinases and CaMKII, different 
methodological approaches were taken:
1) Uptake and binding assays for GroPIns4P in intact and permeabilised cells, 
and to membranes from NIH 3T3 cells. This should finally answer the 
question about the presence of a specific membrane receptor for GroPIns4P.
2) Pull-down assays to see if  GroPIns4P can modulate the interaction between 
TIAM1 and Racl
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3) Immunoprecipitation and binding experiments to identify the interactors of 
GroPIns4P
4.2 Identification of a membrane receptor for GroPIns4P
4.2.1 General description
From previous results, it was clear that GroPIns4P enters cells, and there was no 
evidence for specific GroPIns4P binding to the membrane. Thus GroPIns4P was able to 
cross the plasma membrane of FRTL5 and Swiss 3T3 cells, and to rapidly reach 
equilibrium with the cell cytosol. Its concentration was high enough to allow the 
correlation of the biological effects of externally applied GroPIns4P (Berrie et al., 1999) 
with those of receptor-stimulated increases in intracellular levels of GroPIns4P (Falasca et 
al., 1997). However, to determine whether extracellularly applied GroPIns4P mediates 
these effects via a specific GroPIns4P receptor, a classic centrifugation binding assay on 
post-nuclear membranes obtained from Swiss 3T3 cells was carried out, and no significant 
specific “receptor” (high-affinity) binding sites were seen (Berrie et al., 1999).
To see if it is also possible to follow uptake of GroPIns4P in NIH 3T3 cells, and to 
conclusively understand if  this compound can bind to the plasma membrane or enter cells, 
uptake experiments in intact and permeabilised NIH 3T3 cells were performed.
4.2.2 There is no evidence for the presence of a specific plasma membrane receptor 
for GroPIns4P
The uptake assay was performed in cell suspensions. Intact or tetanolysin- 
permeabilised cells (see Section 2.12.1) were incubated with [3 H]GroPIns4P for 10 min 
(the time needed for the maximal uptake of GroPIns4P, as reported in Berrie et al., 1999)
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and then spotted onto nitrocellulose filters. The filters were then counted by p-scintillation 
counting (see Section 2.12.2.1). The amount of [3 H]GroPIns4P that was taken up within 10 
min was compared to the time 0 sample (cells and [3 H]GroPIns4P were spotted separately 
on the same nitrocellulose filter). The non-specific binding to the filter was calculated by 
spotting the radioactive mixture directly onto the filters without the cells, and this was 
subtracted from the total bound [ H]GroPIns4P obtained for each sample.
The aim of this assay was to determine if the uptake of GroPIns4P observed in 
intact cells was due to a real entry of the compound or to a binding at the level of the cell 
membrane. If an increase in GroPIns4P concentration is observed only in intact cells that 
would mean that GroPIns4P is able to enter the cells. However, if  uptake is also observed 
in permeabilised cells that would mean that GroPIns4P binds to the cellular membranes or 
to a protein complex. The advantage of using permeabilisation with tetanolysin was to 
produce small pores at the plasma membrane that do not alter the structure of the cells, and 
do not allow the exit of the majority of the proteins (Riese et al., 2002).
It was possible to follow an increase in the intracellular concentration of GroPIns4P 
(even though different extents) both in intact and in permeabilised cells: the GroPIns4P 
concentration increased by 70% in intact cells (from 2.98±0.1 pmols at time 0 to 4.89±0.5 
pmols after a 10-min incubation) and presented a 40% increase also in permeabilised cells 
(from 1.61±0.46 pmols at time 0 to 2.64±0.42 pmols after a 10-min incubation), as shown 
in Figure 4.1. With the permeabilisation, the portion of GroPIns4P that remains soluble in 
the cytosol or bound with a low affinity to a protein complex was lost. The 40% increase in 
GroPIns4P uptake in permeabilised cells represents the fraction that is tightly bound to its 
specific target (a protein complex or the membrane). These data indicated that GroPIns4P 
associated with NIH 3T3 cells represents the amount taken up and bound to intracellular 
elements or to the cellular membrane.
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Figure 4.1 - GroPIns4P-uptake in NIH 3T3 cells. 1.5xl06 intact or permeabilised 
NIH 3T3 cells were diluted in 150 pi of growth medium plus 10 mM HEPES and 
incubated with 150 pi of growth medium plus [3H]GroPIns4P (9 x l0 4 cpm/sample), 
10 pM GroPIns4P and 10 mM HEPES for 10 min. Then after 3 washes with a buffer 
containing HBSS, 2 mg/ml BSA and lOpM GroPIns4P, the samples were spotted 
onto nitrocellulose filters. Each sample was tested in quadruplicate. The filters were 
counted using a p-scintillation counter. The total pmols of GroPIns4P bound to the 
samples are reported in the y axis. The bars represent the mean (±SD) of three 
independent experiments. ***P<0.001, versus time 0 (Section 1.14).
185
4.2.3 GroPIns4P does not bind to membranes
To see if membranes could be providing the binding site for GroPIns4P, plasma 
membrane and total membranes of NIH 3T3 cells were used in the same binding assay. 
The assay was performed using the quantity of plasma membrane and total membranes that 
should be present in the amount of cells used for the equivalent cell assay. The theoretical 
amount of total membranes present in a single NIH 3T3 cell is about 80 pg (see Section
2.12.2.2). The uptake assay was performed with 1.5 x 106  cells per sample, and thus the 
amount of total membranes should be 1 2 0  pg, with 6  pg plasma membrane (in general, the 
plasma membrane represents 5% of the total membranes; Gettys et al., 1994).
The binding was performed comparing the amount of GroPIns4P bound after a 10-min 
incubation with that at time 0 (membranes and [3 H]GroPIns4P were spotted separately on 
the same nitrocellulose filter) (see Section 1.12.2). In terms of cpm, the specific binding to 
both plasma membrane and total membranes of [3 H]GroPIns4P (the tritiated compound 
was 9 xlO4  cpm/sample and represented 1/120 of the total GroPIns4P, used at a 
concentration of 10 pM ) was very low. Here, 40 cpm (that corresponds to ~0.5 pmols of 
total GroPIns4P) represented the non-specific binding to the filters, and an increase of 40- 
50 cpm (0.8-0.9 pmols of total GroPIns4P) was observed in the presence of plasma 
membrane and total membranes, whereas the binding in intact and permeabilised cells 
ranged from a 400 cpm binding normal to 1100 cpm (from 1.61 to 4.89). At the same time, 
following the 1 0 -min incubation, both the plasma membrane and total membranes do not 
show any increase in the binding of GroPIns4P, as shown in Figure 4.2. Therefore, the 
GroPIns4P associated with NIH 3T3 cells represents the amount taken up and bound to 
intracellular elements, and not to membranes. These data suggest that exogenously applied 
GroPIns4P can enter NIH 3T3 cells and remain tightly bound to a protein or protein 
complex inside the cells even performing cell permeabilisation.
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Figure 4.2 - GroPIns4P-binding to NIH 3T3 plasma and total membranes. Plasma 
membranes ( 6  pg) and total membranes (120 pg) of NIH 3T3 were diluted in 150 pi 
of growth medium plus 10 mM HEPES and incubated with 150 pi of growth medium 
plus [3 H]GroPIns4P (9 xlO4 cpm/sample), 10 pM GroPIns4P and 10 mM HPES for 10 
min. Then the samples were spotted onto nitrocellulose filters and washed three times 
with a buffer containing HBSS, 2 mg/ml BSA and 10 pM GroPIns4P. Each sample 
was tested in quadruplicate. The filters were counted by (3-scintillation counting. The 
total pmols of GroPIns4P bound to the samples are reported in the y axis, they 
correspond in terms of cpm to 100-150. The bars represent the mean (±SD) of two 
independent experiments.
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4.2.4 Conclusion
This data thus indicates that GroPIns4P accumulates in cells and binds to an 
intracellular target, and there is no evidence for specific high affinity membrane receptor 
binding. Using uptake experiments, it was possible to follow an increase in the intracellular 
concentration of GroPIns4P, both in intact and permeabilised cells. Plasma membranes and 
total membranes of NIH 3T3 cells do not show any specific binding of GroPIns4P. At the 
same time, GroPIns4P is able to permeate into cells, rapidly reaching an equilibrium with 
the extracellular concentration (Berrie et al., 1999). The amount of GroPIns4P taken up in 
intact cells is twice the amount taken up in permeabilised cells; thus the portion of 
GroPIns4P that permeates into intact cells and remains soluble in the cytosol is lost in the 
permeabilised cells. This is consistent with the hypothesis that there is a protein complex to 
which GroPIns4P binds with a high affinity, and that this binding is not altered upon 
permeabilisation of the cells.
4.3 GroPIns4P increases the binding between Racl and TIAM1
4.3.1 General description
The exchange activity of TIAM1 implies its direct interaction with Racl-GDP. 
GroPIns4P can favour the translocation of both Racl and TIAM1 to the plasma membrane, 
where the two proteins have been shown to co-localise (see Section 3.3.3). To evaluate if 
GroPIns4P can affect the binding between Racl and TLAM1, a biochemical approach, 
consisting of pull-down assays, was used. The results obtained have highlighted another 
possible mechanism of action of GroPIns4P that could act in parallel with the pathway 
described in Chapter 3.
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4.3.2 The pull down assay
In the light of the data showing a GroPIns4P-dependent co-localization of TIAM1 
and Racl at the level of the plasma membrane (see Section 3.3), the idea was to see if 
GroPIns4P can affect the formation of a complex between these two proteins. The pull­
down assay was performed with cell cytosol from HEK293T cells overexpressing TIAM1- 
HA (the C-1199-TIAM1-HA) (see Section 2.8.1), incubated with GroPIns4P (50 pM) for 
10 min at 37 °C. The purified GDP-bound form of Racl-GST was then added to the 
samples, and the Racl-GST was precipitated using the glutathione resin (see Section
2.11.2). The amount of TIAM1-HA that co-precipitated with Racl-GST was evaluated by 
immuno-blotting with the anti-HA antibody and quantified by densitometric analysis with 
the NIH image analysis program. To remove the non-specific binding, the same 
experiment was performed with purified GST instead of Racl-GST (see Section 2.11.2 for 
details). Upon incubation with 50 pM GroPIns4P, the binding between TIAM1-HA and 
Racl-GST increased by 2.7-fold when compared with the untreated samples (as quantified 
in Figure 4.3b). GST did not produce any specific binding (Fig. 4.3a).
In the pull-down assay, the incubation between cell cytosol overexpressing TIAM1- 
HA and GroPIns4P was performed at 37 °C for 10 min. To see if there was a temperature- 
dependent effect of GroPIns4P, the incubation was performed at different temperatures: 0 
°C, 20 °C and 37 °C for 10 min. However, the increase in binding between TIAM1 and 
Racl was observed only at 37 °C (Fig. 4.4a). If there was a physical interaction, the 
decrease in temperature would have lowered the rate of the interaction. Thus, to see if the 
effect was still present (even if  delayed), the time of incubation was prolonged to 1 h. 
Here, a 2.7-fold increase in the binding was observed also at 20 °C, whereas at 0 °C no 
relevant effects were visible (Fig. 4.4b).
From these data it was not possible to conclude whether GroPIns4P acts on TIAM1 
directly or indirectly through the activation of an enzymatic pathway. The temperature-
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Figure 4.3 -  Racl-GST puSi-down assay with cell cytosol overexpressing TIAM1.
120 pg of cell cytosol overexpressing TIAM1-HA (see Section 2.8.1) were first 
diluted (1:15) in reaction buffer (see Section 2.11.1). The cytosol was then pre-cleared 
with glutathione resin for 1 h at 4 °C on a rotating wheel (10 pl/sample) and then 
incubated for 10 min at 37 °C with 50 pM GroPIns4P. Finally, 4 pg of Racl-GST 
purified protein, 10 pi glutathione resin and 20 pi of 2 mg/ml BSA (final volume 200 
pi) were added to the samples and incubated for 1 h at 4 °C on a rotating wheel. The 
pellets were recovered and analysed by immuno-blotting with the antibody anti- 
TIAM1 (as described in Section 2.11.2). In a) the western blot of a representative 
pull-down assay is shown. In b) the quantification of the amount of TIAM1 co­
precipitated with Racl-GST, quantified by densitometric analysis with the NIH image 
program is shown. The effect of GroPIns4P is presented as percentage increase versus 
the untreated samples and the bars represent the mean (±SD) of four independent 
experiments, each performed in duplicate. **P<0.01 versus control (w/o GroPIns4P)
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Figure 4.4 -  Racl-GST pull-down assay with cell cytosol overexpressing TIAM1.
The pull down was performed as described in figure 4.3. In a) the samples were 
incubated with GroPIns4P for 10 min at different temperatures (37 °C, 20 °C and 0 
°C). In b) the samples at 0 and 20 °C were incubated for 1 h. The quantification was 
performed by densitometric analysis with the NIH image program. The effect of 
GroPIns4P is presented as percentage increase versus the untreated samples and the 
bars represent the mean (±SD) of three independent experiments, each performed in 
duplicate. **P<0.01 versus control (w/o GroPIns4P) (Section 1.14).
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dependence would favour the second hypothesis, because at 0 °C there is no increase in 
binding between TIAM1 and Racl even increasing the time of incubation. However, the 
characteristics of the cytosol used tend to exclude the activation of an enzymatic pathway, 
since the [Ca2+]j increase that is required for the initiation of the pathway from CaMKII 
activation that leads to TIAM1 and Racl activation cannot occur in this system. In fact, the 
cytosol is prepared in the presence of 1% NP-40 (which will solubilise all of the 
membranes) and with a 90,000 xg centrifugation (that eliminates any residual membrane 
complexes) (see Section 2.8.1; Labeta et al., 1988).
4.3.3 The pull-down assay with purified TIAM1
To see if GroPIns4P interacts directly with TIAM1, thus activating it and enhancing 
its binding to Racl, a pull-down assay with purified TIAM1 was performed. Purified 
TIAM1 (C-1199-TIAM1) (see Section 2.9.2) was incubated for 10 min at 37 °C with 
GroPIns4P (50 pM). The pull down assay was performed as described for the cell cytosol 
(Section 4.3.2) and the TIAM1 was detected by immuno-blotting with the anti-TIAMl 
antibody (as described in Section 2.11.3). Figure 4.5 shows the Western blot of an 
experiment (representative of three) in which it is clear that the binding between Racl- 
GST and TIAM1 was not affected by the presence of GroPIns4P, as the amount of TIAM1 
co-immunoprecipitated with Racl in the absence of GroPIns4P was similar to the amount 
precipitated in the presence of GroPIns4P. When GST was used instead of Racl-GST, a 
signal for TIAM1 was not detectable (Fig. 4.5), thus suggesting that the binding between 
TIAM1 and Racl-GST detected in the assay was specific.
These data exclude the hypothesis that a direct binding between GroPIns4P and 
TIAM1 could be enough to activate the exchange factor. However, it was still unclear how 
GroPIns4P increases the binding between TIAM1 and Racl. The most probable hypothesis 
was the presence of a complex including TIAM1, Racl and other proteins that could have
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Figure 4.5 - Pull-down with purified TIAM1. 2 pg of purified TIAM1 (see Section
2.9.2) was incubated for 10 min at 37 °C with 50 pM GroPIns4P, then 2 pg of Racl- 
GST or purified GST, 10 pi of 50% glutathione resin and the reaction buffer (see 
Section 2.11.3) were added to the samples (final volume 200 pi); finally the samples 
were incubated in a rotating wheel for 1 h at 4 °C. The pellets were recovered by 
centrifugation for 6 min at 800x g  and then, after 3 steps of washing with the reaction 
buffer, analysed by immuno-blotting with the antibody anti-TIAMl (as described in 
Section 2.11.3). The immuno-blot of TIAM1 (upper panel) and the ponceau red with 
the bands of Racl-GST and GST (lower panel) are shown. This experiment is 
representative of three.
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a role in favouring their interaction. Thus, the target of GroPIns4P could be a protein that, 
by interacting with TIAM1, favours its binding with Racl, although it cannot be excluded 
that the interaction between GroPIns4P and TIAM1 itself allows a conformational change 
in TIAM1, which might result in interactions with other proteins (e.g. scaffolding proteins) 
that could increase the TIAM1 affinity for R acl.
4.3.4 The effects of KN-93 in the pull-down assay
The pull-down assays indicated that GroPIns4P is able to increase the binding 
between Racl and TIAM1, but it is difficult to integrate this data into the pathway from 
PLC activation to membrane ruffle formation. The CaMKII-dependent phosphorylation of 
TIAM1 is important for its activation and favours its exchanging activity versus Racl 
(Michiels et al., 1997). As reported in Chapter 3, the activity of CaMKII can be modulated 
by GroPIns4P, and so it could be hypothesised that CaMKII is also involved in the 
GroPIns4P-dependent increase in Racl-TIAMl binding. To test this hypothesis, KN-93 (a 
specific inhibitor of CaMKII; see introduction, Section 1.3.4) was applied in the pull-down 
assay. The assay was performed with the same cell cytosol as for the previous pull-down 
assays, prepared from HEK293T cells transfected with TIAM1-HA (Section 4.3.2). The 
cytosol was incubated for 10 min at 37 °C with 50 pM GroPIns4P in the presence and 
absence of 20 pM KN-93 (the same concentration applied to completely prevent the 
translocation of TIAM1 to the plasma membrane; see Section 3.3.5). After the incubation, 
the pull-down assay was performed as described above (see Section 4.3.2).
The treatment with KN-93 completely prevented the GroPIns4P-dependent increase in 
Racl-TIAMl binding, as shown in Figure 4.6c, where the percentage increase in Racl- 
TIAMl binding is given with respect to the untreated samples. However, the treatment 
with KN-93 per se induced an increase in the basal level of interaction between Racl and 
TIAM1. The Western blotting with its relative quantification (Fig. 4.6a,b), revealed that
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Figure 4.6 -  Racl-GST pull-down assay with cell cytosol overexpressing TIAM1.
120 pg of cell cytosol overexpressing TIAM1-HA (see Section 2.8.1) were first 
diluted (1:15) in reaction buffer (see Section 2.11.1), then the cytosol was pre-cleared 
with glutathione resin for 1 h at 4 °C on a rotating wheel (10 pl/sample) and incubated 
for 10 min at 37 °C with 50 pM GroPIns4P. Twenty pM KN-93 (CaMKII inhibitor) 
was added with the GroPIns4P during the 37 °C-incubation. Then the assay was 
performed as described in Figure 4.3 a) immuno-blot analysis of the experiment 
revealed with the Ab-anti TIAM1. b) quantification with the NIH program of the the 
experiment in a (was performed in duplicates), c) Average of three independent 
experiments; each sample was quantified by NIH image and then expressed as 
percentage of stimulation compared to the un-stimulated samples, d) Pull-down with 
KN-93 and DMSO: DMSO was added instead of KN-93, at the same concentration 
(0.4 pi of KN-93 were added to each sample to have a final concentration of 20 pM; 
thus 0.4 pi of DMSO were added as a control). **P<0.01 versus control (w/o 
GroPIns4P) (Section 1.14).
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the amount of TIAM1 co-precipitated with Racl upon treatment with KN-93 is similar to 
the amount obtained upon treatment with GroPIns4P. This increase in the basal interaction 
could explain why the GroPIns4P was not able to increase the binding between TIAM1 
and Racl in the presence of KN-93. Thus, the CaMKII inhibitor appears to have a non­
specific action in this assay and makes the results obtained difficult to interpret.
The KN-93 was dissolved in DMSO, which could also influence the final result; for 
this reason, the same pull-down assay was performed in the presence of DMSO. The cell 
cytosol overexpressing TIAM1-HA was incubated with GroPIns4P and KN-93 or with the 
same quantity of DMSO (control). DMSO itself produced an increase in the binding 
between TIAM1 and Racl, thus confirming that the presence of DMSO could act in a non­
specific way. The Figure 4.6d shows the densitometric quantification of the GroPIns4P- 
dependent binding between TIAM1 and Racl in the presence of KN-93 and DMSO. In 
conclusion, the KN-93-dependent reduction in the binding cannot be considered as an 
inhibition of the GroPIns4P effect, but as an increase in the basal level, due to the DMSO, 
that masks the activity of GroPIns4P.
There is still a possibility that CaMKII has an important role also in the GroPIns4P- 
dependent increase in Racl-TIAMl binding, and in this case, it remains to be elucidated 
how GroPIns4P activates this kinase. Neither direct activation of the kinase (the CaMKII 
activity assay performed with the purified enzyme does not shows any effect of 
GroPIns4P) nor a [Ca2+]i increase appear to be the starting events that lead to the 
GroPIns4P-dependent increase in Racl-TIAMl binding in this in vitro pull-down assay.
4.3.4 Conclusion
The exchange activity of TIAM1 implies its direct interaction with Racl-GDP. 
With the pull-down assay, it was possible to demonstrate that GroPIns4P facilitates the 
interaction between Racl and TIAM1. This action was temperature-dependent: there was
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an increase in the binding with a short incubation at 37 °C or a long incubation at 20 °C, 
but not at 0 °C. From these data, it was not possible to conclude whether GroPIns4P acts 
on TIAM1 directly or indirectly through the activation of an enzymatic pathway. In 
addition, GroPIns4P was not active when the pull-down assay was performed with purified 
TIAM1, suggesting that GroPIns4P cannot act directly on the TIAM1. The attempt to 
evaluate if CaMKII is involved in the GroPIns4P-dependent increase in Racl-TIAMl 
binding was unsuccessful. There are no tools available to determine if GroPIns4P requires 
CaMKII to favour the binding between Racl and TIAM1, or if  per se, by interacting with 
other proteins, GroPIns4P could be able to modulate this interaction. This second 
hypothesis is the most probable, even if to date we have not been able to find any specific 
interactor.
4.4 GroPIns4P interacts with a protein complex co-iinmunoprecipitated with 
TIAM1
4.4.1 General description
From the data obtained in the uptake experiments, the potential target of GroPIns4P 
should be a cytosolic protein that can also be complexed inside the cells in insoluble 
structures. Looking at the proteins involved in the GroPIns4P-dependent pathway that 
leads to ruffle formation and taking into consideration the data of the pull-down assay, 
which show that GroPIns4P favours the interaction between TIAM1 and Racl, TIAM1 or 
a protein that binds this exchange factor could be good candidates.
A potential direct binding between GroPIns4P and TIAM1 could induce a change 
in the conformation of TIAM1 that favours its interaction with Racl. However, this 
hypothesis is difficult to support, since much of the data are not in line with this direct 
interaction. First, the exchange activity of TIAM1 was not affected by GroPIns4P (as was
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demonstrated by GEF assays performed in Mancini et al., 2003), and second, GroPIns4P 
does not bind with a high affinity to the two PH domains present in TIAM1 (as shown by 
the GroPIns4P competition assays with PC-liposomes containing 2% PIP2 , performed in 
this laboratory by Stefania Mariggio, see Section 1.13.4). In addition, GroPIns4P was not 
able to increase the binding between purified TIAM1 and Racl-GST in a pull-down assay. 
A potential interaction between Racl and GroPIns4P is also unlikely, since GroPIns4P is 
not able to affect the GEF or GAP activity of this small G-protein in in vitro assays 
(Mancini et al., 2003; see Section 1.4.3.2.2). Therefore, the presence of a third protein that 
interacts with TIAM1 and mediates the activation of TIAM1 by GroPIns4P, favouring the 
binding between Racl and its GEF, has to be considered the most plausible.
To further analyse the potential binding of GroPIns4P with a TIAM1-containing 
complex, binding experiments between immunoprecipitated or purified TIAM1 and 
GroPIns4P were performed, as reported in the following sections.
4.4.2 Binding experiments between GroPIns4P and TIAM1-HA 
immunoprecipitated from cell lysates.
TIAM1-HA was overexpressed in HEK293T cells, then immunoprecipitated from 
the cytosol with an anti-HA antibody, and finally, the immunoprecipitate was incubated 
with different concentrations of GroPIns4P in the presence of a tritiated tracer 
([3H]GroPIns4P) (see Sections 2.8.3 and 2.13.2). The specific binding was then calculated 
by subtracting the amount of [3H]GroPIns4P bound to the cytosol of wild-type HEK293T 
cells incubated with the same antibody against the HA tag. The Western blot presented in 
Figure 4.7 shows the immunoprecipitation with the anti-HA antibody in the wild-type- and 
TIAM1-transfected cytosols. The incubation with [3H]GroPIns4P was carried out at 37 °C 
for 45 min, then the samples were centrifuged and the pellets analysed by scintillation 
counting (see Section 2.13.2).
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Figure 4.7 - Binding between a TIAMl-containing protein complex and 
GroPIns4P. a) Acrylamide gel of the immunoprecipitation. TIAM 1-HA 
overexpressed in HEK293 cell lysate was immunoprecipitated with anti-HA 
antibody. The lanes represent the HEK293 wild type (2) and TIAM 1-HA 
overexpressing (1) cell lysate immunoprecipitated with the antibody against the HA 
tag. Molecular weight markers (MW) are shown, b) The immunoprecipitates were 
incubated with GroPIns4P at different concentrations in the presence of a 
[3 H]GroPIns4P (see Section 2.13.2). The specific binding (-*-) was calculated 
subtracting the non-specific (—♦-) from the total binding (-■-). The bars represent the 
mean (±SD) of two independent experiments, each performed in triplicates.
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GroPIns4P was able to interact with the TIAM1 immunoprecipitate, thus 
supporting the idea that there is a potential binding between GroPIns4P and TIAM1 or a 
protein that co-precipitates with TIAM1. To calculate the affinity of GroPIns4P for this 
interactor, a dose-response curve was performed: GroPIns4P was applied to the samples in 
a range of concentrations from 0. 1 pM to 50 pM (see Section 2.13.2). This experiment 
showed that GroPIns4P was able to bind the immunoprecipitated TIAM 1-HA with a Kd of 
~13 pM (see Section 1.13.2), and thus the binding affinity is compatible with the 
GroPIns4P concentrations normally used and would support the hypothesis of the presence 
of specific binding between a complex containing TIAM1 and GroPIns4P in living cells 
(Fig. 4.7).
Thus, GroPIns4P could directly interact with TIAM1 or with another protein that is 
an interactor of TIAM1. This event could be the key point for our understanding of an 
alternative mechanism used by GroPIns4P to activate TIAM1 and R acl.
4.4.3 Binding experiments between GroPIns4P and PH-domain-deleted mutants of 
TIAM1
If the interaction between GroPIns4P and TIAM1 is direct, it has to be understood where 
GroPIns4P binds TIAM1 and if there is a specific domain of interaction for GroPIns4P. If 
the interaction is not direct, the elucidation of the TIAM1 domain that could be responsible 
for the co-immunoprecipitation of the GroPIns4P-interactor may help us to understand the 
mechanism by which TIAM1 is activated by GroPIns4P.
This Racl exchange factor contains several sites of potential interaction with 
GroPIns4P. Besides the two PH domains (N- and C-terminal), a Ras binding domain 
(RBD) and a PDZ domain could be important for the interaction of TIAM1 with its 
effectors. TIAM1 activity can be modulated by different cellular events, like 
phosphorylation, interactions with phosphoinositides, and also with proteins (as discussed
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in Section 1.2.3.2). Thus, one or more of these events could be important also for the 
activity of GroPIns4P.
As demonstrated by the GroPIns4P competition assays with PC-liposome 
containing 2% PIP2  (Stefania Mariggio, Section 2.13.4), GroPIns4P does not bind with a 
high affinity to the two PH domains of TIAM1. The PIP2  binding assays were performed 
under different conditions to those using GroPIns4P (to follow the interaction between 
GroPIns4P and immunoprecipitated TIAM1), and thus it cannot be excluded that the PH 
domains are important for the binding of GroPIns4P either as sites of direct interaction or 
as binding elements of the protein that interacts with GroPIns4P. To solve this problem, 
PH-domain-deleted mutants of TIAM1 were used in the same binding assay. These 
mutants selectively lacked the N-terminal PH domain (APHn-TIAMl), the C-terminal PH 
domain (APHc-TIAMl) or both (APH-TIAM1), as showed in Figure 3.7a (Chapter 3). The 
mutants were expressed in vectors that contain the GFP tag, thus the immunoprecipitation 
was performed using an antibody against GFP. Each mutant was compared with the GFP- 
tagged wild-type construct (TIAM 1-GFP) for binding with GroPIns4P, and the non­
specific binding was calculated by overexpressing and immunoprecipitating GFP alone in 
the same cell system.
Even if this comparison was affected by differences in the overexpression and 
immunoprecipitation efficiencies, the indication was that all the mutants were able to 
interact with the GroPIns4P. As shown in Figure 4.8b, both TIAM1-GFP and APH-TIAM1 
showed a 1.5-fold increase in [3H]GroPIns4P binding when compared to GFP, thus 
suggesting that the absence of the PH domains does not affect the binding of GroPIns4P. 
The other two mutants showed lower levels of interaction, although in both cases the 
amount of overexpressed and immunoprecipitated protein was lower (Fig 4.8a). Thus, the 
data support the initial observation that the PH domains are not important for the activity 
of GroPIns4P. They appear not to be sites for direct interactions with GroPIns4P and they 
are most likely not important for the formation of a complex that contains TIAM1 and
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Figure 4.8 - Binding between GroPIns4P and TIAM1 or deleted mutants GFP- 
tagged (see Fig. 3.7a). HEK 293 cells were transfected with the GFP-tagged TIAM1 
and its deletion mutants. The cells were then lysed after 48 h of transfection and the 
cytosol prepared (as described in Section 2.8.1). a) western blot of the 
immunoprecipitation performed using an antibody against the GFP. b) Binding assay. 
Each immunoprecipitated mutant was tested for the ability to bind GroPIns4P (as 
explained in Figure 4.7 and Section 2.13.2. Each mutant has to be compared with the 
GFP-tagged wild tipe construct for the binding to GroPIns4P and the non specific 
binding was calculated by overexpressing GFP in the same cell system. The bars 
represent the mean of two independent experiments, each performed in triplicate. 
*P<0.05, **P<0.01, ***JP<0.001, versus GFP (Section 1.14).
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GroPIns4P. Therefore, there should be another domain of TIAM1 that has an important 
role in this process. This domain should be a regulatory one that by interacting with 
different proteins, can modulate the behaviour of TIAM 1.
4.4.4 GroPIns4P binding studies with purified TIAM1 and Racl
The data obtained up to now tend to exclude the possibility that GroPIns4P 
interacts directly with TIAM1. However, to exclude this possibility by alternative 
approaches, binding assays were performed with purified GST-tagged TIAM1. Purified 
Racl-GST was also tested in this assay, to check if  it could interact with GroPIns4P.
The assay buffer, GroPIns4P concentration and time of incubation where the same 
as those used in the previous binding assays with immunoprecipitated TIAM 1-HA (see 
Section 1.13.3). Two different approaches were used to determine if GroPIns4P binds 
directly to TIAM 1 -GST:
1. TIAM1-GST was incubated with [3H]GroPIns4P (the tritiated compound 
was 9 xlO4 cpm/sample and represented 1/120 of the total GroPIns4P, used 
at a concentration of 10 pM) and then precipitated with glutathione resin to 
separate the unbound fraction. The non-specific binding was calculated by 
using purified GST instead of TIAM 1-GST (see Section 2.13.3). There was 
no difference in the amount of GroPIns4P bound to TIAM 1-GST or to GST 
alone, thus suggesting that GroPIns4P does not bind TIAM1 specifically 
(Fig 4.9a).
2. TIAM1-GST was incubated with [3H]GroPIns4P as above, spotted onto 
nitrocellulose filters and washed twice using a vacuum filtration apparatus. 
Again, GST was used to evaluate the non-specific binding (see Section
2.13.3). However, no significant differences were seen between the samples 
with TIAM1-GST and those with GST (Fig. 4.9b). Purified Racl-GST
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Figure 4.9 - Binding between GroPIns4P and purified TIAM1-GST or Racl-GST.
a) TIAM 1-GST (5 pg), purified as reported in Section 2.9.2, was incubated with 
[3 H]GroPIns4P and then precipitated with the glutathione resin to separate the unbound 
fraction. The non-specific binding was calculated by using purified GST (5 pg, purified 
as described in Section 2.9.2) instead of TIAM1-GST (as described in Section 2.13.3.
b) TIAM 1-GST (5 pg) was incubated with [3 H]GroPIns4P, spotted on nitrocellulose 
filters and washed twice with a vacuum filtration apparatus. GST was used to evaluate 
the non specific binding (Section 2.13.3). c) the same assay with vacuum apparatus 
was used to test the binding between Racl-GST (5 pg) (purified as described in Section
2.9.1) and GroPIns4P.
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was also tested in this assay, and also in this case no specific binding was 
observed (Fig. 4.9c).
These data further confirmed the idea that GroPIns4P does not directly interact with 
TIAM1 or Racl. It is presumably possible, however, that the conditions applied in the 
binding assay were not suitable to follow the interactions between TIAM1 or Racl and 
GroPIns4P.
4.4.5 CaMKII is co-immiinoprecipitated with TIAM1
CaMKII was present in the complex that co-immunoprecipitated with TIAM1, as showed 
in Figure 4.10a. It could be hypothesized that CaMKII interacts directly with GroPIns4P, 
even if GroPIns4P was not able to directly activate the purified CaMKII (see Section
3.4.3). To verify if GroPIns4P can affect the activity of CaMKII co-immunoprecipitated 
with TIAM1, the ability of CaMKII to phosphorylate TIAM1 in the immunoprecipitated 
complex was analysed. After immunoprecipitation, the complex was incubated in the 
ADBII buffer and [y32P]ATP (see Section 2.6.2) in the presence of GroPIns4P (50 pM). 
The level of TIAM1 phosphorylation was then analysed by Western blotting and quantified 
by an analysis with the Instant Imager (see Section 2.6.2). GroPIns4P did not affect the 
level of CaMKII-dependent phosphorylation of TIAM 1 under these conditions, as shown 
in Figure 4.10b. The specificity of the CaMKII activity was tested by adding KN-93 to the 
samples, which caused complete inhibition of the TIAM1 phosphorylation (Fig.4.10b).
The activity of CaMKII versus its substrate TIAM1 was not influenced by 
GroPIns4P. This observation was confirmed also when the assay was performed in the 
presence of purified TIAM1 and CaMKII instead of the immunoprecipitate. TIAM 1-GST 
and CaMKII were incubated in ADBII buffer with [y32P]ATP (see Section 2.6.2), in the 
presence of GroPIns4P (50 pM). Then the samples were analysed by Westm blotting and 
quantified by the instant imager. In Figure 4.10c is reported the autoradiography of a
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Figure 4.10 - CaMKII-dependeot phosphorylation of TIAM1. a) Western blotting 
of the immunoprecipitation of TIAM 1-HA (T) compared with the non transfected 
cytosol (NT) revealed with the antibody against TIAM1 and CaMKII. b) HEK293 cells 
were transfected with TIAM1-HA, then, after 48 h, treated for 24 h with KN-93 and 
lysed and immunoprecipitated with the anti-HA Ab. The immunoprecipitated samples 
were treated for 10 min with GroPIns4P prior to be used for the phosphorylation assay 
(Section 2.6.2). Samples 6  and 7 are respectively the negative (untrasfected cells) and 
positive controls (cell cytosol used for previous experiments overexpressing TIAM1) 
for the immunoprecipitation and phosphorylation, c) 2 pg of TIAM 1 purified, 0.05 pg 
of purified CaMKII and [y3 2P] ATP were incubated in the absence and presence of 50 
pM GroPIns4P for 45 min at 30 °C in the ADBII buffer, to follow the CaMKII- 
dependent TIAM1 phosphorylation (see Section 2.6.2). The figure shows a 
representative experiment, with the autoradiography and its relative quantification 
performed by Instant Imager. The plot represent the mean of each duplicate (2 and 3)
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representative experiment with its relative quantification, from which it is clear that the 
CaMKII specifically phosphorylates TIAM1, but GroPIns4P does not affect the levels of 
TIAM1 phosphorylation. Thus, GroPIns4P can interact with a protein complex containing 
TIAM1, CaMKII and Racl without affecting the level of CaMKII-dependent 
phosphorylation of TIAM 1.
4.4.6 Conclusion
The mechanism of action of GroPIns4P that could be hypothesized from the experimental 
evidence (obtained in Chapter 3) involves a PLC-dependent increase [Ca2+]j that activates 
CaMKII; this kinase in turn phosphorylates TIAM1, allowing its translocation to the 
plasma membrane where Racl is activated, and consequently, where membrane ruffles are 
formed. Whether the binding between the TIAM 1-containing complex and GroPIns4P is a 
crucial event for this pathway needs further analysis. In fact, the final effect (ruffle 
formation) could be the result of a double action of GroPIns4P, which on the one hand 
increases [Ca2+]i, activating in this way CaMKII, and on the other hand, modulates directly 
the activity of TIAM1 by bringing this GEF into contact with the relevant proteins. 
GroPIns4P could have a tethering function, allowing the formation of a large complex that 
could be responsible for the TIAM 1/Racl activation, and consequently, ruffle formation.
4.5 Final discussion
When exogenously added to cells, GroPIns4P is able to equilibrate across the membrane 
due to the activity of a specific membrane transporter (as discussed in Section 1.4.4). 
Using uptake experiments it was possible to follow an increase in the intracellular 
concentration of GroPIns4P, both in intact and permeabilised cells. Plasma membranes and 
total membranes of NIH 3T3 cells do not show any specific binding of GroPIns4P. Thus
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there is no experimental evidence that supports the presence of a specific membrane 
receptor, suggesting that the cellular effects of this compound are due to its action at the 
level of intracellular targets. Preliminary data, obtained form a competition assay between 
[3H]GroPIns4P and unlabelled GroPIna4P, indicates that the affinity of GroPIns4P for its 
target is high because a complete displacement occurs in the range of 0.1-10 pM 
GroPIns4P (Fig. 4.11). Here the assay was performed by incubating permeabilised NIH 
3T3 cells with a fixed amount of [3H]GroPIns4P and then adding increasing amount of 
GroPIns4P. The uptake was followed as described in Section 2.12.2.1. The non specific 
binding was calculated by performing the same assay using total membranes (see Section 
2.12.2.2). Further experiments will be performed in order to calculate the Kd for 
GroPIns4P and its unknown interactor.
As well as the Src-dependent pathway that starts from Src activation and via [Ca2+]i 
increase, leads to the CaMKII-dependent TIAM 1/Racl plasma membrane translocation 
and ruffle formation, GroPIns4P is able to increase the binding between Racl and TIAM1 
and appears to interact directly with a protein complex associated with immunoprecipitated 
TIAM 1-HA. How these two effects are connected is not yet clear. Three common elements 
are present: TIAM1, Racl and CaMKII.
Ruffle formation is strictly dependent on the localization of both TIAM1 and Racl 
at the plasma membrane and also on the activation of Racl by TIAM1. The action of 
GroPIns4P on these two proteins goes in two directions: on the one hand, it favours their 
translocation to the plasma membrane in a Src-dependent way, and on the other, it 
increases their interaction in a way that does not require Src-dependent signalling. TIAM1 
is phosphorylated and thus activated by CaMKII, and GroPIns4P is able to activate this 
kinase by acting through Src. CaMKII is part of a complex that co-immunoprecipitates 
with TIAM1 and that interacts with GroPIns4P. The experimental evidence tends to 
exclude a direct interaction with or activation of CaMKII by GroPIns4P. In addition, the 
inhibition of CaMKII completely abolishes GroPIns4P-dependent ruffle formation,
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Figure 4.11 - Competition assay. Competition assay between the unlabelled and 
[3H]GroPIns4P using permeabilised NIH 3T3 cells (1.5xl06 cells) (0). Total 
membrane (120 pg) of NIH 3T3 cells were used to see the non specific binding, (□) 
of GroPIns4P (see Figure 4.2 and Section 4.2.3). The concentration of GroPIns4P 
applied to the system was from 0.1 pM to 500 pM. The cells or the membranes were 
diluted in 150 pi of growth medium plus 10 pM HEPES and incubated with 150 pi 
of growth medium plus [3 H]GroPIns4P (9 xlO4 cpm/sample), 10 pM HEPES and 
GroPIns4P at the different concentrations for 10 min. After 3 washes with a buffer 
containing HBSS, 2 mg/ml BSA and GroPIns4P (each sample with the same 
concentration of GroPIns4P applied for the competition assay), the samples were 
spotted in nitrocellulose filters. Each sample was tested in quadruplicate. The filters 
were counted by (3-scintillation counter. The total pmols of GroPIns4P bound to the 
samples are reported in the y axis. The bars represent the average (±SD) between the 
4 samples analyzed for the experiment.
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whereas the inhibition of Src still allows a 30% increase in ruffles (as shown in Section
3.9.3). The question that arises from these data is whether this residual activity of 
GroPIns4P is related to its ability to increase the binding between Racl and TIAM1, or to 
its ability to interact with a protein complex containing CaMKII and TIAM1. Coming back 
to the unknown target mentioned in Chapter 3 (Section 3.10), it is possible that what is co- 
immunoprecipitated with TIAM1 and specifically interacts with GroPIns4P is a scaffolding 
protein that tethers TIAM1, CaMKII and Racl together, forming a complex that has a 
fundamental role in ruffle formation. Under normal conditions, GroPIns4P can cause the 
full activation of CaMKII, by a Src-dependent pathway, thus reaching its maximal effect 
on ruffle formation (2.5-fold increase). When Src is blocked, the CaMKII portion that 
maintains a residual basal activity also after starvation, could be involved in the activation 
of TIAM 1. GroPIns4P could interact with this unknown target, and in this way, favour the 
formation of a multi-protein complex, at the level of the membrane, containing TIAM1, 
Racl and CaMKII, which together cooperate in ruffle formation (Fig. 4.12).
This hypothesis needs to be challenged experimentally. First, the specific 
interactors of GroPIns4P have to be defined. New experimental approaches will be 
followed, such as two-dimensional gel electrophoresis to separate the proteins in the 
complex, followed by analysis by mass spectrometry to identify the proteins that are co- 
immunoprecipitated with TIAM1. However, this work is in progress and is not part of the 
present study.
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Figure 4.12 - Final scheme. GroPIns4P could interact with an unknown target (x 
protein), and in this way, favour the formation of a multi-protein complex containing 
TIAM1, Racl and CaMKII, which together cooperate in ruffle formation.
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CHAPTER 5
OTHER BIOLOGICAL ACTIVITYES OF GroPIns4P
5.1 Introduction
As well as the pathway that leads to membrane ruffle formation described in 
Chapter 3 and 4, exogenously applied GroPIns4P causes other cellular events, such as the 
inhibition of G protein-activated adenylyl cyclase (AC) (Iacovelli et al., 1993), and stress 
fibre formation both in Swiss and NIH 3T3 cells. This latter event is dependent on the 
activation of the small GTPase RhoA (Mancini et al., 2003).
The aim of this Chapter is to describe the mechanisms by which GroPIns4P affects 
AC activation and stress fibre formation in fibroblasts and to discuss the correlation 
between the different effects that GroPIns4P can produce in cells.
5.2 GroPIns4P activates adenvlvl cyclase acting through Gq; in NIH 3T3 cells
5.2.1 General description
The biological activities of the glycerophosphoinositols have been associated with 
G-proteins: it has been shown that exogenously applied GroPIns4P inhibits Gs-activated 
AC (Iacovelli et al., 1993). In thyroid cells, cholera toxin (CTX) or aluminium fluoride- 
activated AC was inhibited by GroPIns4P; moreover GroPIns4P was able to prevent CTX 
and forskolin-dependent activation of AC in Swiss 3T3 cells (Falasca et al., 1997). Several 
isoforms of AC exist, and they are regulated in different ways: isoforms I, III and VIII are 
activated synergistically by a s, together with Ca2+-calmodulin; isoforms II, IV and VII are 
activated synergistically by the a s and Py subunits; and isoforms V and VI are inhibited by
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otj and Ca2+ (Sunahara and Taussig, 2002) (see Section 1.3.3). Considering that isoforms V 
and VI are expressed in NIH 3T3 cells (Smit et al., 1998), it can be hypothesized that the 
inhibition of AC operated by GroPIns4P is mediated by the activation of a Gaj.
The mechanism by which GroPIns4P inhibits AC was investigated using different 
experimental approaches, including GTPyS binding to plasma membranes of NIH 3T3 
cells, to see if GroPIns4P can activate the heterotrimeric G proteins, and cAMP 
measurements, to determine if GroPIns4P can inhibit AC.
5.2.2 GroPIns4P increases GTPyS binding to the plasma membranes of NIH 3T3 
cells
To investigate a possible activation of heterotrimeric G proteins by GroPIns4P, 
assays of GTPyS binding to the plasma membranes of NIH 3T3 cells treated with 
GroPIns4P were performed. The plasma membranes were prepared from NIH 3T3 cells as 
reported in Section 2.10.2. The incubation with the stimuli was performed for 1 h at 37 °C 
in a GTPyS buffer containing [35S]GTPyS (see Section 2.13.1). After the incubation, the 
samples were spotted onto nitrocellulose filters, washed 3 times with wash buffer, and then 
counted in a p-scintillation counter. The non-specific binding was calculated by spotting 
the radioactive mixture alone onto the filter (as described in Section 2.13.1).
The membranes were stimulated with 50 pM GroPIns4P, and to follow the 
activation of the heterotrimeric G-proteins, Mas7 (25 pM), a non-specific activator that 
mostly activates Gi, and LPA (10 pM), which can activate both Gj (for AC inhibition; van 
Corven et al., 1989) and Gn (for stress fibre formation; Ridley and Hall, 1992) were used. 
After 1 h of incubation of the plasma membranes with GroPIns4P, a 30% increase in
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Figure 5.1 - GTPyS binding to the plasma membranes from NIH 3T3 cells.
Plasma membranes from NIH 3T3 cells were untreated (blue) or treated (violet) with 
PTX (5 nM) and with different stimuli (25 jiM Mas7, 10 pM LPA, and 50 pM 
GroPIns4P) for 30 min at 30 °C in the presence of [3 5 S]GTPyS. Then the samples 
were fdtered using a vacuum filtration apparatus, and washed 3 times. The filters 
were added to scintillation fluid and counted in a P-scintillation counter, as described 
in Section 2.13.1. The data are presented as the percent response over untreated 
membranes (control). The bars represent the mean (±SD) of three independent 
experiments, each performed in triplicate. **P<0 . 0 1  ***P<0.001, versus control 
(Section 1.14).
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GTPyS binding was seen. This increase was lower than that obtained by stimuli like Mas7 
(200%) and LPA (140%), as shown in Figure 5.1.
To identify which class of G proteins are activated by GroPIns4P, the same assay 
was performed using plasma membranes obtained from NIH 3T3 cells treated with 
pertussis toxin (PTX), which blocks all of the G j/G o classes of G proteins. PTX has been 
widely used as a reagent to characterize the involvement of heterotrimeric G proteins in 
signalling. PTX catalyses the ADP-ribosylation of specific G protein a  subunits of the G, 
family, and this modification prevents the occurrence of the receptor-G protein interaction 
(Pittman, 1984). The NIH 3T3 cells were treated for 24 h with 5 nM PTX, and then 
harvested and the plasma membranes prepared as described in Section 2.10.2. This 
procedure leads to the full ribosylation of the Gaj subunits present in the membranes, as 
observed in the ADP-ribosylation assay reported in Figure 5.2. Here, the plasma 
membranes obtained from cells that were treated with (5 nM) PTX and from untreated 
cells were incubated with the catalytic subunit of PTX (100 nM) in the presence of
39[ P]NAD, and the extent of ADP-ribosylation of the Gaj subunit was analysed (as 
described in Section 2.10.4). The treatment with the catalytic subunit of PTX caused a full 
ADP-ribosylation of the Gaj subunit of the plasma membranes obtained from the control 
cells, whereas the plasma membranes from the cells that were treated with PTX did not 
shown any ADP-ribosylation of the Gaj subunit (because Gcti was already ADP- 
ribosylated by treatment of the intact cells with PTX). This indicated that a 24 h-treatment 
with (5 nM) PTX of NIH 3T3 cells performed prior to the preparation of the plasma 
membranes was enough to obtain full ADP ribosylation of the Got; subunit (Fig. 5.2).
The GroPIns4P-dependent increase in GTPyS binding to the plasma membranes 
was completely inhibited by PTX, and the same also happened for LPA and Mas7 (Fig.
5.1). Thus, GroPIns4P can act at the level of the Gj/Go family of heterotrimeric G proteins, 
and this action may be the key point for an explanation of its ability to inhibit AC in
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Figure 5.2 - PTX-dependent ADP-ribosylation of plasma membranes from NIH 
3T3 cells. Plasma membranes were obtained from NIH 3T3 cells that were treated with 
5 nM PTX (see Section 2.10.1) and from untreated cells. The membranes were 
incubated with the catalytic subunit of PTX (100 nM) in the presence of [3 2 P]NAD, and 
the extent of ADP-ribosylation of the Gaj subunit was analysed (as described in 
Section 2.10.4). The ADP-ribosylation levels were analysed by autoradiography.
The experiment was performed by Nadia Dani, Di Girolamo’ s laboratory (our 
department)
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fibroblasts (Falasca et al., 1997).
5.2.3 The GroPIns4P-dependent inhibition of AC is prevented by PTX
To investigate whether after blocking the Gi/Go classes of G proteins, GroPIns4P 
can still prevent the activation of AC, cAMP measurements were carried out in the 
presence of PTX, in NIH 3T3 cells. AC was activated by CTX, which transfers the ADP- 
ribose to the Gas subunit, forming a covalent bond with an arginine residue situated in 
close vicinity to the y-phosphate of the bound GTP. This modification prevents the GTPase 
activity of G as and causes Gas to remain activated (Gill and Meren, 1978). LPA was used 
to show Gaj-dependent AC inhibition (van Corven et al., 1989). GroPIns4P (50 pM) and 
LPA (10 pM) were added to NIH 3T3 cells for 30 min, together with CTX (10 nM). In this 
way, it was possible to allow the blockage of AC inside the cells, and to prevent their 
CTX-dependent activation. The PTX (5 nM) was added 24 h before to prevent any residual 
activation of the Gaj proteins.
After the treatments, cAMP was extracted by the ethanol method (see Section
2.6.4) and measured using a commercial radioimmunoassay (“Cyclic AMP [3H] assay 
system”, from Amersham). This assay is based on competition between unlabelled cAMP 
and a fixed quantity of tritium labelled cAMP for binding to a protein which has a high 
specificity and affinity for cAMP. The amount of labelled protein-cAMP complex formed 
is inversely related to the amount of unlabelled cAMP present in the assay (see Section
2.6.4). The results are expressed as pmol of cAMP/well.
GroPIns4P was given for 30 min together with CTX and it caused a 30% inhibition
of CTX-activated AC (Fig. 5.3). When LPA was applied under the same conditions as
GoPIns4P, it caused a 70% inhibition. As shown in Figure 5.3, in the untreated samples,
there were 4±1 pmols/well of cAMP, and upon treatment with CTX, the cAMP increased
to 88±10 pmols/well. When CTX was given to the cells with the GroPIns4P, the amount of
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Figure 5.3 - Measurements of cAMP production in NIH 3T3 cells. NIH 3T3 cells 
were grown to confluence in 12-well plates in complete growth medium. Cells were 
then washed twice with HBSS and stimulated for different times at 37 °C in HBSS 
containing 0.4% BSA, 10 mM HEPES and 0.5 mM 3-isobutyl- 1-methylxanthine (pH
7.4) in the presence of the various compounds to be assayed: CTX (10 nM), GroPIns4P 
(50 pM) and LPA (10 pM), as described in Section 2.6.4 The intracellular cAMP 
content was measured using a radioimmunoassay, as described in Section 2.6.4. The 
experiments were performed in triplicate, and the results are expressed as pmols of 
cAMP/well. The bars represent the mean (± SD) of three independent experiments, 
each performed in duplicate.
* *70.01  ***7*0.001 (versus the stimulation by CTX) (Section 1.14).
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cAMP produced was 61 ±6 pmols/well, and in the presence of LPA, it was 25±5 
pmols/well.
When NIH 3T3 cells were pre-treated with PTX for 24 h both the GroPIns4P- and 
the LPA-dependent inhibition of AC were impaired (Fig. 5.3). This result demonstrates 
that GroPIns4P inhibits the AC activity by acting at the level of the Gaj proteins.
5.2.4 Conclusion
GroPIns4P is able to increase the GTPyS binding to plasma membranes of NIH 3T3 
cells, and this increase is prevented by pre-treating the cells with PTX. The data highlight 
the potential action of GroPIns4P through the Gaj proteins. The ability of GroPIns4P to 
inhibit AC was tested for its dependence on the Gotj proteins, and PTX treatment prevented 
the inhibition of AC produced by GroPIns4P. Thus, this inhibition of AC caused by 
GroPIns4P in NIH 3T3 cells depends on the activation of the Gaj proteins.
5.3 The potential involvement of Got; proteins in GroPIns4P-dependent ruffle 
formation
5.3.1 General description
GroPIns4P acts through the Gaj class of heterotrimeric G proteins, at least with 
regard to AC inhibition. It cannot be excluded, however, that the activation of Gaj by 
GroPIns4P could be the key point in the pathway that leads from Src/PLCyl activation and
O I
a [Ca ]i increase to ruffle formation. There are interesting data that show how, by direct 
interaction, Gaj can activate Src (Ma et al., 2000) (Section 1.3.4). For this reason, an 
attempt was made to correlate all of the data obtained so far, from the Ca2+ measurements 
in the presence of inhibitors of the heterotrimeric G proteins to the immunofluorescence
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assays, to see if GroPIns4P-dependent ruffle formation can be mediated by heterotrimeric 
G proteins.
5.3.2 GroPIns4P-dependent Ca2+ increases in the presence of PTX
NIH 3T3 cells were treated for 24 h with (5 nM) PTX to block all of the Gi/o classes 
of heterotrimeric G proteins; then, the ability of GroPIns4P to increase [Ca2+]i levels was 
investigated using the Till-Photonics live imaging of Fluo-3-loaded cells (as described in 
Section 2.5.1 and in Section 3.6). ATP was applied after GroPIns4P to check if the 
treatment with PTX alters the ability of the cells to increase their [Ca2+]j.
The PTX treatment did not prevent the [Ca2+]i increases induced by adding 
GroPIns4P to the cells. In Figure 5.4, a representative experiment is shown, in which the 
cells were treated with GroPIns4P (50 pM) in the presence and absence of PTX; ATP (100 
pM) was added to the samples as the positive control. The fluorescence changes, expressed 
as the pseudoratio AF/FO (see Section 2.5.2 and 3.6), obtained in the control and PTX- 
treated cells were comparable, both for the GroPIns4P- and ATP-treated samples, as shown 
in Table 5.1.
There was no direct correlation between the GroPIns4P-dependent Goti activation 
and [Ca2+]j increases. Thus, these two effects of GroPIns4P ([Ca2+]i increase and AC 
inhibition) cannot be associated with a single initial event like Gaj activation.
5.3.3 GroPIns4P-dependent ruffle formation in the presence of PTX
^ I
Even if the increase in [Ca ]j produced by GroPIns4P was not mediated by a Goti 
protein, it could not be excluded that this heterotrimeric G-protein could be involved in 
GroPIns4P-dependent ruffle formation. As mentioned before (Chapter 3 and 4), the
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Figure 5.4 - Till photonics live imaging of Fluo3-AM loaded NIH 3T3 cells. The
cells were incubated with 4 pM Fluo3-AM, for 30 min at 37 °C. After two washes in 
HEPES-buffered saline solution, the cells were placed in an open chamber at 37 °C 
with 1 ml of HEPES solution, and positioned on the stage of a Till photonics 
microscope (as described Section 2.5). For each experiment, the cells were monitored 
for at least 30 sec to establish a base-line fluorescence reading before the sequential 
addition of 50 pM GroPIns4P and 100 pM ATP. All of the incubations were carried 
out while monitoring the cells every 200 ms (first movie), and each second for 6 min 
(second movie) (as explained in Section 2.5). The treatment with PTX (5 nM) was 
performed 24 h before the stimulation, as explained in Section 2.3.5. The plots present 
the kinetics of [Ca2+]j increases caused by 50 pM GroPIns4P (a, b) and 100 pM ATP 
(c, d) in the absence (a, c) and presence (b, d) of PTX. The arrows indicate the times at 
which the stimuli were given to the cells. The data shown are representative of four 
independent experiments. Each plot represents the behaviour of two cells (pink and 
blue).
Control
(AF/F0)
PTX
(AF/F0)
GroPIns4P 1.42±0.44*** 0.9±0.35***
ATP 1.7±0.4*** 1.71±0.43***
Table 5.1 - Quantification of the changes in fluorescence relative to the baseline 
(pseudo ratio: AF/F0=(F-F0)/(F0-B)) (see Section 2.5.1). The values represent the 
means of 4 independent experiments. ***/><0.001, versus untreated samples (Section 
1.14).
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• • 94- •increase in [Ca ]j is not the only event that is involved in ruffle formation. There is a 
parallel event that, independently from this [Ca2+]j increase, produces a GroPIns4P- 
dependent formation of a CaMKII-TIAMl-Racl complex and consequent ruffle formation 
(see Chapter 4). Gaj could be involved in this second event; for this reason the ability of 
GroPIns4P to induce membrane ruffles upon a 24 h-treatment with PTX was tested. After 
the incubation with (5 nM) PTX, the NIH 3T3 cells were treated with 50 pM GroPIns4P or 
10 ng/ml PDGF for different times (2-30 min). The actin was stained with TRITC- 
phalloidin and the samples analysed blind for the presence of membrane ruffles.
Figure 5.5 presents the means of three independent experiments quantified blind, 
for the ability of GroPIns4P to induce ruffles (see Section 2.4.3). Within 2 min of 
treatment, GroPIns4P increased the ruffles by 1.7-1.8-fold versus the control, both under 
normal conditions and with the PTX treatment. Thus, the PTX treatment did not influence 
GroPIns4P-dependent ruffle formation; these data support the idea that Gaj activation 
cannot be associated with the pathway promoted by GroPIns4P that leads to Racl- 
dependent actin cytoskeleton modifications.
5.3.4 Conclusion and discussion
GroPIns4P is able to inhibit AC by acting through the Goq proteins. These proteins 
are involved in a variety of cellular events, which also include Src activation (Ma et al.,
2000). For this reason, the involvement of the Gi proteins in the GroPIns4P-dependent Ca2+ 
increases and ruffle formation was analysed but neither cellular events was affected by Gj 
inhibition.
These results reveal that GroPIns4P is a multifunctional compound that is able to 
act inside the cells at different levels and to produce effects that are not always related to 
each other. There is a pathway that leads to ruffle formation (Fig. 3.24), and a different
pathway that produces the Goij-dependent inhibition of AC (Fig. 5.6).
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Figure 5.5 - Effect of PTX on ruffle formation in NIH 3T3 cells. Serum-starved 
NIH 3T3 cells were treated with GroPIns4P (50 jjM) or PDGF (10 ng/ml) for different 
times (from 2 to 30 min), in the absence and presence of a 24 h treatment with 5 nM 
PTX. The cells were fixed and stained with TRITC-labelled phalloidin and quantified 
blind for the extent of ruffle formation, as described in Section 2.4.3. The results 
shown are means (±SD) of three independent experiments, each performed in 
duplicate. *^<0.05, versus the control (Section 1.14).
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Figure 5.6 - GroPIns4P is able to inhibit AC by acting through Gj proteins.
Schematic representation of the pathway involved.
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It is still unclear how GroPIns4P activates the Gotj class of heterotrimeric G 
proteins. It is probably not through receptor-dependent signalling, as supported by the 
demonstration that GroPIns4P does not bind directly to plasma membrane and total 
membranes of NIH 3T3 cells (Berrie et al., 1999). One possibility could be a direct 
interaction between GroPIns4P and Gaj, but so far there is no direct proof of this. An 
indirect activation of the Gi proteins through another unknown GroPIns4P-activated- 
element could be also plausible. In this case the presence of a common element cannot be 
excluded, which would be activated by GroPIns4P, and which would act on Src and induce 
ruffle formation on the one hand, and activate Gaj, thus inhibiting AC on the other.
Several cAMP-elevating agents are known to inhibit cell migration towards 
chemoattractant (Armstrong, 1995; Harvath, 1991; Horio et al., 1995). Moreover, it has 
recently been demonstrated that an increase in cAMP can prevent Racl activation, thereby 
inhibiting membrane ruffling and chemotaxis; vice versa, an increase in Racl activity can 
go in parallel with a decrease in cAMP (Nagasawa et al., 2005). The two parallel effects of 
GroPIns4P that can activate Racl and inhibit AC could proceed in the same direction and 
lead to ruffle formation. Nevertheless, we do not have direct proof that the AC inhibition is 
relevant for GroPIns4P-dependent ruffle formation.
5.4 GroPIns4P induces stress fibre formation acting through RhoA
5.4.1 General description
GroPIns4P acts upstream of Racl and RhoA and requires active Racl (but not 
Cdc42 and RhoA) to form ruffles, and active RhoA (but not Racl and Cdc42) to form 
stress fibres (Mancini et al., 2003). The addition of GroPIns4P (50 pM) to serum-starved 
Swiss and NIH 3T3 fibroblasts caused the rapid formation of membrane ruffles, followed 
by the formation of stress fibres. The membrane ruffling induced by GroPIns4P is
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dependent on a functional Racl protein, but the stress fibre formation is not. To examine 
whether the latter effect required RhoA, serum-starved Swiss 3T3 cells were microinjected 
with C. botulinum C3 transferase (160 pg/ml), which ADP ribosylates and inactivates 
RhoA, leaving the functions of Racl and Cdc42 unchanged (Ridley and Hall, 1992; Ridley 
et al., 1992). GroPIns4P-dependent stress fibre formation was completely inhibited by C. 
botulinum C3, indicating that this effect of GroPIns4P needs a functional RhoA protein. 
However, the formation of membrane ruffles induced by GroPIns4P was not influenced by 
C. botulinum C3 (Mancini et al., 2003).
GroPIns4P-dependent ruffle formation was addressed in the previous Chapters, whereas 
the study of the pathway from GroPIns4P stimulation to stress fibre formation has not been 
investigated here yet. The two pathways should be different, at least at the level of the 
small G protein involved, but the starting events that initiate the GroPIns4P-dependent 
signal cascade could be the same.
TIAM1 is specific for Racl and does not activate RhoA (see Section 1.2.3.2). 
Moreover there are no data that associate CaMKII with RhoA activation. There is a 
possibility that the increase of [Ca+2]i stimulated by GroPIns4P is involved in stress fibre
o I
formation, even if no relevant indications that RhoA activity can be modulated by a [Ca ]j 
rise have been reported to date.
In some cellular systems RhoA can be activated via heterotrimeric G proteins. For 
example, upon treatment of cells with LPA, there is an increase in RhoA-dependent stress 
fibres in fibroblasts (Ridley and Hall, 1992). As demonstrated above, GroPIns4P can act 
through Gi proteins for its AC inhibition, and thus it is possible that RhoA-dependent stress 
fibre formation is a consequence of this Gj activation. Although many attempts have been 
made to clarify the mechanisms by which GroPIns4P induces stress fibres in fibroblasts, no 
definitive results have been obtained to date.
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5.4.2 GroPIns4P does not produce any change in RhoA localization
It is well known that GroPIns4P can induce stress fibre formation in Swiss and NIH 
3T3 cells via RhoA activation (Mancini et al., 2003), but nothing is known about the 
effects of GroPIns4P on RhoA localisation. By immunofluorescence experiments, an 
attempt was made to answer this question. NIH 3T3 cells were transfected with Myc 
tagged RhoA, and after 24 h of serum starvation, the cells were stimulated with 50 pM 
GroPIns4P for different times (from 2 to 30 min). Actin was stained with TRITC- 
phalloidin and the analysis was performed by confocal microscopy (as reported in Section
2.4.3). The aim of this experiment was to see if  GroPIns4P can modulate the activity of 
RhoA by affecting its localisation, as was seen for Racl (Mancini et al., 2003). RhoA 
should also translocate to the plasma membranes upon activation, and it is known that 
RhoA can be found at the level of focal adhesions (Michaelson et al., 2001).
From this analysis it is evident that no particular changes in RhoA localisation 
occur upon treatment with GroPIns4P (Fig 5.7). The cells were treated for 2 to 30 min, but 
under all conditions the localisation of the RhoA-myc was cytosolic. Within 15 min of 
treatment with GroPIns4P (50 pM), the formation of stress fibres was seen, as expected, 
and a partial co-localisation of RhoA with the stress fibres was visible (Fig. 5.7).
5.4.3 Calcium mobilisation and GtXi activation are not involved in GroPIns4P- 
dependent stress fibre formation
If the GroPIns4P-dependent [Ca2+]i increase is an event that initiates the signal 
cascade that leads to stress fibre formation, it should be possible to prevent the assembly of 
stress fibres by blocking the [Ca2+]i increase. This blockage can be obtained by treating the 
cells either with a PLCs inhibitor (U-73122) or with a Src kinase inhibitor (PP2) (as shown 
in Section 3.6.3). The technical problems of using U-73122 is that it cannot be given to the
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Figure 5.7 - RhoA localisation upon GroPIns4P treatment in NIH 3T3 cells. Sub­
confluent NIH 3T3 cells were transfected with the RhoA-myc tagged expression 
construct, as described Section 2.3.4. Twenty-four h after transfection, the cells were 
serum-starved for 24 h and then treated with GroPIns4P (50 pM) for 15 min, fixed, and 
stained with an anti-myc antibody for RhoA visualization and TRITC-labelled 
phalloidin for actin visualization (as described in Section 2.4.3). Bar=20 pM
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cells for longer than 20 min, otherwise the cells start to detach. For this reason, after pre­
incubation with the inhibitor (for 1 0  min to allow its incorporation into the cells), stimuli 
longer than 5-10 min cannot be used. The time necessary to see GroPIns4P-dependent 
stress fibre formation is 15-30 min, thus, this was at the limit and too many cells detached 
during the experiments. As a consequence, U-73122 was not suitable for testing the effects 
of [Ca2+]i on RhoA-dependent stress fibre formation produced by GroPIns4P. Instead, the 
Src family kinases inhibitor PP2, which can be applied to cells also for long incubations, 
was used in an immunofluorescence system.
NIH 3T3 cells were treated with 10 pM PP2 for 15 min, and then the cells were 
incubated with GroPIns4P (50 pM) for different times (2, 15, 30 min) (see Section 2.4.2). 
A two min incubation was used to check the functionality of the inhibitor, by following 
GroPIns4P-dependent ruffle formation and its inhibition by PP2. The longer time 
incubations (15-30 min) were used to follow the formation of stress fibres, which is 
maximal upon 15 min of treatment with 50 pM GroPIns4P (see Section 3.2).
Under normal conditions, the treatment with GroPIns4P caused the formation of 
membrane ruffles within 2 min (2.4-fold increase) and of stress fibres within 15 min (1.7- 
fold response over basal). LPA was applied at a concentration of 10 pM to follow the 
classical RhoA-dependent stress fibre formation, and it caused a 2.5-fold increase in stress 
fibres within 15 min of treatment (Fig. 5.8). The treatment with 10 pM PP2 caused the 
inhibition of GroPIns4P-induced ruffle formation as expected, and also the formation of 
stress fibres was altered both upon GroPIns4P and LPA treatment. GroPIns4P treatment 
showed a delayed and weaker increase in stress fibres (within 30 min there was only a 1.5- 
fold increase), and LPA produced a 1.6-fold increase in stress fibres within 15 min of 
treatment, lower when compared with the 2.5-fold increase obtained with LPA under 
normal conditions (Fig. 5.8)
The initial hypothesis was that blocking the [Ca2+]j increase, could also prevent the
GroPIns4P-dependent activation of RhoA and stress fibre formation, and the results
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Figure 5.8 - Effects of the Src inhibitor PP2 on GroPIns4P-dependent stress fibre 
formation. Twenty-four hour starved NIH 3T3 were treated with PP2 (10 pM) for 15 
min and then incubated with 50 pM GroPIns4P (2, 15 and 30 min) or 10 pM LPA (5 
and 15 min). The cells were then fixed and stained with TRITC-labelled phalloidin and 
quantified blind for the extent of ruffle and stress fibre formation, as described in 
Section 2.4.3. The results shown are the means (±SD) of two independent experiments, 
each performed in duplicate.* P<0.05 **P<0.01 ***P<0.001, versus control (Section 
1.14).
Control (±SD) PP2 10 fiM (±SD)
{ CONTROL 69.5 ± 7.5 97±16
GroPIns4P 
(50 jiM) 15 min
137 ± 1 82 ± 1 1
GroPIns4P 
(50 jiM) 30 min
95.5 ± 4.5 146 ± 15
LPA 
(10 pM) 15 min
169.5 ± 2 5 156 ± 18.5
Table 5.2 - Scores of the quantification of stress fibre formation in the absence and 
presence of PP2. The quantification was performed by counting 200 cells and giving 
each one a score of 0 in the absence of stress fibre and of 1 or 2, depending on the 
quality of the stress fibres formed (1 if they were thin, and 2 if they were thick). The 
values presented in the Table are expressed as scores obtained with the quantification 
over a maximal value that is 400 (200 x2) (see Section 2.4.3 for details). The standard 
deviation is representative of the mean of four different samples.
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obtained show that PP2 causes altered formation of stress fibres in response to the 
GroPIns4P treatment. However as the activity of LPA was also reduced, this indicates that 
the inhibition of Src can per se modify the behaviour of the cells. Indeed, LPA should 
activate the G an  which directly interacts with and activates the pll5RhoAGEF, thus 
favouring GDP/GTP exchange of RhoA and the consequent formation of stress fibres
i
(without a [Ca ]i increase) (as reported in Section 1.2.3).
Src activity has been reported to be important for turnover of focal adhesions (see 
Section 1.2.2); it phosphorylates the focal adhesion kinase (FAK), causing the disassembly 
of focal adhesions (Timpson et al., 2001). Moreover, Src can activate the pl90RhoGAP, 
which enhances the GTP hydrolysis of RhoA; the result is RhoA inactivation and the 
consequent disassembly of stress fibres (Brandt et al., 2002). Blocking Src there is a basal 
increase in stress fibres caused by the persistence of focal adhesions, and this increase 
could mask the effects of stimuli like LPA and GroPIns4P. As shown in Table 5.2, which 
gives the scores obtained in the quantification of stress fibre formation (see in Section
2.4.3) in absolute numbers, the basal stress fibres score was 69.5±7.5 over a maximum of 
400 under normal conditions, and 97±16 in the presence of PP2. However, the values 
obtained upon stimulation with GroPIns4P and LPA were not so different from those 
treated and untreated with PP2. For GroPIns4P alone there was a delay in the formation of 
stress fibres due to the presence of the inhibitor (within 30 min), but in numbers, the extent 
of the increase was 146±15, which is comparable with that obtained under normal 
condition with 15 min of treatment (137 ±1) (Table 5.2).
This was also observed in SYF cells, in which the absence of Src kinase activity 
caused a basal increase in stress fibres and a parallel absence of stimulus-dependent stress 
fibre formation. Neither GroPIns4P (given at 50 pM for 15-30 min) nor LPA (given at 10 
pM for 5-15 min) were able to induce stress fibre assembling, as shown in Figure 5.9.
From this data, it is not possible to determine whether the signal cascade that is 
activated by GroPIns4P and leads to a Src-dependent [Ca2+]j increase and to ruffle
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Figure 5.9 - GroPIns4P-dependent stress fibre formation in SYF cells. SYF cells 
were serum-starved for 12 h in DMEM, 0.1% foetal bovine serum, and then were 
treated with 50 pM GroPIns4P (from 2 to 30 min) or 10 pM LPA (5-15 min). The cells 
were then fixed and stained with TRITC-labelled phalloidin and quantified blind for 
the extent of ruffle formation as described in Section 2.4.3. The results shown are the 
means of two independent experiment, each performed in duplicate.
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formation, can also favour RhoA-dependent stress fibre formation. Indeed, the Src kinases 
are involved in the turnover of focal adhesions, and the use of PP2 to inhibit the
o I
GroPIns4P-dependent [Ca ]; increase caused a basal increase in stress fibres that can 
affect the analysis. The best approach would be to treat the cells with PLC inhibitors, but 
as indicated above, during long incubations the cells tend to detach.
The same stress fibre quantification was performed in NIH 3T3 cells pre-treated 
with PTX, to inhibit all Gj proteins. Also in this case, the treatment with GroPIns4P was 
performed for different times (from 2 to 30 min). The GroPIns4-dependent stress fibre 
formation was not affected by the presence of PTX, thus excluding a correlation between 
Goci activation and the RhoA dependent stress fibre formation induced by GroPIns4P (Fig. 
5.10).
5.4.5 Conclusion and discussion
Exogenously added GroPIns4P is able to induce ruffle formation in a very short 
time, and stress fibre assembly after a prolonged treatment, in fibroblasts. The pathway that 
leads to ruffle formation was well elucidated in the previous Chapters, while for stress 
fibres no clear mechanism has been described. RhoA is involved in GroPIns4P-dependent 
stress fibre formation, as was well demonstrated in Mancini et al. (2003), but how 
GroPIns4P activates this small G protein and induces stress fibre formation is not yet 
understood.
We tested the hypothesis that GroPIns4P stimulation triggers ruffle and stress fibre 
formation via the same initial event. Since CaMKII and TIAM1 are specific for Racl 
activation, they can be excluded from the range of possible RhoA activators, whereas the 
[Ca2+]i increase produced by GroPIns4P could be a potential signal that leads to Racl and 
RhoA activation; for this reason a possible involvement of PLCs was analysed. However, 
PLC inhibitors could not be used for long incubations, and so the inhibition of Src kinases
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Figure 5.10 - Stress fibre formation in NIH 3T3 cells treated with PTX. Serum- 
starved NIH 3T3 cells were treated with GroPIns4P (50 pM) or LPA (10 pM) for 
different times (from 2 to 30 min), in the absence and presence of a 24 h treatment with 
5 nM PTX. The cells were fixed and stained with TRITC-labelled phalloidin and 
quantified blind for the extent of stress fibre formation, as described in Section 2.4.3. 
The results shown are mean (±SD) of three independent experiments, each performed 
in duplicate. *P<0.05, versus the control (Section 1.14).
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was used to prevent GroPIns4P-dependent [Ca ]i increase. Here, there was a basal 
increase in stress fibres that lowered the level of cellular response to either GroPIns4P and 
LPA treatments. Thus, we could not determine specifically whether the [Ca2+]i increase is 
relevant also for RhoA activation. The potential involvement of Got; was also analysed; 
indeed GroPIns4P could activate RhoA by acting through Gi proteins. However Gi was 
also not involved in GroPIns4P-dependent stress fibres formation.
Probably there is a net division between the signal cascades initiated by GroPIns4P 
that lead to ruffle versus stress fibre formation. These two events occur in different time 
frames and involve different proteins. There are also no similarities in the ways in which 
Racl and RhoA are activated: there is a translocation of Racl to the plasma membranes 
upon treatment with GroPIns4P, and this translocation defines Racl activation; the 
localisation of RhoA does not change upon addition of GroPIns4P however. There is only 
a partial co-localisation of RhoA with the stress fibres, and thus it is difficult to determine 
if this localisation is strictly dependent on GroPIns4P or occurs as consequence of RhoA 
activation.
The pathway of RhoA thus need further analysis to understand how GroPIns4P 
induces stress fibre formation.
235
CHAPTER 6
FINAL DISCUSSION
The main achievement of this study has been the identification of the mechanism of 
action of GroPIns4P. This compound is the product of the double deacylation of PI4P, 
which involves a Pi-specific PLA2 . GroPIns4P is accumulated inside cells upon growth
o 1
factor or Ca -dependent Ras activation, or upon Ras transformation (see Section 1.4.3.1). 
When added exogenously to cells, GroPIns4P is able to equilibrate across the membrane, 
probably due to the activity of a membrane transporter specific for 
glycerophosphoinositols (as discussed in Section 1.4.4), and it has many biological effects. 
GroPIns4P can inhibit AC and PLA2  (in thyroid cells and fibroblasts; see Section 
1.4.3.2.1), can modulate the actin cytoskeleton organization (ruffle and stress fibre 
formation in fibroblasts; see Section 1.4.3.2.2), and can inhibit tumour cell invasion (see 
Section 1.4.3.2.3).
The pathway of ruffle formation has been characterized best in this work. In 
particular, I have shown how GroPIns4P is able to induce membrane ruffles in fibroblasts. 
It can act via two different mechanisms. On the one hand, GroPIns4P can activate a 
member of the Src kinase family (potentially Yes in NIH 3T3 cells), and this kinase 
phosphorylates and activates PLCyl, resulting in IP3 production and thus a [Ca2+]i increase. 
The latter event promotes the activation of CaMKII, which in turn phosphorylates TIAM1, 
facilitating the translocation of this Racl GEF to the plasma membrane, and enhancing its 
exchange activity versus Racl. The small GTPase Racl is also translocated to the plasma 
membrane upon treatment with GroPIns4P, where it can interact with TIAM1. Once 
activated at the level of plasma membrane, Racl can lead to the formation of membrane 
ruffles (as demonstrated in Chapter 3) (Fig. 6.1). On the other hand, GroPIns4P is able to 
increase the binding between Racl and TIAM1, and appears to interact directly with a
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protein complex that is associated with immunoprecipitated TIAM1-HA (as shown in 
Chapter 4). How these two effects are interconnected is not yet clear. The common 
elements that are present in these two pathways are TIAM1 and Racl, which are both 
necessary for ruffle formation, and CaMKII, which can be co-immunoprecipitated with 
TIAM1 (see Section 4.4.5). CaMKII is also fundamental in GroPIns4P-dependent ruffle 
formation, since the inhibition of CaMKII with its specific inhibitor completely abolished 
GroPIns4P-dependent ruffle formation. In contrast, blocking the Src kinases only reduces, 
rather than completely blocking, GroPIns4P-depent ruffle formation.
The hypothesis that I am proposing is that under normal conditions, GroPIns4P can 
cause the full activation of CaMKII, through a Src-dependent pathway, thus reaching its 
maximal effect on ruffle formation (2.5-fold response). When Src is inhibited, the CaMKII 
portion that maintains a residual basal activity also after starvation could still be involved 
in the activation of TIAM1. GroPIns4P would thus also interact with an as yet unknown 
target, and in this way, favour the formation of a multi-protein complex containing 
TIAM1, Racl and CaMKII, which together cooperate in ruffle formation (Fig. 6.1).
In fibroblasts, exogenously added GroPIns4P is able to rapidly induce ruffle 
formation, with stress fibre formation requiring a prolonged treatment with GroPIns4P. 
RhoA is involved in GroPIns4P-dependent stress fibre formation, as was demonstrated by 
Mancini et al. (2003). We tested the hypothesis that the initial event that follows 
GroPIns4P stimulation is the same for both ruffle and stress fibre formation pathways, and 
found that separate signalling cascades are activated (Chapter 5). These two events 
happened within different time frames, and they involve different signalling proteins. In 
addition, GroPIns4P can inhibit AC by acting through Gj proteins. However, this cannot be 
related to the ability of GroPIns4P to induce ruffles and stress fibres, since inhibition of Gj 
proteins does not affect the GroPIns4P-dependent actin cytoskeleton modifications (as 
described in Chapter 5) (Fig. 6.1).
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These results reveal that GroPIns4P is a multifunctional compound, which is able to 
act inside cells at different levels, and to produce effects that are not always related to each 
other. There is a pathway that leads to ruffle formation, another that favours Rho- 
dependent stress fibre formation, and a third that causes the Gaj-dependent inhibition of 
AC (Fig. 6.1).
Many points along these GroPIns4P signalling pathways remain unclear. Firstly, 
how are the Src kinases activated by GroPIns4P? The Src kinases are regulated by 
alternative phosphorylation/de-phosphorylation events (see Section 1.3.5), and thus 
GroPIns4P could either directly interact with a Src kinase to favour its autophosphorylation 
on Tyr-416, or alternatively, GroPIns4P could activate a phosphatase that de- 
phosphorylates the inhibitory Tyr-527. In the case of the kinase, CSK, that inhibits Src by 
phosphorylating Tyr-527 we can not exclude the possibility that it is inhibited by 
GroPIns4P. Secondly, what protein interacts with GroPIns4P? One possibility could be 
that it is a scaffolding protein that is able to hold TIAM1, CaMKII and Racl in a complex, 
in this way favouring the activation of TLAM1 and consequent Racl-dependent ruffle 
formation. GroPIns4P could interact with this scaffolding protein, potentially causing 
changes in its conformation, and enhancing its affinity for TIAM1 and CaMKII. Thirdly, 
how does GroPIns4P activate RhoA to induce stress fibre formation? We have so far not 
been able to find a clear correlation between the pathway that leads to ruffle formation and 
that promotes the RhoA-dependent increase in stress fibres caused by GroPIns4P. Finally, 
how does GroPIns4P activate Gctj? GroPIns4P could directly interact with Gj proteins, or it 
could activate proteins like the AGS (activators of G-protein signalling), that have been 
characterised as putative GEFs for G a subunits (Lanier, 2004). The possibility that 
GroPIns4P can inhibit the RGS (regulators of G-protein signalling) proteins, which are 
known to accelerate the GTP-hydrolysis of the G a subunits (Siderovski et al., 1996), has 
also to be considered.
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Figure 6.1 - Schematic representation of the regulatory cascades initiated by 
exogenously added GroPIns4P in cells.
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The pathway elucidated in Chapter 3 that indicates that Src activation can lead to 
ruffle formation implies the activation of many different proteins, all of which are involved 
in the activation of other effectors that were not taken into direct consideration in the 
present study. For example, Src can activate VAV2, another specific exchange factor for 
Racl, by phosphorylation. As with TIAM1, VAV2 is also ubiquitously expressed (also in 
fibroblasts), and it can be activated by Src, thus favouring ruffle formation (Arthur et al., 
2004). However, there is evidence against the involvement of VAV2 in GroPIns4P- 
dependent ruffle formation: by blocking CaMKII, ruffle formation is completely prevented 
and TIAM1 is the only known exchange factor for Racl that can be activated by CaMKII. 
Nevertheless, there is no direct evidence that VAV2 is not involved in GroPIns4P- 
dependent ruffle formation, and thus further analysis will need to be carried out in order to 
clarify this possibility.
The most plausible explanation for the multiple effects of GroPIns4P would be the 
presence of a membrane receptor that is specific for this compound, even though there is 
no experimental evidence that supports such a hypothesis. Instead, GroPIns4P has been 
shown to enter the cells, where it can interact with a specific target or targets (as 
demonstrated in Chapter 4).
It is possible that one specific interactor for GroPIns4P initiates both Racl- and 
RhoA-dependent actin cytoskeleton modifications, and also Gj-dependent AC inhibition. 
As described in Section 5.4.3, a decrease in cAMP is associated with an increased activity 
of Racl and the consequent augmentation of membrane ruffles (Nagasawa et al., 2005). 
The GroPIns4P-dependent sequential activation of Racl and RhoA could also be 
associated with a common final effect: cell movement. A moving cell creates new sites of 
adhesion at its leading edge, and disassembles trailing adhesions at its rear. Adhesion 
assemblies originate as ‘focal complexes’ (Nobes and Hall, 1995; Rottner et al., 1999) in 
association with lamellipodia (modulated via Rac) or filopodia (modulated via Cdc42). 
Focal complexes can exist briefly and turn over within a few minutes, or they can undergo
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a transition into larger and longer-lived focal adhesions (modulated via Rho) (Kaverina et 
al., 2002). Both focal complexes and early focal adhesions remain stationary relative to the 
substrate and serve as traction points for the forward translocation of cells (Beningo et al.,
2001). Without anchorage points, the actin cytoskeleton would not develop sufficiently at 
the rear to support the translocation of the cell body. This has been given as the reason for 
the requirement of at least low levels of Rho activity for cell migration (Nobes and Hall, 
1999). Although Racl triggers the protrusion of lamellipodia, a recent study has shown 
that without appropriate adhesion, these lamellipodia are not able to support forward 
movement and are quickly retracted as membrane ruffles (Borm et al., 2005). So, to have 
active cell migration, the lamellipodial structure should persist for longer times, and RhoA 
can stabilise lamellipodia by creating stable focal adhesions. Thus, the sequential 
activation of Racl and RhoA that can be obtained upon treatment with GroPIns4P, 
together with the cAMP decrease, could be related to a single starting event (such as the 
interaction of GroPIns4P with a protein that is able to initiate all of the signal cascade), 
which thus leads to the actin reorganization that is necessary for cell movement.
On the other hand, the multiple effects observed upon treatment of cells with 
GroPIns4P could be independent of each other, and GroPIns4P could have many different 
targets inside cells, all of which might share sequence similarity. It would be very 
interesting to find a protein domain that is specific for GroPIns4P. There are many 
potential unknown interactors and effectors of GroPIns4P in cells, and they could all 
contain the same domain. The identification of all of the proteins that are present in the 
complex that can be co-immunoprecipitated with GroPIns4P should allow the final 
determination of which of these is the specific interactor for GroPIns4P, and also what 
form the machinery involved in TIAM1 -dependent Racl activation and ruffle formation 
takes. As already mentioned in Section 4.5, new experimental approaches will be followed 
in the future, such as the use of two-dimensional gels to separate the proteins in the 
complex that co-immunoprecipitates with TIAM1, followed by their identification by mass
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spectrometry. This will allow us to determine the specific interactor for GroPIns4P, as well 
as to identify all of the protein machineries that cooperate with TIAM1 for Racl activation 
and ruffle formation. The identification of a GroPIns4P-specific protein domain will 
significantly help in the definition of the multiple pathways modulated by GroPIns4P and 
should open the way to a further understanding of the reason why the activity of 
GroPIns4P cannot be mimicked by other similar compounds, such as GroPIns and 
GroPIns4 ,5 P2 . Furthermore, the presence of a specific domain for GroPIns4P will allow us 
to also better understand its functions inside cells when GroPIns4P is produced upon 
receptor stimulation.
Ruffle formation is an event associated with cell protrusions (linear ruffles at the 
leading edge of lamellipodia) and macropinocytosis, and with structures involved in 
receptor internalization (dorsal ruffles or waves). This morphological feature is visible 
mostly upon growth factor stimulation (see Section 1.2.2). The action of GroPIns4P can 
thus mimic the activity of growth factors, even if it differs in the extent of its effects and
\
the pathway that is activated. The production of GroPIns4P in fibroblasts has been seen 
upon growth-factor stimulation (Falasca et al., 1997). Thus it cannot be ruled out that 
GroPIns4P has a role as a second messenger in the pathway from growth-factor stimulation 
to actin cytoskeleton modification. GroPIns4P can induce a 50% increase in ruffle 
formation when compared to the extent of the PDGF-induced increase (see Section 3.2.2), 
but in terms of CaMKII activation or IP3 production, both GroPIns4P and PDGF have 
similar effects (see Sections 3.4.2 and 3.7.2). It appears that there is a partial overlap of the 
two pathways and that PDGF also activates other proteins that can favour ruffle formation 
(Jimenez et al., 2000; Rosenmuller et al., 2001); in a CaMKII-independent way. Since 
GroPIns4P can be produced upon PDGF stimulation (Corda et al., 2002), it can be 
hypothesized that the production of GroPIns4P contributes to signalling by PDGF, maybe 
through activating CaMKII. At the moment, we are not able to say if GroPIns4P is indeed 
a second messenger, because we have no tools to block its production in a specific way.
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Thus, it is not yet possible to separate the signalling associated with PDGF that leads to 
ruffle formation from the PDGF-dependent GroPIns4P production in cells.
Together with the search for a potential GroPIns4P-binding domain through its 
interaction with the CaMKII, TIAM1 and Racl complex, future work will focus on the 
definition of the metabolic pathways of the glycerophosphoinositols and their potential 
roles in pathological and physiological conditions. The identification of the specific PLA2  
involved in the synthesis of the glycerophosphoinositols will also provide further 
information that will help us to understand their roles in cells better. This will establish 
whether the glycerophosphoinositols, and GroPIns4P in particular, as well as being 
biologically active compounds able to enter the cells and to modulate many different 
cellular functions, can also be considered as novel second messengers produced upon Ras 
activation, and that can be associated with several cellular activities.
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ABBREVIATIONS
[Ca2+]i intracellular Ca2+
AA arachidonic acid
AA arachidonic acid
ABP actin binding protein
AC adenylyl cyclases
ADF actin depolymerising factor
AID an auto-inhibitory domain
A IF 4 aluminium fluoride
Arp Actin related protein
ATP adenosine triphosphate
BAPTA-AM 1,2-bis-(o-Aminophenoxy)-ethane-N,N,-N’,N’-tetraacetic acid 
tetraacetoxy-Methyl ester 
BSA bovine serum albumin
C3 Clostridium botulinum toxin
Ca2+/CaM Ca2+/calmodulin complex
CaBP calcium binding protein
cADPR cyclic ADP ribose
CaMK Ca2 +/calmodulin-dependent protein kinases
CaMKII Ca2+/calmodulin kinase II
cAMP cyclic AMP
cAPKs cAMP-dependent protein kinases
CC coiled-coil region
CD44v3 hyaluronic acid (HA) receptor isoform
cDNA complementary DNA
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c s calf serum
CSK C-terminal Src kinase
CTX cholera toxin
DAD diaphanous auto-regulatory domain
DAG Diacylglycerol
DAG diacylglycerol
Dbi diffuse B-cell lymphoma
DH Dbl-homology
DID diaphanous inhibitory domain
DMEM Dulbecco’s modified minimal essential medium
DMSO Dimethyl Sulfoxide
DNA deoxyribonuclease
DOCK180 180-kDa protein downstream of Crk,
Drfs Diaphanous-related formins
DTT dithiothreitol
E C 5 0 50% effective concentration
ECL Enhanced chemiluminescence
ECM extracellular matrix
EDTA Ethylenedi amine tetraacetic acid
EGF epidermal growth factor
EGTA thyleneglycol-bis-(2-aminoethyllether)-N,N,N’,N’-tetracetic acid
Ena/VASP Vasodilator stimulating phosphoprotein
ER endoplasmic reticulum
EVH2 Ena/VASP homology domain
EX extra sequence
FCS foetal calf serum
FGD1 Faciogenital Dysplasia;
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FIVE Fabl, YOTB, Vacl and EEA1
FRT-Fibro Ras-transformed fibroblasts
FRTL-5 fisher rat thyroid cell line 5
GAP GTPase-activating protein
GBD GTPase-binding domains
GDI GDP dissociation inhibitors
GDP Guanosine 5’-diphosphate
GEF guanine-nucleotide exchange factor
GFP Green fluorescence protein
GIT1 glucose yeast transporter
GPCR G-protein coupled receptors
GRK G protein coupled receptor kinase
GroPIns glycerophosphoinositol
GroPIns4 ,5 P2 glycerophosphoinositol 4,5-bisphosphate
GroPIns4P glycerophosphoinositol 4-phosphate
GST Glutathione S-transferase
GTP guanosine 5’-triphosphate
GTPase Guanosine triphosphatese
GTPyS Guanosine 5 ’ -0-(3 -thiotriphosphate)
h hour
HA Hemagglutinin
HEPES N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid
HF Human fibroblast
HGF hepatic growth factor
HKT Buffer containing HEPES, KC1 and Triton x-100
HPLC High pressure liquid chromatography
Ib2/JIP2 pancreatic p-cell/brain-specific protein
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Insl:2cP inositol 1 :2 -cyclic monophosphate
IP 3 1,4,5-trisphosphate
IPTG Isopropyl p-D-thiogalactopyranoside
IRSp53 Insulin receptor tyrosine kinase substrate p53
JNK c-Jun N-terminal kinase
Kd dissociation constant
kDa kilo Dalton
KiKi K-Ras oncogene transformed thyroid cells
LB Luria Broth
LIMK activates LIM kinase
LPA Lysophosphatidic acid
LPC Lysophosphatidylcholine
LPI lysophosphatidylinositol
LPIPs phosphorylate derivatives, the LPI
MAFP methyl arachidonil fluorophosphonate
MAPK mitogen activated protein kinase
MMPs matrix metallo proteases
MOPS 4-morpholinepropanesulfonic acid
MTOC microtubule organizing center
NAADP nicotinic acid adenine dinucleotide phosphate
NAD Nicotinamide adenine dinucleotide
NIH 3T3 NIH Swiss mouse embryo
NP40 nonylphenoxy polyethoxy ethanol
pl30Cas Crk-associated substrate
pl60ROCK Rho associated kinase
PA phosphatidic acid
PAF platelet-activating factor
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PAGE polyacrylamide gel electrophoresis
PAK1 p21-activated protein kinase 1
PBS phosphate buffered saline
PC phosphatidylcholine
PDGF platelet-derived growth factor
PDZ PSD-95/DlgA/ZO-1
PE phosphatidylethanolamine
PEST sequences that are rich in proline-P- glutamic acid-E- serine-S- and
threonine-T-)
PH pleckstrin homology domain
PI phosphatidylinositol
PI3 ,4 ,5 P3  phosphatidylinositol 3,4,5-triphosphate
PI3 ,4 P2  phosphatidylinositol 3,4-bisphosphate
PI3K phosphatidylinositol 3-kinase
PI3P phosphatidylinositol 3-phosphate
PI4 ,5 P2  phosphatidylinositol 4,5-bisphosphate
PI4K phosphatidylinositol 4-kinase
PI4P phosphatidylinositol 4-sphosphate
PIK phosphatidylinositol kinase
PIKs phosphoinositide kinases
PIP4K phosphatidylinositol 5-phosphate 4-kinase
PIP5K phosphatidylinositol 4-phosphate 5-kinase
PIPK phosphatidylinositol monophosphate kinase
PIX PAK-interactive exchange factor
PKC protein kinase C
PLA2  phospholipase A2
PLC phospholipase C
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PLD phospholipase D
PMA Phorbol 12-Myristate 13-Acetate
PMSF Phenylmethylsulphonyl fluoride
PTX pertussis toxin
PX phox homology domain
RBD Ras-binding domain
rpm revolutions per minute
RTK Tyrosine kinase receptors
SIP sphingosine-1 - phosphate
SDS Sodium dodecyl sulphate
SH Src homology domain
SHD N -terminal Scar homology domain. Subsequently,
Src Rous sarcoma virus kinase
Swiss 3T3 3T3 Swiss albin, mouse fibroblast
TBS 150 mM NaCl, 50 mM Tris-HCl pH 7.5
TIAM1 T-lymphoma cells as an invasion- and metastasis-inducing gene
TRIS tris(hydroxymethyl)aminomethane
TRITC tetramethylrhodamineisothiocyanate
Ts temperature sensitive
TTBS 0.05% Tween 20,150 mM NaCl, 50 mM Tris-HCl pH 7.5
U unit
VCA verprolin-cofilin-homology-acidic
WASP Wiskot-Aldrich-syndrome protein
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